#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=EEG coherence related to fMRI resting state synchrony in long-term abstinent alcoholics
#Text=Recent work suggests that faulty co-activation or synchrony of multiple brain regions comprising “networks,” or an imbalance between opposing brain networks, is important in alcoholism.
1-1	0-3	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
1-2	4-13	coherence	_	
1-3	14-21	related	_	
1-4	22-24	to	_	
1-5	25-29	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]|http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[2]	
1-6	30-37	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]	
1-7	38-43	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]	
1-8	44-53	synchrony	_	
1-9	54-56	in	_	
1-10	57-66	long-term	_	
1-11	67-76	abstinent	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent[3]	
1-12	77-87	alcoholics	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent[3]	
1-13	88-94	Recent	_	
1-14	95-99	work	_	
1-15	100-108	suggests	_	
1-16	109-113	that	_	
1-17	114-120	faulty	_	
1-18	121-134	co-activation	_	
1-19	135-137	or	_	
1-20	138-147	synchrony	_	
1-21	148-150	of	_	
1-22	151-159	multiple	_	
1-23	160-165	brain	_	
1-24	166-173	regions	_	
1-25	174-184	comprising	_	
1-26	185-186	“	_	
1-27	186-194	networks	_	
1-28	194-195	,	_	
1-29	195-196	”	_	
1-30	197-199	or	_	
1-31	200-202	an	_	
1-32	203-212	imbalance	_	
1-33	213-220	between	_	
1-34	221-229	opposing	_	
1-35	230-235	brain	_	
1-36	236-244	networks	_	
1-37	244-245	,	_	
1-38	246-248	is	_	
1-39	249-258	important	_	
1-40	259-261	in	_	
1-41	262-272	alcoholism	_	
1-42	272-273	.	_	

#Text=Previous studies showed higher fMRI resting state synchrony (RSS) within the executive control (inhibitory control and emotion regulation) networks and lower RSS within the appetitive drive network in long-term (multi-year) abstinent alcoholics (LTAA) vs. non substance abusing controls (NSAC).
2-1	274-282	Previous	_	
2-2	283-290	studies	_	
2-3	291-297	showed	_	
2-4	298-304	higher	_	
2-5	305-309	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[4]|http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[5]	
2-6	310-317	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[4]	
2-7	318-323	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[4]	
2-8	324-333	synchrony	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[4]	
2-9	334-335	(	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[4]	
2-10	335-338	RSS	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[4]	
2-11	338-339	)	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[4]	
2-12	340-346	within	_	
2-13	347-350	the	_	
2-14	351-360	executive	_	
2-15	361-368	control	_	
2-16	369-370	(	_	
2-17	370-380	inhibitory	_	
2-18	381-388	control	_	
2-19	389-392	and	_	
2-20	393-400	emotion	_	
2-21	401-411	regulation	_	
2-22	411-412	)	_	
2-23	413-421	networks	_	
2-24	422-425	and	_	
2-25	426-431	lower	_	
2-26	432-435	RSS	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging	
2-27	436-442	within	_	
2-28	443-446	the	_	
2-29	447-457	appetitive	_	
2-30	458-463	drive	_	
2-31	464-471	network	_	
2-32	472-474	in	_	
2-33	475-484	long-term	_	
2-34	485-486	(	_	
2-35	486-496	multi-year	_	
2-36	496-497	)	_	
2-37	498-507	abstinent	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent[6]	
2-38	508-518	alcoholics	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent[6]	
2-39	519-520	(	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent[6]	
2-40	520-524	LTAA	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent[6]	
2-41	524-525	)	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent[6]	
2-42	526-528	vs	_	
2-43	528-529	.	_	
2-44	530-533	non	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[7]	
2-45	534-543	substance	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[7]	
2-46	544-551	abusing	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[7]	
2-47	552-560	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[7]	
2-48	561-562	(	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[7]	
2-49	562-566	NSAC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[7]	
2-50	566-567	)	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[7]	
2-51	567-568	.	_	

#Text=Our goal was to identify EEG networks that are correlated with the appetitive drive and executive function networks identified with fMRI in our previous alcohol studies.
3-1	569-572	Our	_	
3-2	573-577	goal	_	
3-3	578-581	was	_	
3-4	582-584	to	_	
3-5	585-593	identify	_	
3-6	594-597	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
3-7	598-606	networks	_	
3-8	607-611	that	_	
3-9	612-615	are	_	
3-10	616-626	correlated	_	
3-11	627-631	with	_	
3-12	632-635	the	_	
3-13	636-646	appetitive	_	
3-14	647-652	drive	_	
3-15	653-656	and	_	
3-16	657-666	executive	_	
3-17	667-675	function	_	
3-18	676-684	networks	_	
3-19	685-695	identified	_	
3-20	696-700	with	_	
3-21	701-705	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging	
3-22	706-708	in	_	
3-23	709-712	our	_	
3-24	713-721	previous	_	
3-25	722-729	alcohol	_	
3-26	730-737	studies	_	
3-27	737-738	.	_	

#Text=We used parallel ICA for multimodal data fusion for the 20 LTAA and 21 NSAC that had both usable fMRI and 64-channel EEG data.
4-1	739-741	We	_	
4-2	742-746	used	_	
4-3	747-755	parallel	_	
4-4	756-759	ICA	_	
4-5	760-763	for	_	
4-6	764-774	multimodal	_	
4-7	775-779	data	_	
4-8	780-786	fusion	_	
4-9	787-790	for	_	
4-10	791-794	the	_	
4-11	795-797	20	_	
4-12	798-802	LTAA	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent	
4-13	803-806	and	_	
4-14	807-809	21	_	
4-15	810-814	NSAC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
4-16	815-819	that	_	
4-17	820-823	had	_	
4-18	824-828	both	_	
4-19	829-835	usable	_	
4-20	836-840	fMRI	_	
4-21	841-844	and	_	
4-22	845-847	64	_	
4-23	847-848	-	_	
4-24	848-855	channel	_	
4-25	856-859	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
4-26	860-864	data	_	
4-27	864-865	.	_	

#Text=Our major result was that parallel ICA identified a pair of components that significantly separated NSAC from LTAA and were correlated with each other.
5-1	866-869	Our	_	
5-2	870-875	major	_	
5-3	876-882	result	_	
5-4	883-886	was	_	
5-5	887-891	that	_	
5-6	892-900	parallel	_	
5-7	901-904	ICA	_	
5-8	905-915	identified	_	
5-9	916-917	a	_	
5-10	918-922	pair	_	
5-11	923-925	of	_	
5-12	926-936	components	_	
5-13	937-941	that	_	
5-14	942-955	significantly	_	
5-15	956-965	separated	_	
5-16	966-970	NSAC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
5-17	971-975	from	_	
5-18	976-980	LTAA	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent	
5-19	981-984	and	_	
5-20	985-989	were	_	
5-21	990-1000	correlated	_	
5-22	1001-1005	with	_	
5-23	1006-1010	each	_	
5-24	1011-1016	other	_	
5-25	1016-1017	.	_	

#Text=Examination of the resting-state fMRI seed-correlation map component showed higher bilateral nucleus accumbens seed-correlation in the dorsolateral prefrontal cortex bilaterally and lower seed-correlation in the thalamus.
6-1	1018-1029	Examination	_	
6-2	1030-1032	of	_	
6-3	1033-1036	the	_	
6-4	1037-1050	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[8]	
6-5	1051-1055	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[8]|http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[9]	
6-6	1056-1072	seed-correlation	_	
6-7	1073-1076	map	_	
6-8	1077-1086	component	_	
6-9	1087-1093	showed	_	
6-10	1094-1100	higher	_	
6-11	1101-1110	bilateral	_	
6-12	1111-1118	nucleus	_	
6-13	1119-1128	accumbens	_	
6-14	1129-1145	seed-correlation	_	
6-15	1146-1148	in	_	
6-16	1149-1152	the	_	
6-17	1153-1165	dorsolateral	_	
6-18	1166-1176	prefrontal	_	
6-19	1177-1183	cortex	_	
6-20	1184-1195	bilaterally	_	
6-21	1196-1199	and	_	
6-22	1200-1205	lower	_	
6-23	1206-1222	seed-correlation	_	
6-24	1223-1225	in	_	
6-25	1226-1229	the	_	
6-26	1230-1238	thalamus	_	
6-27	1238-1239	.	_	

#Text=This single component thus encompassed both the executive control and appetitive drive networks, consistent with our previous work.
7-1	1240-1244	This	_	
7-2	1245-1251	single	_	
7-3	1252-1261	component	_	
7-4	1262-1266	thus	_	
7-5	1267-1278	encompassed	_	
7-6	1279-1283	both	_	
7-7	1284-1287	the	_	
7-8	1288-1297	executive	_	
7-9	1298-1305	control	_	
7-10	1306-1309	and	_	
7-11	1310-1320	appetitive	_	
7-12	1321-1326	drive	_	
7-13	1327-1335	networks	_	
7-14	1335-1336	,	_	
7-15	1337-1347	consistent	_	
7-16	1348-1352	with	_	
7-17	1353-1356	our	_	
7-18	1357-1365	previous	_	
7-19	1366-1370	work	_	
7-20	1370-1371	.	_	

#Text=The correlated EEG coherence component showed mostly higher theta and alpha coherence in LTAA compared to NSAC, and lower gamma coherence in LTAA compared to NSAC.
8-1	1372-1375	The	_	
8-2	1376-1386	correlated	_	
8-3	1387-1390	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
8-4	1391-1400	coherence	_	
8-5	1401-1410	component	_	
8-6	1411-1417	showed	_	
8-7	1418-1424	mostly	_	
8-8	1425-1431	higher	_	
8-9	1432-1437	theta	_	
8-10	1438-1441	and	_	
8-11	1442-1447	alpha	_	
8-12	1448-1457	coherence	_	
8-13	1458-1460	in	_	
8-14	1461-1465	LTAA	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent	
8-15	1466-1474	compared	_	
8-16	1475-1477	to	_	
8-17	1478-1482	NSAC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
8-18	1482-1483	,	_	
8-19	1484-1487	and	_	
8-20	1488-1493	lower	_	
8-21	1494-1499	gamma	_	
8-22	1500-1509	coherence	_	
8-23	1510-1512	in	_	
8-24	1513-1517	LTAA	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent	
8-25	1518-1526	compared	_	
8-26	1527-1529	to	_	
8-27	1530-1534	NSAC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
8-28	1534-1535	.	_	

#Text=The EEG theta and alpha coherence results suggest enhanced top-down control in LTAA and the gamma coherence results suggest impaired appetitive drive in LTAA.
9-1	1536-1539	The	_	
9-2	1540-1543	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[10]|http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[11]	
9-3	1544-1549	theta	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[10]	
9-4	1550-1553	and	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[10]	
9-5	1554-1559	alpha	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[10]	
9-6	1560-1569	coherence	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[10]	
9-7	1570-1577	results	_	
9-8	1578-1585	suggest	_	
9-9	1586-1594	enhanced	_	
9-10	1595-1603	top-down	_	
9-11	1604-1611	control	_	
9-12	1612-1614	in	_	
9-13	1615-1619	LTAA	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent	
9-14	1620-1623	and	_	
9-15	1624-1627	the	_	
9-16	1628-1633	gamma	_	
9-17	1634-1643	coherence	_	
9-18	1644-1651	results	_	
9-19	1652-1659	suggest	_	
9-20	1660-1668	impaired	_	
9-21	1669-1679	appetitive	_	
9-22	1680-1685	drive	_	
9-23	1686-1688	in	_	
9-24	1689-1693	LTAA	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent	
9-25	1693-1694	.	_	

#Text=Our results support the notion that fMRI RSS is reflected in spontaneous EEG, even when the EEG and fMRI are not obtained simultaneously.
10-1	1695-1698	Our	_	
10-2	1699-1706	results	_	
10-3	1707-1714	support	_	
10-4	1715-1718	the	_	
10-5	1719-1725	notion	_	
10-6	1726-1730	that	_	
10-7	1731-1735	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[12]	
10-8	1736-1739	RSS	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[12]	
10-9	1740-1742	is	_	
10-10	1743-1752	reflected	_	
10-11	1753-1755	in	_	
10-12	1756-1767	spontaneous	_	
10-13	1768-1771	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
10-14	1771-1772	,	_	
10-15	1773-1777	even	_	
10-16	1778-1782	when	_	
10-17	1783-1786	the	_	
10-18	1787-1790	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
10-19	1791-1794	and	_	
10-20	1795-1799	fMRI	_	
10-21	1800-1803	are	_	
10-22	1804-1807	not	_	
10-23	1808-1816	obtained	_	
10-24	1817-1831	simultaneously	_	
10-25	1831-1832	.	_	

#Text=Highlights
#Text=fMRI and EEG were obtained for 20 long-term abstinent alcoholics and 21 controls.
11-1	1833-1843	Highlights	_	
11-2	1844-1848	fMRI	_	
11-3	1849-1852	and	_	
11-4	1853-1856	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
11-5	1857-1861	were	_	
11-6	1862-1870	obtained	_	
11-7	1871-1874	for	_	
11-8	1875-1877	20	_	
11-9	1878-1887	long-term	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent[13]	
11-10	1888-1897	abstinent	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent[13]	
11-11	1898-1908	alcoholics	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent[13]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[14]	
11-12	1909-1912	and	_	
11-13	1913-1915	21	_	
11-14	1916-1924	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
11-15	1924-1925	.	_	

#Text=Parallel ICA was used to identify analogous networks in each modality.
12-1	1926-1934	Parallel	_	
12-2	1935-1938	ICA	_	
12-3	1939-1942	was	_	
12-4	1943-1947	used	_	
12-5	1948-1950	to	_	
12-6	1951-1959	identify	_	
12-7	1960-1969	analogous	_	
12-8	1970-1978	networks	_	
12-9	1979-1981	in	_	
12-10	1982-1986	each	_	
12-11	1987-1995	modality	_	
12-12	1995-1996	.	_	

#Text=One pair of components separated groups and were correlated across modalities.
#Text=fMRI component encompassed executive control and appetitive drive networks.
13-1	1997-2000	One	_	
13-2	2001-2005	pair	_	
13-3	2006-2008	of	_	
13-4	2009-2019	components	_	
13-5	2020-2029	separated	_	
13-6	2030-2036	groups	_	
13-7	2037-2040	and	_	
13-8	2041-2045	were	_	
13-9	2046-2056	correlated	_	
13-10	2057-2063	across	_	
13-11	2064-2074	modalities	_	
13-12	2074-2075	.	_	
13-13	2076-2080	fMRI	_	
13-14	2081-2090	component	_	
13-15	2091-2102	encompassed	_	
13-16	2103-2112	executive	_	
13-17	2113-2120	control	_	
13-18	2121-2124	and	_	
13-19	2125-2135	appetitive	_	
13-20	2136-2141	drive	_	
13-21	2142-2150	networks	_	
13-22	2150-2151	.	_	

#Text=EEG coherence component involves top-down control and appetitive drive.
14-1	2152-2155	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
14-2	2156-2165	coherence	_	
14-3	2166-2175	component	_	
14-4	2176-2184	involves	_	
14-5	2185-2193	top-down	_	
14-6	2194-2201	control	_	
14-7	2202-2205	and	_	
14-8	2206-2216	appetitive	_	
14-9	2217-2222	drive	_	
14-10	2222-2223	.	_	

#Text=Introduction
#Text=The diagnosis of alcoholism requires the continuing engagement in dangerous or risky drinking in the face of recurring negative consequences of the drinking behavior in the social, physical, work, or family domains.
15-1	2224-2236	Introduction	_	
15-2	2237-2240	The	_	
15-3	2241-2250	diagnosis	_	
15-4	2251-2253	of	_	
15-5	2254-2264	alcoholism	_	
15-6	2265-2273	requires	_	
15-7	2274-2277	the	_	
15-8	2278-2288	continuing	_	
15-9	2289-2299	engagement	_	
15-10	2300-2302	in	_	
15-11	2303-2312	dangerous	_	
15-12	2313-2315	or	_	
15-13	2316-2321	risky	_	
15-14	2322-2330	drinking	_	
15-15	2331-2333	in	_	
15-16	2334-2337	the	_	
15-17	2338-2342	face	_	
15-18	2343-2345	of	_	
15-19	2346-2355	recurring	_	
15-20	2356-2364	negative	_	
15-21	2365-2377	consequences	_	
15-22	2378-2380	of	_	
15-23	2381-2384	the	_	
15-24	2385-2393	drinking	_	
15-25	2394-2402	behavior	_	
15-26	2403-2405	in	_	
15-27	2406-2409	the	_	
15-28	2410-2416	social	_	
15-29	2416-2417	,	_	
15-30	2418-2426	physical	_	
15-31	2426-2427	,	_	
15-32	2428-2432	work	_	
15-33	2432-2433	,	_	
15-34	2434-2436	or	_	
15-35	2437-2443	family	_	
15-36	2444-2451	domains	_	
15-37	2451-2452	.	_	

#Text=This propensity toward continued hazardous drinking despite continuing consequences suggests that the short-term appetitive outcomes of drinking (e.g. intoxication, disinhibition) have greater control over behavior than do the potential short-term and long-term negative consequences of drinking (e.g., drunk driving arrests, liver disease, loss of family or job, etc.).
16-1	2453-2457	This	_	
16-2	2458-2468	propensity	_	
16-3	2469-2475	toward	_	
16-4	2476-2485	continued	_	
16-5	2486-2495	hazardous	_	
16-6	2496-2504	drinking	_	
16-7	2505-2512	despite	_	
16-8	2513-2523	continuing	_	
16-9	2524-2536	consequences	_	
16-10	2537-2545	suggests	_	
16-11	2546-2550	that	_	
16-12	2551-2554	the	_	
16-13	2555-2565	short-term	_	
16-14	2566-2576	appetitive	_	
16-15	2577-2585	outcomes	_	
16-16	2586-2588	of	_	
16-17	2589-2597	drinking	_	
16-18	2598-2599	(	_	
16-19	2599-2602	e.g	_	
16-20	2602-2603	.	_	
16-21	2604-2616	intoxication	_	
16-22	2616-2617	,	_	
16-23	2618-2631	disinhibition	_	
16-24	2631-2632	)	_	
16-25	2633-2637	have	_	
16-26	2638-2645	greater	_	
16-27	2646-2653	control	_	
16-28	2654-2658	over	_	
16-29	2659-2667	behavior	_	
16-30	2668-2672	than	_	
16-31	2673-2675	do	_	
16-32	2676-2679	the	_	
16-33	2680-2689	potential	_	
16-34	2690-2700	short-term	_	
16-35	2701-2704	and	_	
16-36	2705-2714	long-term	_	
16-37	2715-2723	negative	_	
16-38	2724-2736	consequences	_	
16-39	2737-2739	of	_	
16-40	2740-2748	drinking	_	
16-41	2749-2750	(	_	
16-42	2750-2753	e.g	_	
16-43	2753-2754	.	_	
16-44	2754-2755	,	_	
16-45	2756-2761	drunk	_	
16-46	2762-2769	driving	_	
16-47	2770-2777	arrests	_	
16-48	2777-2778	,	_	
16-49	2779-2784	liver	_	
16-50	2785-2792	disease	_	
16-51	2792-2793	,	_	
16-52	2794-2798	loss	_	
16-53	2799-2801	of	_	
16-54	2802-2808	family	_	
16-55	2809-2811	or	_	
16-56	2812-2815	job	_	
16-57	2815-2816	,	_	
16-58	2817-2820	etc	_	
16-59	2820-2821	.	_	
16-60	2821-2822	)	_	
16-61	2822-2823	.	_	

#Text=From a neurobiological perspective this pattern implies weak “top-down” executive control over impulsive and compulsive urges to consume alcohol, and a strong “bottom-up” appetitive drive to impulsively and compulsively consume alcohol.
17-1	2824-2828	From	_	
17-2	2829-2830	a	_	
17-3	2831-2846	neurobiological	_	
17-4	2847-2858	perspective	_	
17-5	2859-2863	this	_	
17-6	2864-2871	pattern	_	
17-7	2872-2879	implies	_	
17-8	2880-2884	weak	_	
17-9	2885-2886	“	_	
17-10	2886-2894	top-down	_	
17-11	2894-2895	”	_	
17-12	2896-2905	executive	_	
17-13	2906-2913	control	_	
17-14	2914-2918	over	_	
17-15	2919-2928	impulsive	_	
17-16	2929-2932	and	_	
17-17	2933-2943	compulsive	_	
17-18	2944-2949	urges	_	
17-19	2950-2952	to	_	
17-20	2953-2960	consume	_	
17-21	2961-2968	alcohol	_	
17-22	2968-2969	,	_	
17-23	2970-2973	and	_	
17-24	2974-2975	a	_	
17-25	2976-2982	strong	_	
17-26	2983-2984	“	_	
17-27	2984-2993	bottom-up	_	
17-28	2993-2994	”	_	
17-29	2995-3005	appetitive	_	
17-30	3006-3011	drive	_	
17-31	3012-3014	to	_	
17-32	3015-3026	impulsively	_	
17-33	3027-3030	and	_	
17-34	3031-3043	compulsively	_	
17-35	3044-3051	consume	_	
17-36	3052-3059	alcohol	_	
17-37	3059-3060	.	_	

#Text=In 2013, we measured social deviance proneness, antisocial disposition, and both lifetime and current antisocial symptoms in both short-term abstinent alcoholics (STAA) and long-term abstinent alcoholics (LTAA) compared to controls.
18-1	3061-3063	In	_	
18-2	3064-3068	2013	_	
18-3	3068-3069	,	_	
18-4	3070-3072	we	_	
18-5	3073-3081	measured	_	
18-6	3082-3088	social	_	
18-7	3089-3097	deviance	_	
18-8	3098-3107	proneness	_	
18-9	3107-3108	,	_	
18-10	3109-3119	antisocial	_	
18-11	3120-3131	disposition	_	
18-12	3131-3132	,	_	
18-13	3133-3136	and	_	
18-14	3137-3141	both	_	
18-15	3142-3150	lifetime	_	
18-16	3151-3154	and	_	
18-17	3155-3162	current	_	
18-18	3163-3173	antisocial	_	
18-19	3174-3182	symptoms	_	
18-20	3183-3185	in	_	
18-21	3186-3190	both	_	
18-22	3191-3201	short-term	_	
18-23	3202-3211	abstinent	_	
18-24	3212-3222	alcoholics	_	
18-25	3223-3224	(	_	
18-26	3224-3228	STAA	_	
18-27	3228-3229	)	_	
18-28	3230-3233	and	_	
18-29	3234-3243	long-term	_	
18-30	3244-3253	abstinent	_	
18-31	3254-3264	alcoholics	_	
18-32	3265-3266	(	_	
18-33	3266-3270	LTAA	_	
18-34	3270-3271	)	_	
18-35	3272-3280	compared	_	
18-36	3281-3283	to	_	
18-37	3284-3292	controls	_	
18-38	3292-3293	.	_	

#Text=Lifetime antisocial symptoms, social deviance proneness, and antisocial disposition were highly elevated in both STAA and LTAA.
19-1	3294-3302	Lifetime	_	
19-2	3303-3313	antisocial	_	
19-3	3314-3322	symptoms	_	
19-4	3322-3323	,	_	
19-5	3324-3330	social	_	
19-6	3331-3339	deviance	_	
19-7	3340-3349	proneness	_	
19-8	3349-3350	,	_	
19-9	3351-3354	and	_	
19-10	3355-3365	antisocial	_	
19-11	3366-3377	disposition	_	
19-12	3378-3382	were	_	
19-13	3383-3389	highly	_	
19-14	3390-3398	elevated	_	
19-15	3399-3401	in	_	
19-16	3402-3406	both	_	
19-17	3407-3411	STAA	_	
19-18	3412-3415	and	_	
19-19	3416-3420	LTAA	_	
19-20	3420-3421	.	_	

#Text=Current antisocial symptoms were dramatically reduced in LTAA compared to STAA, close to levels observed in controls.
20-1	3422-3429	Current	_	
20-2	3430-3440	antisocial	_	
20-3	3441-3449	symptoms	_	
20-4	3450-3454	were	_	
20-5	3455-3467	dramatically	_	
20-6	3468-3475	reduced	_	
20-7	3476-3478	in	_	
20-8	3479-3483	LTAA	_	
20-9	3484-3492	compared	_	
20-10	3493-3495	to	_	
20-11	3496-3500	STAA	_	
20-12	3500-3501	,	_	
20-13	3502-3507	close	_	
20-14	3508-3510	to	_	
20-15	3511-3517	levels	_	
20-16	3518-3526	observed	_	
20-17	3527-3529	in	_	
20-18	3530-3538	controls	_	
20-19	3538-3539	.	_	

#Text=In contrast, social deviance proneness and antisocial disposition remained highly elevated in LTAA, comparable to STAA.
21-1	3540-3542	In	_	
21-2	3543-3551	contrast	_	
21-3	3551-3552	,	_	
21-4	3553-3559	social	_	
21-5	3560-3568	deviance	_	
21-6	3569-3578	proneness	_	
21-7	3579-3582	and	_	
21-8	3583-3593	antisocial	_	
21-9	3594-3605	disposition	_	
21-10	3606-3614	remained	_	
21-11	3615-3621	highly	_	
21-12	3622-3630	elevated	_	
21-13	3631-3633	in	_	
21-14	3634-3638	LTAA	_	
21-15	3638-3639	,	_	
21-16	3640-3650	comparable	_	
21-17	3651-3653	to	_	
21-18	3654-3658	STAA	_	
21-19	3658-3659	.	_	

#Text=These findings suggest that antisocial behaviors are reduced in extended abstinence despite continued social deviance proneness and antisocial disposition, consistent with the notion that extended abstinence requires strong “top-down” executive control to inhibit deviance-prone tendencies.
22-1	3660-3665	These	_	
22-2	3666-3674	findings	_	
22-3	3675-3682	suggest	_	
22-4	3683-3687	that	_	
22-5	3688-3698	antisocial	_	
22-6	3699-3708	behaviors	_	
22-7	3709-3712	are	_	
22-8	3713-3720	reduced	_	
22-9	3721-3723	in	_	
22-10	3724-3732	extended	_	
22-11	3733-3743	abstinence	_	
22-12	3744-3751	despite	_	
22-13	3752-3761	continued	_	
22-14	3762-3768	social	_	
22-15	3769-3777	deviance	_	
22-16	3778-3787	proneness	_	
22-17	3788-3791	and	_	
22-18	3792-3802	antisocial	_	
22-19	3803-3814	disposition	_	
22-20	3814-3815	,	_	
22-21	3816-3826	consistent	_	
22-22	3827-3831	with	_	
22-23	3832-3835	the	_	
22-24	3836-3842	notion	_	
22-25	3843-3847	that	_	
22-26	3848-3856	extended	_	
22-27	3857-3867	abstinence	_	
22-28	3868-3876	requires	_	
22-29	3877-3883	strong	_	
22-30	3884-3885	“	_	
22-31	3885-3893	top-down	_	
22-32	3893-3894	”	_	
22-33	3895-3904	executive	_	
22-34	3905-3912	control	_	
22-35	3913-3915	to	_	
22-36	3916-3923	inhibit	_	
22-37	3924-3938	deviance-prone	_	
22-38	3939-3949	tendencies	_	
22-39	3949-3950	.	_	

#Text=The brain regions associated with executive control and appetitive drive have been extensively probed using functional magnetic resonance imaging (fMRI), and many observed differences in activation in these brain regions have been associated with alcohol use, abuse, and dependence, suggesting that multiple brain regions can contribute to the poor decision making and risky behaviors seen in alcoholism (for a review, see).
23-1	3951-3954	The	_	
23-2	3955-3960	brain	_	
23-3	3961-3968	regions	_	
23-4	3969-3979	associated	_	
23-5	3980-3984	with	_	
23-6	3985-3994	executive	_	
23-7	3995-4002	control	_	
23-8	4003-4006	and	_	
23-9	4007-4017	appetitive	_	
23-10	4018-4023	drive	_	
23-11	4024-4028	have	_	
23-12	4029-4033	been	_	
23-13	4034-4045	extensively	_	
23-14	4046-4052	probed	_	
23-15	4053-4058	using	_	
23-16	4059-4069	functional	_	
23-17	4070-4078	magnetic	_	
23-18	4079-4088	resonance	_	
23-19	4089-4096	imaging	_	
23-20	4097-4098	(	_	
23-21	4098-4102	fMRI	_	
23-22	4102-4103	)	_	
23-23	4103-4104	,	_	
23-24	4105-4108	and	_	
23-25	4109-4113	many	_	
23-26	4114-4122	observed	_	
23-27	4123-4134	differences	_	
23-28	4135-4137	in	_	
23-29	4138-4148	activation	_	
23-30	4149-4151	in	_	
23-31	4152-4157	these	_	
23-32	4158-4163	brain	_	
23-33	4164-4171	regions	_	
23-34	4172-4176	have	_	
23-35	4177-4181	been	_	
23-36	4182-4192	associated	_	
23-37	4193-4197	with	_	
23-38	4198-4205	alcohol	_	
23-39	4206-4209	use	_	
23-40	4209-4210	,	_	
23-41	4211-4216	abuse	_	
23-42	4216-4217	,	_	
23-43	4218-4221	and	_	
23-44	4222-4232	dependence	_	
23-45	4232-4233	,	_	
23-46	4234-4244	suggesting	_	
23-47	4245-4249	that	_	
23-48	4250-4258	multiple	_	
23-49	4259-4264	brain	_	
23-50	4265-4272	regions	_	
23-51	4273-4276	can	_	
23-52	4277-4287	contribute	_	
23-53	4288-4290	to	_	
23-54	4291-4294	the	_	
23-55	4295-4299	poor	_	
23-56	4300-4308	decision	_	
23-57	4309-4315	making	_	
23-58	4316-4319	and	_	
23-59	4320-4325	risky	_	
23-60	4326-4335	behaviors	_	
23-61	4336-4340	seen	_	
23-62	4341-4343	in	_	
23-63	4344-4354	alcoholism	_	
23-64	4355-4356	(	_	
23-65	4356-4359	for	_	
23-66	4360-4361	a	_	
23-67	4362-4368	review	_	
23-68	4368-4369	,	_	
23-69	4370-4373	see	_	
23-70	4373-4374	)	_	
23-71	4374-4375	.	_	

#Text=Recent work suggests that faulty co-activation or synchrony of multiple brain regions comprising “networks,” or an imbalance between opposing brain networks, is important in alcoholism.
24-1	4376-4382	Recent	_	
24-2	4383-4387	work	_	
24-3	4388-4396	suggests	_	
24-4	4397-4401	that	_	
24-5	4402-4408	faulty	_	
24-6	4409-4422	co-activation	_	
24-7	4423-4425	or	_	
24-8	4426-4435	synchrony	_	
24-9	4436-4438	of	_	
24-10	4439-4447	multiple	_	
24-11	4448-4453	brain	_	
24-12	4454-4461	regions	_	
24-13	4462-4472	comprising	_	
24-14	4473-4474	“	_	
24-15	4474-4482	networks	_	
24-16	4482-4483	,	_	
24-17	4483-4484	”	_	
24-18	4485-4487	or	_	
24-19	4488-4490	an	_	
24-20	4491-4500	imbalance	_	
24-21	4501-4508	between	_	
24-22	4509-4517	opposing	_	
24-23	4518-4523	brain	_	
24-24	4524-4532	networks	_	
24-25	4532-4533	,	_	
24-26	4534-4536	is	_	
24-27	4537-4546	important	_	
24-28	4547-4549	in	_	
24-29	4550-4560	alcoholism	_	
24-30	4560-4561	.	_	

#Text=Network synchrony is often referred to in the literature as “functional connectivity,” and resting state fMRI (rs-fMRI), electroencephalography (EEG), and magnetoencephalography (MEG) can be used to investigate different properties of brain networks, such as spatial specificity, magnitude of the synchrony among its constituent components, or timing of event processing.
25-1	4562-4569	Network	_	
25-2	4570-4579	synchrony	_	
25-3	4580-4582	is	_	
25-4	4583-4588	often	_	
25-5	4589-4597	referred	_	
25-6	4598-4600	to	_	
25-7	4601-4603	in	_	
25-8	4604-4607	the	_	
25-9	4608-4618	literature	_	
25-10	4619-4621	as	_	
25-11	4622-4623	“	_	
25-12	4623-4633	functional	_	
25-13	4634-4646	connectivity	_	
25-14	4646-4647	,	_	
25-15	4647-4648	”	_	
25-16	4649-4652	and	_	
25-17	4653-4660	resting	_	
25-18	4661-4666	state	_	
25-19	4667-4671	fMRI	_	
25-20	4672-4673	(	_	
25-21	4673-4680	rs-fMRI	_	
25-22	4680-4681	)	_	
25-23	4681-4682	,	_	
25-24	4683-4705	electroencephalography	_	
25-25	4706-4707	(	_	
25-26	4707-4710	EEG	_	
25-27	4710-4711	)	_	
25-28	4711-4712	,	_	
25-29	4713-4716	and	_	
25-30	4717-4739	magnetoencephalography	_	
25-31	4740-4741	(	_	
25-32	4741-4744	MEG	_	
25-33	4744-4745	)	_	
25-34	4746-4749	can	_	
25-35	4750-4752	be	_	
25-36	4753-4757	used	_	
25-37	4758-4760	to	_	
25-38	4761-4772	investigate	_	
25-39	4773-4782	different	_	
25-40	4783-4793	properties	_	
25-41	4794-4796	of	_	
25-42	4797-4802	brain	_	
25-43	4803-4811	networks	_	
25-44	4811-4812	,	_	
25-45	4813-4817	such	_	
25-46	4818-4820	as	_	
25-47	4821-4828	spatial	_	
25-48	4829-4840	specificity	_	
25-49	4840-4841	,	_	
25-50	4842-4851	magnitude	_	
25-51	4852-4854	of	_	
25-52	4855-4858	the	_	
25-53	4859-4868	synchrony	_	
25-54	4869-4874	among	_	
25-55	4875-4878	its	_	
25-56	4879-4890	constituent	_	
25-57	4891-4901	components	_	
25-58	4901-4902	,	_	
25-59	4903-4905	or	_	
25-60	4906-4912	timing	_	
25-61	4913-4915	of	_	
25-62	4916-4921	event	_	
25-63	4922-4932	processing	_	
25-64	4932-4933	.	_	

#Text=We previously observed in fMRI, higher resting state synchrony (RSS) within the executive control (inhibitory control and emotion regulation) networks and lower RSS within the appetitive drive network in long-term (multi-year) abstinent alcoholics (LTAA) vs non substance abusing controls (NSAC).
26-1	4934-4936	We	_	
26-2	4937-4947	previously	_	
26-3	4948-4956	observed	_	
26-4	4957-4959	in	_	
26-5	4960-4964	fMRI	_	
26-6	4964-4965	,	_	
26-7	4966-4972	higher	_	
26-8	4973-4980	resting	_	
26-9	4981-4986	state	_	
26-10	4987-4996	synchrony	_	
26-11	4997-4998	(	_	
26-12	4998-5001	RSS	_	
26-13	5001-5002	)	_	
26-14	5003-5009	within	_	
26-15	5010-5013	the	_	
26-16	5014-5023	executive	_	
26-17	5024-5031	control	_	
26-18	5032-5033	(	_	
26-19	5033-5043	inhibitory	_	
26-20	5044-5051	control	_	
26-21	5052-5055	and	_	
26-22	5056-5063	emotion	_	
26-23	5064-5074	regulation	_	
26-24	5074-5075	)	_	
26-25	5076-5084	networks	_	
26-26	5085-5088	and	_	
26-27	5089-5094	lower	_	
26-28	5095-5098	RSS	_	
26-29	5099-5105	within	_	
26-30	5106-5109	the	_	
26-31	5110-5120	appetitive	_	
26-32	5121-5126	drive	_	
26-33	5127-5134	network	_	
26-34	5135-5137	in	_	
26-35	5138-5147	long-term	_	
26-36	5148-5149	(	_	
26-37	5149-5159	multi-year	_	
26-38	5159-5160	)	_	
26-39	5161-5170	abstinent	_	
26-40	5171-5181	alcoholics	_	
26-41	5182-5183	(	_	
26-42	5183-5187	LTAA	_	
26-43	5187-5188	)	_	
26-44	5189-5191	vs	_	
26-45	5192-5195	non	_	
26-46	5196-5205	substance	_	
26-47	5206-5213	abusing	_	
26-48	5214-5222	controls	_	
26-49	5223-5224	(	_	
26-50	5224-5228	NSAC	_	
26-51	5228-5229	)	_	
26-52	5229-5230	.	_	

#Text=We found similar effects, although to a lesser degree, in short-term (~ 6–15 weeks abstinent) abstinent alcoholics (STAA).
27-1	5231-5233	We	_	
27-2	5234-5239	found	_	
27-3	5240-5247	similar	_	
27-4	5248-5255	effects	_	
27-5	5255-5256	,	_	
27-6	5257-5265	although	_	
27-7	5266-5268	to	_	
27-8	5269-5270	a	_	
27-9	5271-5277	lesser	_	
27-10	5278-5284	degree	_	
27-11	5284-5285	,	_	
27-12	5286-5288	in	_	
27-13	5289-5299	short-term	_	
27-14	5300-5301	(	_	
27-15	5301-5302	~	_	
27-16	5302-5303	 	_	
27-17	5303-5304	6	_	
27-18	5304-5305	–	_	
27-19	5305-5307	15	_	
27-20	5307-5308	 	_	
27-21	5308-5313	weeks	_	
27-22	5314-5323	abstinent	_	
27-23	5323-5324	)	_	
27-24	5325-5334	abstinent	_	
27-25	5335-5345	alcoholics	_	
27-26	5346-5347	(	_	
27-27	5347-5351	STAA	_	
27-28	5351-5352	)	_	
27-29	5352-5353	.	_	

#Text=We believe these cross-sectional differences reflect adaptive changes that support abstinence both because of the observation of graded effects in short-term vs. long-term abstinence and because these networks play important roles in the changes needed for continued abstinence, where inhibiting behavior and reducing appetitive drive are central.
28-1	5354-5356	We	_	
28-2	5357-5364	believe	_	
28-3	5365-5370	these	_	
28-4	5371-5386	cross-sectional	_	
28-5	5387-5398	differences	_	
28-6	5399-5406	reflect	_	
28-7	5407-5415	adaptive	_	
28-8	5416-5423	changes	_	
28-9	5424-5428	that	_	
28-10	5429-5436	support	_	
28-11	5437-5447	abstinence	_	
28-12	5448-5452	both	_	
28-13	5453-5460	because	_	
28-14	5461-5463	of	_	
28-15	5464-5467	the	_	
28-16	5468-5479	observation	_	
28-17	5480-5482	of	_	
28-18	5483-5489	graded	_	
28-19	5490-5497	effects	_	
28-20	5498-5500	in	_	
28-21	5501-5511	short-term	_	
28-22	5512-5514	vs	_	
28-23	5514-5515	.	_	
28-24	5516-5525	long-term	_	
28-25	5526-5536	abstinence	_	
28-26	5537-5540	and	_	
28-27	5541-5548	because	_	
28-28	5549-5554	these	_	
28-29	5555-5563	networks	_	
28-30	5564-5568	play	_	
28-31	5569-5578	important	_	
28-32	5579-5584	roles	_	
28-33	5585-5587	in	_	
28-34	5588-5591	the	_	
28-35	5592-5599	changes	_	
28-36	5600-5606	needed	_	
28-37	5607-5610	for	_	
28-38	5611-5620	continued	_	
28-39	5621-5631	abstinence	_	
28-40	5631-5632	,	_	
28-41	5633-5638	where	_	
28-42	5639-5649	inhibiting	_	
28-43	5650-5658	behavior	_	
28-44	5659-5662	and	_	
28-45	5663-5671	reducing	_	
28-46	5672-5682	appetitive	_	
28-47	5683-5688	drive	_	
28-48	5689-5692	are	_	
28-49	5693-5700	central	_	
28-50	5700-5701	.	_	

#Text=If it can be confirmed in longitudinal studies that the degree of these changes in the appetitive drive and executive control networks is associated with and predictive of successful abstinence, then interventions that directly augment these changes, such as neurofeedback that “feeds back” measures of brain network synchrony, may have treatment potential for recovering alcoholics.
29-1	5702-5704	If	_	
29-2	5705-5707	it	_	
29-3	5708-5711	can	_	
29-4	5712-5714	be	_	
29-5	5715-5724	confirmed	_	
29-6	5725-5727	in	_	
29-7	5728-5740	longitudinal	_	
29-8	5741-5748	studies	_	
29-9	5749-5753	that	_	
29-10	5754-5757	the	_	
29-11	5758-5764	degree	_	
29-12	5765-5767	of	_	
29-13	5768-5773	these	_	
29-14	5774-5781	changes	_	
29-15	5782-5784	in	_	
29-16	5785-5788	the	_	
29-17	5789-5799	appetitive	_	
29-18	5800-5805	drive	_	
29-19	5806-5809	and	_	
29-20	5810-5819	executive	_	
29-21	5820-5827	control	_	
29-22	5828-5836	networks	_	
29-23	5837-5839	is	_	
29-24	5840-5850	associated	_	
29-25	5851-5855	with	_	
29-26	5856-5859	and	_	
29-27	5860-5870	predictive	_	
29-28	5871-5873	of	_	
29-29	5874-5884	successful	_	
29-30	5885-5895	abstinence	_	
29-31	5895-5896	,	_	
29-32	5897-5901	then	_	
29-33	5902-5915	interventions	_	
29-34	5916-5920	that	_	
29-35	5921-5929	directly	_	
29-36	5930-5937	augment	_	
29-37	5938-5943	these	_	
29-38	5944-5951	changes	_	
29-39	5951-5952	,	_	
29-40	5953-5957	such	_	
29-41	5958-5960	as	_	
29-42	5961-5974	neurofeedback	_	
29-43	5975-5979	that	_	
29-44	5980-5981	“	_	
29-45	5981-5986	feeds	_	
29-46	5987-5991	back	_	
29-47	5991-5992	”	_	
29-48	5993-6001	measures	_	
29-49	6002-6004	of	_	
29-50	6005-6010	brain	_	
29-51	6011-6018	network	_	
29-52	6019-6028	synchrony	_	
29-53	6028-6029	,	_	
29-54	6030-6033	may	_	
29-55	6034-6038	have	_	
29-56	6039-6048	treatment	_	
29-57	6049-6058	potential	_	
29-58	6059-6062	for	_	
29-59	6063-6073	recovering	_	
29-60	6074-6084	alcoholics	_	
29-61	6084-6085	.	_	

#Text=Though technically possible, it is at present neither practical nor economically feasible to use neurofeedback to modify fMRI RSS.
30-1	6086-6092	Though	_	
30-2	6093-6104	technically	_	
30-3	6105-6113	possible	_	
30-4	6113-6114	,	_	
30-5	6115-6117	it	_	
30-6	6118-6120	is	_	
30-7	6121-6123	at	_	
30-8	6124-6131	present	_	
30-9	6132-6139	neither	_	
30-10	6140-6149	practical	_	
30-11	6150-6153	nor	_	
30-12	6154-6166	economically	_	
30-13	6167-6175	feasible	_	
30-14	6176-6178	to	_	
30-15	6179-6182	use	_	
30-16	6183-6196	neurofeedback	_	
30-17	6197-6199	to	_	
30-18	6200-6206	modify	_	
30-19	6207-6211	fMRI	_	
30-20	6212-6215	RSS	_	
30-21	6215-6216	.	_	

#Text=Furthermore, although fMRI provides high confidence in the identification of anatomical regions that contribute to the executive control and appetitive drive networks, it is unable to reflect the sequential neural activity underlying cognitive states of readiness or execution of a task due to the poor time resolution of the BOLD response, which at best is on the scale of hundreds of milliseconds, compared to the millisecond resolution of EEG.
31-1	6217-6228	Furthermore	_	
31-2	6228-6229	,	_	
31-3	6230-6238	although	_	
31-4	6239-6243	fMRI	_	
31-5	6244-6252	provides	_	
31-6	6253-6257	high	_	
31-7	6258-6268	confidence	_	
31-8	6269-6271	in	_	
31-9	6272-6275	the	_	
31-10	6276-6290	identification	_	
31-11	6291-6293	of	_	
31-12	6294-6304	anatomical	_	
31-13	6305-6312	regions	_	
31-14	6313-6317	that	_	
31-15	6318-6328	contribute	_	
31-16	6329-6331	to	_	
31-17	6332-6335	the	_	
31-18	6336-6345	executive	_	
31-19	6346-6353	control	_	
31-20	6354-6357	and	_	
31-21	6358-6368	appetitive	_	
31-22	6369-6374	drive	_	
31-23	6375-6383	networks	_	
31-24	6383-6384	,	_	
31-25	6385-6387	it	_	
31-26	6388-6390	is	_	
31-27	6391-6397	unable	_	
31-28	6398-6400	to	_	
31-29	6401-6408	reflect	_	
31-30	6409-6412	the	_	
31-31	6413-6423	sequential	_	
31-32	6424-6430	neural	_	
31-33	6431-6439	activity	_	
31-34	6440-6450	underlying	_	
31-35	6451-6460	cognitive	_	
31-36	6461-6467	states	_	
31-37	6468-6470	of	_	
31-38	6471-6480	readiness	_	
31-39	6481-6483	or	_	
31-40	6484-6493	execution	_	
31-41	6494-6496	of	_	
31-42	6497-6498	a	_	
31-43	6499-6503	task	_	
31-44	6504-6507	due	_	
31-45	6508-6510	to	_	
31-46	6511-6514	the	_	
31-47	6515-6519	poor	_	
31-48	6520-6524	time	_	
31-49	6525-6535	resolution	_	
31-50	6536-6538	of	_	
31-51	6539-6542	the	_	
31-52	6543-6547	BOLD	_	
31-53	6548-6556	response	_	
31-54	6556-6557	,	_	
31-55	6558-6563	which	_	
31-56	6564-6566	at	_	
31-57	6567-6571	best	_	
31-58	6572-6574	is	_	
31-59	6575-6577	on	_	
31-60	6578-6581	the	_	
31-61	6582-6587	scale	_	
31-62	6588-6590	of	_	
31-63	6591-6599	hundreds	_	
31-64	6600-6602	of	_	
31-65	6603-6615	milliseconds	_	
31-66	6615-6616	,	_	
31-67	6617-6625	compared	_	
31-68	6626-6628	to	_	
31-69	6629-6632	the	_	
31-70	6633-6644	millisecond	_	
31-71	6645-6655	resolution	_	
31-72	6656-6658	of	_	
31-73	6659-6662	EEG	_	
31-74	6662-6663	.	_	

#Text=Converging evidence suggests that the fMRI BOLD response reflects the summed neural activity of several oscillatory EEG networks (for a review, see).
32-1	6664-6674	Converging	_	
32-2	6675-6683	evidence	_	
32-3	6684-6692	suggests	_	
32-4	6693-6697	that	_	
32-5	6698-6701	the	_	
32-6	6702-6706	fMRI	_	
32-7	6707-6711	BOLD	_	
32-8	6712-6720	response	_	
32-9	6721-6729	reflects	_	
32-10	6730-6733	the	_	
32-11	6734-6740	summed	_	
32-12	6741-6747	neural	_	
32-13	6748-6756	activity	_	
32-14	6757-6759	of	_	
32-15	6760-6767	several	_	
32-16	6768-6779	oscillatory	_	
32-17	6780-6783	EEG	_	
32-18	6784-6792	networks	_	
32-19	6793-6794	(	_	
32-20	6794-6797	for	_	
32-21	6798-6799	a	_	
32-22	6800-6806	review	_	
32-23	6806-6807	,	_	
32-24	6808-6811	see	_	
32-25	6811-6812	)	_	
32-26	6812-6813	.	_	

#Text=These EEG networks may oscillate at multiple frequencies (e.g., theta, alpha, or gamma) and the activity of separate networks may vary as a function of cognitive states lasting only a few hundred milliseconds. fMRI networks involved in task processing are likely to be comprised of multiple oscillatory EEG networks reflecting both induced and evoked EEG responses, including those that derive from frequency-dependent changes in phase alignment.
33-1	6814-6819	These	_	
33-2	6820-6823	EEG	_	
33-3	6824-6832	networks	_	
33-4	6833-6836	may	_	
33-5	6837-6846	oscillate	_	
33-6	6847-6849	at	_	
33-7	6850-6858	multiple	_	
33-8	6859-6870	frequencies	_	
33-9	6871-6872	(	_	
33-10	6872-6875	e.g	_	
33-11	6875-6876	.	_	
33-12	6876-6877	,	_	
33-13	6878-6883	theta	_	
33-14	6883-6884	,	_	
33-15	6885-6890	alpha	_	
33-16	6890-6891	,	_	
33-17	6892-6894	or	_	
33-18	6895-6900	gamma	_	
33-19	6900-6901	)	_	
33-20	6902-6905	and	_	
33-21	6906-6909	the	_	
33-22	6910-6918	activity	_	
33-23	6919-6921	of	_	
33-24	6922-6930	separate	_	
33-25	6931-6939	networks	_	
33-26	6940-6943	may	_	
33-27	6944-6948	vary	_	
33-28	6949-6951	as	_	
33-29	6952-6953	a	_	
33-30	6954-6962	function	_	
33-31	6963-6965	of	_	
33-32	6966-6975	cognitive	_	
33-33	6976-6982	states	_	
33-34	6983-6990	lasting	_	
33-35	6991-6995	only	_	
33-36	6996-6997	a	_	
33-37	6998-7001	few	_	
33-38	7002-7009	hundred	_	
33-39	7010-7022	milliseconds	_	
33-40	7022-7023	.	_	
33-41	7024-7028	fMRI	_	
33-42	7029-7037	networks	_	
33-43	7038-7046	involved	_	
33-44	7047-7049	in	_	
33-45	7050-7054	task	_	
33-46	7055-7065	processing	_	
33-47	7066-7069	are	_	
33-48	7070-7076	likely	_	
33-49	7077-7079	to	_	
33-50	7080-7082	be	_	
33-51	7083-7092	comprised	_	
33-52	7093-7095	of	_	
33-53	7096-7104	multiple	_	
33-54	7105-7116	oscillatory	_	
33-55	7117-7120	EEG	_	
33-56	7121-7129	networks	_	
33-57	7130-7140	reflecting	_	
33-58	7141-7145	both	_	
33-59	7146-7153	induced	_	
33-60	7154-7157	and	_	
33-61	7158-7164	evoked	_	
33-62	7165-7168	EEG	_	
33-63	7169-7178	responses	_	
33-64	7178-7179	,	_	
33-65	7180-7189	including	_	
33-66	7190-7195	those	_	
33-67	7196-7200	that	_	
33-68	7201-7207	derive	_	
33-69	7208-7212	from	_	
33-70	7213-7232	frequency-dependent	_	
33-71	7233-7240	changes	_	
33-72	7241-7243	in	_	
33-73	7244-7249	phase	_	
33-74	7250-7259	alignment	_	
33-75	7259-7260	.	_	

#Text=Therefore, the identification of EEG networks underlying executive control and appetitive drive could potentially reveal more about the mechanisms underlying the processing and inhibition of the cascades consequent to alcohol cues that contribute to the maintenance of abstinence, because of the more complex nature of EEG measures of brain activity that dynamically change at the same pace as cognitive processes.
34-1	7261-7270	Therefore	_	
34-2	7270-7271	,	_	
34-3	7272-7275	the	_	
34-4	7276-7290	identification	_	
34-5	7291-7293	of	_	
34-6	7294-7297	EEG	_	
34-7	7298-7306	networks	_	
34-8	7307-7317	underlying	_	
34-9	7318-7327	executive	_	
34-10	7328-7335	control	_	
34-11	7336-7339	and	_	
34-12	7340-7350	appetitive	_	
34-13	7351-7356	drive	_	
34-14	7357-7362	could	_	
34-15	7363-7374	potentially	_	
34-16	7375-7381	reveal	_	
34-17	7382-7386	more	_	
34-18	7387-7392	about	_	
34-19	7393-7396	the	_	
34-20	7397-7407	mechanisms	_	
34-21	7408-7418	underlying	_	
34-22	7419-7422	the	_	
34-23	7423-7433	processing	_	
34-24	7434-7437	and	_	
34-25	7438-7448	inhibition	_	
34-26	7449-7451	of	_	
34-27	7452-7455	the	_	
34-28	7456-7464	cascades	_	
34-29	7465-7475	consequent	_	
34-30	7476-7478	to	_	
34-31	7479-7486	alcohol	_	
34-32	7487-7491	cues	_	
34-33	7492-7496	that	_	
34-34	7497-7507	contribute	_	
34-35	7508-7510	to	_	
34-36	7511-7514	the	_	
34-37	7515-7526	maintenance	_	
34-38	7527-7529	of	_	
34-39	7530-7540	abstinence	_	
34-40	7540-7541	,	_	
34-41	7542-7549	because	_	
34-42	7550-7552	of	_	
34-43	7553-7556	the	_	
34-44	7557-7561	more	_	
34-45	7562-7569	complex	_	
34-46	7570-7576	nature	_	
34-47	7577-7579	of	_	
34-48	7580-7583	EEG	_	
34-49	7584-7592	measures	_	
34-50	7593-7595	of	_	
34-51	7596-7601	brain	_	
34-52	7602-7610	activity	_	
34-53	7611-7615	that	_	
34-54	7616-7627	dynamically	_	
34-55	7628-7634	change	_	
34-56	7635-7637	at	_	
34-57	7638-7641	the	_	
34-58	7642-7646	same	_	
34-59	7647-7651	pace	_	
34-60	7652-7654	as	_	
34-61	7655-7664	cognitive	_	
34-62	7665-7674	processes	_	
34-63	7674-7675	.	_	

#Text=Other researchers have explored brain networks derived from scalp-recorded EEGs and their relationship to rs-fMRI networks.
35-1	7676-7681	Other	_	
35-2	7682-7693	researchers	_	
35-3	7694-7698	have	_	
35-4	7699-7707	explored	_	
35-5	7708-7713	brain	_	
35-6	7714-7722	networks	_	
35-7	7723-7730	derived	_	
35-8	7731-7735	from	_	
35-9	7736-7750	scalp-recorded	_	
35-10	7751-7755	EEGs	_	
35-11	7756-7759	and	_	
35-12	7760-7765	their	_	
35-13	7766-7778	relationship	_	
35-14	7779-7781	to	_	
35-15	7782-7789	rs-fMRI	_	
35-16	7790-7798	networks	_	
35-17	7798-7799	.	_	

#Text=Earlier work used low-resolution electromagnetic tomography (LORETA) to estimate cortical EEG sources and independent components analysis (ICA) to identify source networks, and demonstrated EEG networks involving similar cortical regions to those of rs-fMRI networks from the literature.
36-1	7800-7807	Earlier	_	
36-2	7808-7812	work	_	
36-3	7813-7817	used	_	
36-4	7818-7832	low-resolution	_	
36-5	7833-7848	electromagnetic	_	
36-6	7849-7859	tomography	_	
36-7	7860-7861	(	_	
36-8	7861-7867	LORETA	_	
36-9	7867-7868	)	_	
36-10	7869-7871	to	_	
36-11	7872-7880	estimate	_	
36-12	7881-7889	cortical	_	
36-13	7890-7893	EEG	_	
36-14	7894-7901	sources	_	
36-15	7902-7905	and	_	
36-16	7906-7917	independent	_	
36-17	7918-7928	components	_	
36-18	7929-7937	analysis	_	
36-19	7938-7939	(	_	
36-20	7939-7942	ICA	_	
36-21	7942-7943	)	_	
36-22	7944-7946	to	_	
36-23	7947-7955	identify	_	
36-24	7956-7962	source	_	
36-25	7963-7971	networks	_	
36-26	7971-7972	,	_	
36-27	7973-7976	and	_	
36-28	7977-7989	demonstrated	_	
36-29	7990-7993	EEG	_	
36-30	7994-8002	networks	_	
36-31	8003-8012	involving	_	
36-32	8013-8020	similar	_	
36-33	8021-8029	cortical	_	
36-34	8030-8037	regions	_	
36-35	8038-8040	to	_	
36-36	8041-8046	those	_	
36-37	8047-8049	of	_	
36-38	8050-8057	rs-fMRI	_	
36-39	8058-8066	networks	_	
36-40	8067-8071	from	_	
36-41	8072-8075	the	_	
36-42	8076-8086	literature	_	
36-43	8086-8087	.	_	

#Text=More recent work studied the effect of acute alcohol intake on the brain's resting state network in social drinkers, by examining the magnitude squared coherence between the activity of cortical sources of EEG within different frequency bands to construct brain networks.
37-1	8088-8092	More	_	
37-2	8093-8099	recent	_	
37-3	8100-8104	work	_	
37-4	8105-8112	studied	_	
37-5	8113-8116	the	_	
37-6	8117-8123	effect	_	
37-7	8124-8126	of	_	
37-8	8127-8132	acute	_	
37-9	8133-8140	alcohol	_	
37-10	8141-8147	intake	_	
37-11	8148-8150	on	_	
37-12	8151-8154	the	_	
37-13	8155-8162	brain's	_	
37-14	8163-8170	resting	_	
37-15	8171-8176	state	_	
37-16	8177-8184	network	_	
37-17	8185-8187	in	_	
37-18	8188-8194	social	_	
37-19	8195-8203	drinkers	_	
37-20	8203-8204	,	_	
37-21	8205-8207	by	_	
37-22	8208-8217	examining	_	
37-23	8218-8221	the	_	
37-24	8222-8231	magnitude	_	
37-25	8232-8239	squared	_	
37-26	8240-8249	coherence	_	
37-27	8250-8257	between	_	
37-28	8258-8261	the	_	
37-29	8262-8270	activity	_	
37-30	8271-8273	of	_	
37-31	8274-8282	cortical	_	
37-32	8283-8290	sources	_	
37-33	8291-8293	of	_	
37-34	8294-8297	EEG	_	
37-35	8298-8304	within	_	
37-36	8305-8314	different	_	
37-37	8315-8324	frequency	_	
37-38	8325-8330	bands	_	
37-39	8331-8333	to	_	
37-40	8334-8343	construct	_	
37-41	8344-8349	brain	_	
37-42	8350-8358	networks	_	
37-43	8358-8359	.	_	

#Text=Our goal in this paper is to identify EEG networks that are correlated with the appetitive drive and executive function networks identified in our previous alcohol studies.
38-1	8360-8363	Our	_	
38-2	8364-8368	goal	_	
38-3	8369-8371	in	_	
38-4	8372-8376	this	_	
38-5	8377-8382	paper	_	
38-6	8383-8385	is	_	
38-7	8386-8388	to	_	
38-8	8389-8397	identify	_	
38-9	8398-8401	EEG	_	
38-10	8402-8410	networks	_	
38-11	8411-8415	that	_	
38-12	8416-8419	are	_	
38-13	8420-8430	correlated	_	
38-14	8431-8435	with	_	
38-15	8436-8439	the	_	
38-16	8440-8450	appetitive	_	
38-17	8451-8456	drive	_	
38-18	8457-8460	and	_	
38-19	8461-8470	executive	_	
38-20	8471-8479	function	_	
38-21	8480-8488	networks	_	
38-22	8489-8499	identified	_	
38-23	8500-8502	in	_	
38-24	8503-8506	our	_	
38-25	8507-8515	previous	_	
38-26	8516-8523	alcohol	_	
38-27	8524-8531	studies	_	
38-28	8531-8532	.	_	

#Text=We use parallel ICA for multimodal data fusion between the rs-fMRI and resting state EEG for the 20 LTAA and 21 NSAC from our prior study that had both usable fMRI and 64-channel EEG data.
39-1	8533-8535	We	_	
39-2	8536-8539	use	_	
39-3	8540-8548	parallel	_	
39-4	8549-8552	ICA	_	
39-5	8553-8556	for	_	
39-6	8557-8567	multimodal	_	
39-7	8568-8572	data	_	
39-8	8573-8579	fusion	_	
39-9	8580-8587	between	_	
39-10	8588-8591	the	_	
39-11	8592-8599	rs-fMRI	_	
39-12	8600-8603	and	_	
39-13	8604-8611	resting	_	
39-14	8612-8617	state	_	
39-15	8618-8621	EEG	_	
39-16	8622-8625	for	_	
39-17	8626-8629	the	_	
39-18	8630-8632	20	_	
39-19	8633-8637	LTAA	_	
39-20	8638-8641	and	_	
39-21	8642-8644	21	_	
39-22	8645-8649	NSAC	_	
39-23	8650-8654	from	_	
39-24	8655-8658	our	_	
39-25	8659-8664	prior	_	
39-26	8665-8670	study	_	
39-27	8671-8675	that	_	
39-28	8676-8679	had	_	
39-29	8680-8684	both	_	
39-30	8685-8691	usable	_	
39-31	8692-8696	fMRI	_	
39-32	8697-8700	and	_	
39-33	8701-8703	64	_	
39-34	8703-8704	-	_	
39-35	8704-8711	channel	_	
39-36	8712-8715	EEG	_	
39-37	8716-8720	data	_	
39-38	8720-8721	.	_	

#Text=This approach is well accepted in the medical image processing community and has been used for joint analysis of fMRI, structural MRI, EEG, and genetic data.
40-1	8722-8726	This	_	
40-2	8727-8735	approach	_	
40-3	8736-8738	is	_	
40-4	8739-8743	well	_	
40-5	8744-8752	accepted	_	
40-6	8753-8755	in	_	
40-7	8756-8759	the	_	
40-8	8760-8767	medical	_	
40-9	8768-8773	image	_	
40-10	8774-8784	processing	_	
40-11	8785-8794	community	_	
40-12	8795-8798	and	_	
40-13	8799-8802	has	_	
40-14	8803-8807	been	_	
40-15	8808-8812	used	_	
40-16	8813-8816	for	_	
40-17	8817-8822	joint	_	
40-18	8823-8831	analysis	_	
40-19	8832-8834	of	_	
40-20	8835-8839	fMRI	_	
40-21	8839-8840	,	_	
40-22	8841-8851	structural	_	
40-23	8852-8855	MRI	_	
40-24	8855-8856	,	_	
40-25	8857-8860	EEG	_	
40-26	8860-8861	,	_	
40-27	8862-8865	and	_	
40-28	8866-8873	genetic	_	
40-29	8874-8878	data	_	
40-30	8878-8879	.	_	

#Text=Parallel ICA allows us to consider two sets of extracted features from each subject's data (e.g., fMRI seed connectivity map and the resting state EEG coherence maps for each subject) and identify components that contribute in a similar way to each subject and are “linked.”
41-1	8880-8888	Parallel	_	
41-2	8889-8892	ICA	_	
41-3	8893-8899	allows	_	
41-4	8900-8902	us	_	
41-5	8903-8905	to	_	
41-6	8906-8914	consider	_	
41-7	8915-8918	two	_	
41-8	8919-8923	sets	_	
41-9	8924-8926	of	_	
41-10	8927-8936	extracted	_	
41-11	8937-8945	features	_	
41-12	8946-8950	from	_	
41-13	8951-8955	each	_	
41-14	8956-8965	subject's	_	
41-15	8966-8970	data	_	
41-16	8971-8972	(	_	
41-17	8972-8975	e.g	_	
41-18	8975-8976	.	_	
41-19	8976-8977	,	_	
41-20	8978-8982	fMRI	_	
41-21	8983-8987	seed	_	
41-22	8988-9000	connectivity	_	
41-23	9001-9004	map	_	
41-24	9005-9008	and	_	
41-25	9009-9012	the	_	
41-26	9013-9020	resting	_	
41-27	9021-9026	state	_	
41-28	9027-9030	EEG	_	
41-29	9031-9040	coherence	_	
41-30	9041-9045	maps	_	
41-31	9046-9049	for	_	
41-32	9050-9054	each	_	
41-33	9055-9062	subject	_	
41-34	9062-9063	)	_	
41-35	9064-9067	and	_	
41-36	9068-9076	identify	_	
41-37	9077-9087	components	_	
41-38	9088-9092	that	_	
41-39	9093-9103	contribute	_	
41-40	9104-9106	in	_	
41-41	9107-9108	a	_	
41-42	9109-9116	similar	_	
41-43	9117-9120	way	_	
41-44	9121-9123	to	_	
41-45	9124-9128	each	_	
41-46	9129-9136	subject	_	
41-47	9137-9140	and	_	
41-48	9141-9144	are	_	
41-49	9145-9146	“	_	
41-50	9146-9152	linked	_	
41-51	9152-9153	.	_	
41-52	9153-9154	”	_	

#Text=In addition, we examined social deviance proneness, antisocial disposition, and both lifetime and current antisocial symptoms in our participants, to determine whether identified networks were accompanied by behavioral changes that implied enhanced “top-down” control.
42-1	9155-9157	In	_	
42-2	9158-9166	addition	_	
42-3	9166-9167	,	_	
42-4	9168-9170	we	_	
42-5	9171-9179	examined	_	
42-6	9180-9186	social	_	
42-7	9187-9195	deviance	_	
42-8	9196-9205	proneness	_	
42-9	9205-9206	,	_	
42-10	9207-9217	antisocial	_	
42-11	9218-9229	disposition	_	
42-12	9229-9230	,	_	
42-13	9231-9234	and	_	
42-14	9235-9239	both	_	
42-15	9240-9248	lifetime	_	
42-16	9249-9252	and	_	
42-17	9253-9260	current	_	
42-18	9261-9271	antisocial	_	
42-19	9272-9280	symptoms	_	
42-20	9281-9283	in	_	
42-21	9284-9287	our	_	
42-22	9288-9300	participants	_	
42-23	9300-9301	,	_	
42-24	9302-9304	to	_	
42-25	9305-9314	determine	_	
42-26	9315-9322	whether	_	
42-27	9323-9333	identified	_	
42-28	9334-9342	networks	_	
42-29	9343-9347	were	_	
42-30	9348-9359	accompanied	_	
42-31	9360-9362	by	_	
42-32	9363-9373	behavioral	_	
42-33	9374-9381	changes	_	
42-34	9382-9386	that	_	
42-35	9387-9394	implied	_	
42-36	9395-9403	enhanced	_	
42-37	9404-9405	“	_	
42-38	9405-9413	top-down	_	
42-39	9413-9414	”	_	
42-40	9415-9422	control	_	
42-41	9422-9423	.	_	

#Text=Methods
#Text=Participants
#Text=Twenty-three LTAA (abstinent 7.91 ± 7.80 years) were compared to 23 gender and age (35–60 years) comparable NSAC, as described in.
43-1	9424-9431	Methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod	
43-2	9432-9444	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-3	9445-9457	Twenty-three	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-4	9458-9462	LTAA	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#Abstinent[16]	
43-5	9463-9464	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#Abstinent[16]	
43-6	9464-9473	abstinent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#Abstinent[16]	
43-7	9474-9478	7.91	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-8	9478-9479	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-9	9479-9480	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-10	9480-9481	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-11	9481-9485	7.80	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-12	9485-9486	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-13	9486-9491	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-14	9491-9492	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-15	9493-9497	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-16	9498-9506	compared	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-17	9507-9509	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-18	9510-9512	23	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-19	9513-9519	gender	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-20	9520-9523	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-21	9524-9527	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-22	9528-9529	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-23	9529-9531	35	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-24	9531-9532	–	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-25	9532-9534	60	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-26	9534-9535	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-27	9535-9540	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-28	9540-9541	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-29	9542-9552	comparable	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-30	9553-9557	NSAC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[17]	
43-31	9557-9558	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-32	9559-9561	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-33	9562-9571	described	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-34	9572-9574	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
43-35	9574-9575	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	

#Text=LTAA met DSM-IV lifetime criteria for alcohol dependence but not for lifetime abuse or dependence on any other drugs of abuse (other than nicotine or caffeine).
44-1	9576-9580	LTAA	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#Abstinent[18]	
44-2	9581-9584	met	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-3	9585-9591	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-4	9592-9600	lifetime	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-5	9601-9609	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-6	9610-9613	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-7	9614-9621	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[19]	
44-8	9622-9632	dependence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[19]	
44-9	9633-9636	but	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-10	9637-9640	not	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-11	9641-9644	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-12	9645-9653	lifetime	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-13	9654-9659	abuse	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-14	9660-9662	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-15	9663-9673	dependence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-16	9674-9676	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-17	9677-9680	any	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-18	9681-9686	other	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-19	9687-9692	drugs	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-20	9693-9695	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-21	9696-9701	abuse	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-22	9702-9703	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-23	9703-9708	other	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-24	9709-9713	than	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-25	9714-9722	nicotine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-26	9723-9725	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-27	9726-9734	caffeine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-28	9734-9735	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
44-29	9735-9736	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	

#Text=Inclusion criteria for the NSAC group was a lifetime drinking average of < 30 standard drinks per month with no periods of drinking > 60 drinks per month, and no lifetime history of alcohol or substance abuse or dependence.
45-1	9737-9746	Inclusion	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-2	9747-9755	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-3	9756-9759	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-4	9760-9763	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-5	9764-9768	NSAC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[20]	
45-6	9769-9774	group	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-7	9775-9778	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-8	9779-9780	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-9	9781-9789	lifetime	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-10	9790-9798	drinking	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-11	9799-9806	average	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-12	9807-9809	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-13	9810-9811	<	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-14	9811-9812	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-15	9812-9814	30	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-16	9815-9823	standard	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-17	9824-9830	drinks	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-18	9831-9834	per	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-19	9835-9840	month	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-20	9841-9845	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-21	9846-9848	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-22	9849-9856	periods	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-23	9857-9859	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-24	9860-9868	drinking	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-25	9869-9870	>	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-26	9870-9871	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-27	9871-9873	60	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-28	9874-9880	drinks	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-29	9881-9884	per	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-30	9885-9890	month	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-31	9890-9891	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-32	9892-9895	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-33	9896-9898	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-34	9899-9907	lifetime	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-35	9908-9915	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-36	9916-9918	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-37	9919-9926	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[21]	
45-38	9927-9929	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-39	9930-9939	substance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorder[22]	
45-40	9940-9945	abuse	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorder[22]	
45-41	9946-9948	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-42	9949-9959	dependence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
45-43	9959-9960	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	

#Text=Participants received monetary compensation for their participation.
46-1	9961-9973	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
46-2	9974-9982	received	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
46-3	9983-9991	monetary	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
46-4	9992-10004	compensation	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
46-5	10005-10008	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
46-6	10009-10014	their	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
46-7	10015-10028	participation	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
46-8	10028-10029	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	

#Text=Exclusion criteria for both groups included: a) a significant history of head trauma or cranial surgery; b) current or lifetime history of diabetes, stroke, or hypertension that required medical intervention; c) current or lifetime history of a significant neurological disorder, including dementia; d) clinical or laboratory evidence of active hepatic disease; e) clinical evidence for Wernicke-Korsakoff syndrome, and f) lifetime diagnosis of schizophrenia or schizophreniform disorder, f) contraindications to MRI.
47-1	10030-10039	Exclusion	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-2	10040-10048	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-3	10049-10052	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-4	10053-10057	both	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-5	10058-10064	groups	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-6	10065-10073	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-7	10073-10074	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-8	10075-10076	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-9	10076-10077	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-10	10078-10079	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-11	10080-10091	significant	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-12	10092-10099	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-13	10100-10102	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-14	10103-10107	head	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-15	10108-10114	trauma	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-16	10115-10117	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-17	10118-10125	cranial	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-18	10126-10133	surgery	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-19	10133-10134	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-20	10135-10136	b	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-21	10136-10137	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-22	10138-10145	current	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-23	10146-10148	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-24	10149-10157	lifetime	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-25	10158-10165	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-26	10166-10168	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-27	10169-10177	diabetes	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-28	10177-10178	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-29	10179-10185	stroke	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-30	10185-10186	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-31	10187-10189	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-32	10190-10202	hypertension	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-33	10203-10207	that	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-34	10208-10216	required	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-35	10217-10224	medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-36	10225-10237	intervention	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-37	10237-10238	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-38	10239-10240	c	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-39	10240-10241	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-40	10242-10249	current	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-41	10250-10252	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-42	10253-10261	lifetime	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-43	10262-10269	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-44	10270-10272	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-45	10273-10274	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-46	10275-10286	significant	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-47	10287-10299	neurological	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-48	10300-10308	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-49	10308-10309	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-50	10310-10319	including	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-51	10320-10328	dementia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-52	10328-10329	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-53	10330-10331	d	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-54	10331-10332	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-55	10333-10341	clinical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-56	10342-10344	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-57	10345-10355	laboratory	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-58	10356-10364	evidence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-59	10365-10367	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-60	10368-10374	active	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-61	10375-10382	hepatic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-62	10383-10390	disease	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-63	10390-10391	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-64	10392-10393	e	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-65	10393-10394	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-66	10395-10403	clinical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-67	10404-10412	evidence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-68	10413-10416	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-69	10417-10435	Wernicke-Korsakoff	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-70	10436-10444	syndrome	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-71	10444-10445	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-72	10446-10449	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-73	10450-10451	f	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-74	10451-10452	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-75	10453-10461	lifetime	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-76	10462-10471	diagnosis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-77	10472-10474	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-78	10475-10488	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-79	10489-10491	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-80	10492-10508	schizophreniform	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-81	10509-10517	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-82	10517-10518	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-83	10519-10520	f	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-84	10520-10521	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-85	10522-10539	contraindications	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-86	10540-10542	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-87	10543-10546	MRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
47-88	10546-10547	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	

#Text=All subjects completed signed informed consent, as approved by our institutional review board (E&I Review Services, LLC, Corte Madera, CA), before study procedures commenced.
48-1	10548-10551	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-2	10552-10560	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-3	10561-10570	completed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-4	10571-10577	signed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-5	10578-10586	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-6	10587-10594	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-7	10594-10595	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-8	10596-10598	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-9	10599-10607	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-10	10608-10610	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-11	10611-10614	our	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-12	10615-10628	institutional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-13	10629-10635	review	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-14	10636-10641	board	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-15	10642-10643	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-16	10643-10644	E	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-17	10644-10645	&	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-18	10645-10646	I	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-19	10647-10653	Review	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-20	10654-10662	Services	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-21	10662-10663	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-22	10664-10667	LLC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-23	10667-10668	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-24	10669-10674	Corte	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-25	10675-10681	Madera	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-26	10681-10682	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-27	10683-10685	CA	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-28	10685-10686	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-29	10686-10687	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-30	10688-10694	before	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-31	10695-10700	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-32	10701-10711	procedures	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-33	10712-10721	commenced	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
48-34	10721-10722	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	

#Text=Participants were studied with fMRI, EEG, clinical, and neuropsychological testing.
49-1	10723-10735	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
49-2	10736-10740	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
49-3	10741-10748	studied	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
49-4	10749-10753	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
49-5	10754-10758	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]|http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[25]	
49-6	10758-10759	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
49-7	10760-10763	EEG	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]|http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[26]	
49-8	10763-10764	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
49-9	10765-10773	clinical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
49-10	10773-10774	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
49-11	10775-10778	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
49-12	10779-10797	neuropsychological	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
49-13	10798-10805	testing	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	
49-14	10805-10806	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]	

#Text=Ideally, all study procedures were completed within one month, but due to scheduling difficulties time between EEG and fMRI acquisition was sometimes longer.
50-1	10807-10814	Ideally	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
50-2	10814-10815	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
50-3	10816-10819	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
50-4	10820-10825	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
50-5	10826-10836	procedures	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
50-6	10837-10841	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
50-7	10842-10851	completed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
50-8	10852-10858	within	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
50-9	10859-10862	one	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
50-10	10863-10868	month	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
50-11	10868-10869	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
50-12	10870-10873	but	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
50-13	10874-10877	due	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
50-14	10878-10880	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
50-15	10881-10891	scheduling	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
50-16	10892-10904	difficulties	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
50-17	10905-10909	time	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
50-18	10910-10917	between	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
50-19	10918-10921	EEG	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[27]	
50-20	10922-10925	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
50-21	10926-10930	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[28]	
50-22	10931-10942	acquisition	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
50-23	10943-10946	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
50-24	10947-10956	sometimes	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
50-25	10957-10963	longer	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
50-26	10963-10964	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	

#Text=For the 41 participants that had both usable fMRI and EEG, 31 (76%) were acquired within one month, with the time between acquisitions of 6.57 ± 8.24 weeks for NSAC and 4.65 ± 9.48 weeks for LTAA (no difference between groups).
51-1	10965-10968	For	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-2	10969-10972	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-3	10973-10975	41	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-4	10976-10988	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-5	10989-10993	that	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-6	10994-10997	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-7	10998-11002	both	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-8	11003-11009	usable	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-9	11010-11014	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[29]	
51-10	11015-11018	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-11	11019-11022	EEG	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[30]	
51-12	11022-11023	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-13	11024-11026	31	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-14	11027-11028	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-15	11028-11031	76%	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-16	11031-11032	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-17	11033-11037	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-18	11038-11046	acquired	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-19	11047-11053	within	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-20	11054-11057	one	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-21	11058-11063	month	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-22	11063-11064	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-23	11065-11069	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-24	11070-11073	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-25	11074-11078	time	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-26	11079-11086	between	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-27	11087-11099	acquisitions	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-28	11100-11102	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-29	11103-11107	6.57	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-30	11107-11108	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-31	11108-11109	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-32	11109-11110	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-33	11110-11114	8.24	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-34	11114-11115	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-35	11115-11120	weeks	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-36	11121-11124	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-37	11125-11129	NSAC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[31]	
51-38	11130-11133	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-39	11134-11138	4.65	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-40	11138-11139	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-41	11139-11140	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-42	11140-11141	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-43	11141-11145	9.48	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-44	11145-11146	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-45	11146-11151	weeks	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-46	11152-11155	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-47	11156-11160	LTAA	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#Abstinent[32]	
51-48	11161-11162	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-49	11162-11164	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-50	11165-11175	difference	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-51	11176-11183	between	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-52	11184-11190	groups	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-53	11190-11191	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
51-54	11191-11192	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	

#Text=LTAA subjects were required to stay sober throughout the study and did not drink between EEG and fMRI acquisitions; NSAC were asked to abstain from alcohol for 24 h prior to any lab visit, but may have continued drinking at their usual low level of drinking between visits and their alcohol use between study procedures was not monitored.
52-1	11193-11197	LTAA	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#Abstinent[33]	
52-2	11198-11206	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-3	11207-11211	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-4	11212-11220	required	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-5	11221-11223	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-6	11224-11228	stay	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-7	11229-11234	sober	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-8	11235-11245	throughout	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-9	11246-11249	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-10	11250-11255	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-11	11256-11259	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-12	11260-11263	did	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-13	11264-11267	not	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-14	11268-11273	drink	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-15	11274-11281	between	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-16	11282-11285	EEG	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[34]	
52-17	11286-11289	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-18	11290-11294	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[35]	
52-19	11295-11307	acquisitions	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-20	11307-11308	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-21	11309-11313	NSAC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[36]	
52-22	11314-11318	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-23	11319-11324	asked	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-24	11325-11327	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-25	11328-11335	abstain	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-26	11336-11340	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-27	11341-11348	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-28	11349-11352	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-29	11353-11355	24	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-30	11355-11356	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-31	11356-11357	h	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-32	11358-11363	prior	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-33	11364-11366	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-34	11367-11370	any	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-35	11371-11374	lab	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-36	11375-11380	visit	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-37	11380-11381	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-38	11382-11385	but	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-39	11386-11389	may	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-40	11390-11394	have	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-41	11395-11404	continued	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-42	11405-11413	drinking	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-43	11414-11416	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-44	11417-11422	their	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-45	11423-11428	usual	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-46	11429-11432	low	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-47	11433-11438	level	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-48	11439-11441	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-49	11442-11450	drinking	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-50	11451-11458	between	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-51	11459-11465	visits	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-52	11466-11469	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-53	11470-11475	their	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-54	11476-11483	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-55	11484-11487	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-56	11488-11495	between	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-57	11496-11501	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-58	11502-11512	procedures	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-59	11513-11516	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-60	11517-11520	not	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-61	11521-11530	monitored	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
52-62	11530-11531	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	

#Text=A breathalyzer test (Intoximeters, Inc., St.
53-1	11532-11533	A	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
53-2	11534-11546	breathalyzer	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
53-3	11547-11551	test	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
53-4	11552-11553	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
53-5	11553-11565	Intoximeters	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
53-6	11565-11566	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
53-7	11567-11570	Inc	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
53-8	11570-11571	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
53-9	11571-11572	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
53-10	11573-11575	St	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
53-11	11575-11576	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	

#Text=Louis, MO) and a rapid oral fluid drug screen test (Innovacon Inc., San Diego, CA) for THC, amphetamines, methamphetamines, cocaine, opioids, and PCP was administered to all participants, with a negative result required for all participants at all sessions.
54-1	11577-11582	Louis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-2	11582-11583	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-3	11584-11586	MO	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-4	11586-11587	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-5	11588-11591	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-6	11592-11593	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-7	11594-11599	rapid	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-8	11600-11604	oral	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-9	11605-11610	fluid	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-10	11611-11615	drug	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-11	11616-11622	screen	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-12	11623-11627	test	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-13	11628-11629	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-14	11629-11638	Innovacon	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-15	11639-11642	Inc	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-16	11642-11643	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-17	11643-11644	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-18	11645-11648	San	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-19	11649-11654	Diego	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-20	11654-11655	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-21	11656-11658	CA	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-22	11658-11659	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-23	11660-11663	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-24	11664-11667	THC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-25	11667-11668	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-26	11669-11681	amphetamines	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-27	11681-11682	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-28	11683-11699	methamphetamines	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-29	11699-11700	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-30	11701-11708	cocaine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-31	11708-11709	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-32	11710-11717	opioids	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-33	11717-11718	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-34	11719-11722	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-35	11723-11726	PCP	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-36	11727-11730	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-37	11731-11743	administered	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-38	11744-11746	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-39	11747-11750	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-40	11751-11763	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-41	11763-11764	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-42	11765-11769	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-43	11770-11771	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-44	11772-11780	negative	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-45	11781-11787	result	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-46	11788-11796	required	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-47	11797-11800	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-48	11801-11804	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-49	11805-11817	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-50	11818-11820	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-51	11821-11824	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-52	11825-11833	sessions	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
54-53	11833-11834	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	

#Text=Clinical and psychological measures
#Text=Participants were interviewed on the lifetime use of alcohol and each drug that they had taken (including nicotine) using a timeline follow-back and lifetime drinking history assessment.
55-1	11835-11843	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-2	11844-11847	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-3	11848-11861	psychological	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-4	11862-11870	measures	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-5	11871-11883	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-6	11884-11888	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-7	11889-11900	interviewed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-8	11901-11903	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-9	11904-11907	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-10	11908-11916	lifetime	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-11	11917-11920	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-12	11921-11923	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-13	11924-11931	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-14	11932-11935	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-15	11936-11940	each	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-16	11941-11945	drug	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-17	11946-11950	that	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-18	11951-11955	they	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-19	11956-11959	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-20	11960-11965	taken	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-21	11966-11967	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-22	11967-11976	including	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-23	11977-11985	nicotine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-24	11985-11986	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-25	11987-11992	using	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-26	11993-11994	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-27	11995-12003	timeline	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-28	12004-12015	follow-back	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-29	12016-12019	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-30	12020-12028	lifetime	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-31	12029-12037	drinking	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-32	12038-12045	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-33	12046-12056	assessment	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
55-34	12056-12057	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	

#Text=ASPD symptoms were obtained using the C-DIS.
56-1	12058-12062	ASPD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
56-2	12063-12071	symptoms	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
56-3	12072-12076	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
56-4	12077-12085	obtained	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
56-5	12086-12091	using	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
56-6	12092-12095	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
56-7	12096-12101	C-DIS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
56-8	12101-12102	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	

#Text=For each symptom the subject endorsed, we asked about currency.
57-1	12103-12106	For	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
57-2	12107-12111	each	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
57-3	12112-12119	symptom	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
57-4	12120-12123	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
57-5	12124-12131	subject	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
57-6	12132-12140	endorsed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
57-7	12140-12141	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
57-8	12142-12144	we	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
57-9	12145-12150	asked	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
57-10	12151-12156	about	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
57-11	12157-12165	currency	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
57-12	12165-12166	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	

#Text=Psychological measures of antisocial behavior were also assessed.
58-1	12167-12180	Psychological	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
58-2	12181-12189	measures	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
58-3	12190-12192	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
58-4	12193-12203	antisocial	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
58-5	12204-12212	behavior	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
58-6	12213-12217	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
58-7	12218-12222	also	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
58-8	12223-12231	assessed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
58-9	12231-12232	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	

#Text=Social deviance proneness was measured by the CPI socialization scale, impulsivity was measured by the Eysenck impulsivity scale, and antisocial disposition was measured by the MMPI psychopathic deviance scale.
59-1	12233-12239	Social	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-2	12240-12248	deviance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-3	12249-12258	proneness	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-4	12259-12262	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-5	12263-12271	measured	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-6	12272-12274	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-7	12275-12278	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-8	12279-12282	CPI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-9	12283-12296	socialization	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-10	12297-12302	scale	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-11	12302-12303	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-12	12304-12315	impulsivity	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-13	12316-12319	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-14	12320-12328	measured	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-15	12329-12331	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-16	12332-12335	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-17	12336-12343	Eysenck	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-18	12344-12355	impulsivity	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-19	12356-12361	scale	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-20	12361-12362	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-21	12363-12366	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-22	12367-12377	antisocial	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-23	12378-12389	disposition	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-24	12390-12393	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-25	12394-12402	measured	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-26	12403-12405	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-27	12406-12409	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-28	12410-12414	MMPI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-29	12415-12427	psychopathic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-30	12428-12436	deviance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-31	12437-12442	scale	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
59-32	12442-12443	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	

#Text=Group comparisons on clinical and psychological measures were examined using the General Linear Model within SPSS (SPSS Inc. 2009).
60-1	12444-12449	Group	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
60-2	12450-12461	comparisons	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
60-3	12462-12464	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
60-4	12465-12473	clinical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
60-5	12474-12477	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
60-6	12478-12491	psychological	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
60-7	12492-12500	measures	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
60-8	12501-12505	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
60-9	12506-12514	examined	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
60-10	12515-12520	using	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
60-11	12521-12524	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
60-12	12525-12532	General	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
60-13	12533-12539	Linear	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
60-14	12540-12545	Model	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
60-15	12546-12552	within	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
60-16	12553-12557	SPSS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
60-17	12558-12559	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
60-18	12559-12563	SPSS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
60-19	12564-12567	Inc	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
60-20	12567-12568	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
60-21	12569-12573	2009	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
60-22	12573-12574	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]	
60-23	12574-12575	.	_	

#Text=Measures of effect size are the odds ratios for rate data and partial η2 (proportion of variance of the dependent variable independently accounted for by group) for symptom counts, psychological measures and other demographic variables.
#Text=fMRI acquisition and processing
#Text=Resting functional magnetic resonance (fMRI) data were collected using a twelve-channel head coil on a Siemens Tim Trio 3.0 T scanner (Siemens Medical Solutions, Erlangen Germany) located at Queen's Medical Center in Honolulu, using a protocol described in.
61-1	12576-12584	Measures	_	
61-2	12585-12587	of	_	
61-3	12588-12594	effect	_	
61-4	12595-12599	size	_	
61-5	12600-12603	are	_	
61-6	12604-12607	the	_	
61-7	12608-12612	odds	_	
61-8	12613-12619	ratios	_	
61-9	12620-12623	for	_	
61-10	12624-12628	rate	_	
61-11	12629-12633	data	_	
61-12	12634-12637	and	_	
61-13	12638-12645	partial	_	
61-14	12646-12648	η2	_	
61-15	12649-12650	(	_	
61-16	12650-12660	proportion	_	
61-17	12661-12663	of	_	
61-18	12664-12672	variance	_	
61-19	12673-12675	of	_	
61-20	12676-12679	the	_	
61-21	12680-12689	dependent	_	
61-22	12690-12698	variable	_	
61-23	12699-12712	independently	_	
61-24	12713-12722	accounted	_	
61-25	12723-12726	for	_	
61-26	12727-12729	by	_	
61-27	12730-12735	group	_	
61-28	12735-12736	)	_	
61-29	12737-12740	for	_	
61-30	12741-12748	symptom	_	
61-31	12749-12755	counts	_	
61-32	12755-12756	,	_	
61-33	12757-12770	psychological	_	
61-34	12771-12779	measures	_	
61-35	12780-12783	and	_	
61-36	12784-12789	other	_	
61-37	12790-12801	demographic	_	
61-38	12802-12811	variables	_	
61-39	12811-12812	.	_	
61-40	12813-12817	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
61-41	12818-12829	acquisition	_	
61-42	12830-12833	and	_	
61-43	12834-12844	processing	_	
61-44	12845-12852	Resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[37]	
61-45	12853-12863	functional	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[37]	
61-46	12864-12872	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[37]	
61-47	12873-12882	resonance	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[37]	
61-48	12883-12884	(	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[37]	
61-49	12884-12888	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[37]|http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[38]	
61-50	12888-12889	)	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[37]	
61-51	12890-12894	data	_	
61-52	12895-12899	were	_	
61-53	12900-12909	collected	_	
61-54	12910-12915	using	_	
61-55	12916-12917	a	_	
61-56	12918-12932	twelve-channel	_	
61-57	12933-12937	head	_	
61-58	12938-12942	coil	_	
61-59	12943-12945	on	_	
61-60	12946-12947	a	_	
61-61	12948-12955	Siemens	_	
61-62	12956-12959	Tim	_	
61-63	12960-12964	Trio	_	
61-64	12965-12968	3.0	_	
61-65	12968-12969	 	_	
61-66	12969-12970	T	_	
61-67	12971-12978	scanner	_	
61-68	12979-12980	(	_	
61-69	12980-12987	Siemens	_	
61-70	12988-12995	Medical	_	
61-71	12996-13005	Solutions	_	
61-72	13005-13006	,	_	
61-73	13007-13015	Erlangen	_	
61-74	13016-13023	Germany	_	
61-75	13023-13024	)	_	
61-76	13025-13032	located	_	
61-77	13033-13035	at	_	
61-78	13036-13043	Queen's	_	
61-79	13044-13051	Medical	_	
61-80	13052-13058	Center	_	
61-81	13059-13061	in	_	
61-82	13062-13070	Honolulu	_	
61-83	13070-13071	,	_	
61-84	13072-13077	using	_	
61-85	13078-13079	a	_	
61-86	13080-13088	protocol	_	
61-87	13089-13098	described	_	
61-88	13099-13101	in	_	
61-89	13101-13102	.	_	

#Text=All imaging data were preprocessed using the AFNI (Analysis of Functional NeuroImages and FMRIB Software Libraries (FSL; FMRIB, Oxford, United Kingdom), as detailed in.
62-1	13103-13106	All	_	
62-2	13107-13114	imaging	_	
62-3	13115-13119	data	_	
62-4	13120-13124	were	_	
62-5	13125-13137	preprocessed	_	
62-6	13138-13143	using	_	
62-7	13144-13147	the	_	
62-8	13148-13152	AFNI	_	
62-9	13153-13154	(	_	
62-10	13154-13162	Analysis	_	
62-11	13163-13165	of	_	
62-12	13166-13176	Functional	_	
62-13	13177-13188	NeuroImages	_	
62-14	13189-13192	and	_	
62-15	13193-13198	FMRIB	_	
62-16	13199-13207	Software	_	
62-17	13208-13217	Libraries	_	
62-18	13218-13219	(	_	
62-19	13219-13222	FSL	_	
62-20	13222-13223	;	_	
62-21	13224-13229	FMRIB	_	
62-22	13229-13230	,	_	
62-23	13231-13237	Oxford	_	
62-24	13237-13238	,	_	
62-25	13239-13245	United	_	
62-26	13246-13253	Kingdom	_	
62-27	13253-13254	)	_	
62-28	13254-13255	,	_	
62-29	13256-13258	as	_	
62-30	13259-13267	detailed	_	
62-31	13268-13270	in	_	
62-32	13270-13271	.	_	

#Text=In summary, preprocessing consisted of: slice time correction; three-dimensional motion correction (using a 6 degree of freedom rigid registration with the first volume as reference); temporal despiking; spatial smoothing, mean-based intensity normalization; temporal bandpass filtering; and linear and quadratic detrending.
63-1	13272-13274	In	_	
63-2	13275-13282	summary	_	
63-3	13282-13283	,	_	
63-4	13284-13297	preprocessing	_	
63-5	13298-13307	consisted	_	
63-6	13308-13310	of	_	
63-7	13310-13311	:	_	
63-8	13312-13317	slice	_	
63-9	13318-13322	time	_	
63-10	13323-13333	correction	_	
63-11	13333-13334	;	_	
63-12	13335-13352	three-dimensional	_	
63-13	13353-13359	motion	_	
63-14	13360-13370	correction	_	
63-15	13371-13372	(	_	
63-16	13372-13377	using	_	
63-17	13378-13379	a	_	
63-18	13380-13381	6	_	
63-19	13382-13388	degree	_	
63-20	13389-13391	of	_	
63-21	13392-13399	freedom	_	
63-22	13400-13405	rigid	_	
63-23	13406-13418	registration	_	
63-24	13419-13423	with	_	
63-25	13424-13427	the	_	
63-26	13428-13433	first	_	
63-27	13434-13440	volume	_	
63-28	13441-13443	as	_	
63-29	13444-13453	reference	_	
63-30	13453-13454	)	_	
63-31	13454-13455	;	_	
63-32	13456-13464	temporal	_	
63-33	13465-13474	despiking	_	
63-34	13474-13475	;	_	
63-35	13476-13483	spatial	_	
63-36	13484-13493	smoothing	_	
63-37	13493-13494	,	_	
63-38	13495-13505	mean-based	_	
63-39	13506-13515	intensity	_	
63-40	13516-13529	normalization	_	
63-41	13529-13530	;	_	
63-42	13531-13539	temporal	_	
63-43	13540-13548	bandpass	_	
63-44	13549-13558	filtering	_	
63-45	13558-13559	;	_	
63-46	13560-13563	and	_	
63-47	13564-13570	linear	_	
63-48	13571-13574	and	_	
63-49	13575-13584	quadratic	_	
63-50	13585-13595	detrending	_	
63-51	13595-13596	.	_	

#Text=In addition, probabilistic independent component analysis was conducted for each individual to denoise individual data by removing components that represented motion, scanner artifacts, and physiological noise.
64-1	13597-13599	In	_	
64-2	13600-13608	addition	_	
64-3	13608-13609	,	_	
64-4	13610-13623	probabilistic	_	
64-5	13624-13635	independent	_	
64-6	13636-13645	component	_	
64-7	13646-13654	analysis	_	
64-8	13655-13658	was	_	
64-9	13659-13668	conducted	_	
64-10	13669-13672	for	_	
64-11	13673-13677	each	_	
64-12	13678-13688	individual	_	
64-13	13689-13691	to	_	
64-14	13692-13699	denoise	_	
64-15	13700-13710	individual	_	
64-16	13711-13715	data	_	
64-17	13716-13718	by	_	
64-18	13719-13727	removing	_	
64-19	13728-13738	components	_	
64-20	13739-13743	that	_	
64-21	13744-13755	represented	_	
64-22	13756-13762	motion	_	
64-23	13762-13763	,	_	
64-24	13764-13771	scanner	_	
64-25	13772-13781	artifacts	_	
64-26	13781-13782	,	_	
64-27	13783-13786	and	_	
64-28	13787-13800	physiological	_	
64-29	13801-13806	noise	_	
64-30	13806-13807	.	_	

#Text=Noise components were selected by spatial and temporal characteristics detailed in the MELODIC (FSL) manual (http://fmrib.ox.ac.uk/fslcourse/lectures/melodic.pdf) using selection criteria of noise components as described in.
65-1	13808-13813	Noise	_	
65-2	13814-13824	components	_	
65-3	13825-13829	were	_	
65-4	13830-13838	selected	_	
65-5	13839-13841	by	_	
65-6	13842-13849	spatial	_	
65-7	13850-13853	and	_	
65-8	13854-13862	temporal	_	
65-9	13863-13878	characteristics	_	
65-10	13879-13887	detailed	_	
65-11	13888-13890	in	_	
65-12	13891-13894	the	_	
65-13	13895-13902	MELODIC	_	
65-14	13903-13904	(	_	
65-15	13904-13907	FSL	_	
65-16	13907-13908	)	_	
65-17	13909-13915	manual	_	
65-18	13916-13917	(	_	
65-19	13917-13921	http	_	
65-20	13921-13922	:	_	
65-21	13922-13923	/	_	
65-22	13923-13924	/	_	
65-23	13924-13938	fmrib.ox.ac.uk	_	
65-24	13938-13939	/	_	
65-25	13939-13948	fslcourse	_	
65-26	13948-13949	/	_	
65-27	13949-13957	lectures	_	
65-28	13957-13958	/	_	
65-29	13958-13969	melodic.pdf	_	
65-30	13969-13970	)	_	
65-31	13971-13976	using	_	
65-32	13977-13986	selection	_	
65-33	13987-13995	criteria	_	
65-34	13996-13998	of	_	
65-35	13999-14004	noise	_	
65-36	14005-14015	components	_	
65-37	14016-14018	as	_	
65-38	14019-14028	described	_	
65-39	14029-14031	in	_	
65-40	14031-14032	.	_	

#Text=A between-groups t-test conducted to look for differences in the sum of total percent variance accounted for in components removed showed no significant group differences (t(1,44) = 0.89, p = 0.38).
66-1	14033-14034	A	_	
66-2	14035-14049	between-groups	_	
66-3	14050-14056	t-test	_	
66-4	14057-14066	conducted	_	
66-5	14067-14069	to	_	
66-6	14070-14074	look	_	
66-7	14075-14078	for	_	
66-8	14079-14090	differences	_	
66-9	14091-14093	in	_	
66-10	14094-14097	the	_	
66-11	14098-14101	sum	_	
66-12	14102-14104	of	_	
66-13	14105-14110	total	_	
66-14	14111-14118	percent	_	
66-15	14119-14127	variance	_	
66-16	14128-14137	accounted	_	
66-17	14138-14141	for	_	
66-18	14142-14144	in	_	
66-19	14145-14155	components	_	
66-20	14156-14163	removed	_	
66-21	14164-14170	showed	_	
66-22	14171-14173	no	_	
66-23	14174-14185	significant	_	
66-24	14186-14191	group	_	
66-25	14192-14203	differences	_	
66-26	14204-14205	(	_	
66-27	14205-14206	t	_	
66-28	14206-14207	(	_	
66-29	14207-14211	1,44	_	
66-30	14211-14212	)	_	
66-31	14212-14213	 	_	
66-32	14213-14214	=	_	
66-33	14214-14215	 	_	
66-34	14215-14219	0.89	_	
66-35	14219-14220	,	_	
66-36	14221-14222	p	_	
66-37	14222-14223	 	_	
66-38	14223-14224	=	_	
66-39	14224-14225	 	_	
66-40	14225-14229	0.38	_	
66-41	14229-14230	)	_	
66-42	14230-14231	.	_	

#Text=Preprocessed resting state images were also registered to the MNI152 atlas for further analysis and seed placement.
67-1	14232-14244	Preprocessed	_	
67-2	14245-14252	resting	_	
67-3	14253-14258	state	_	
67-4	14259-14265	images	_	
67-5	14266-14270	were	_	
67-6	14271-14275	also	_	
67-7	14276-14286	registered	_	
67-8	14287-14289	to	_	
67-9	14290-14293	the	_	
67-10	14294-14300	MNI152	_	
67-11	14301-14306	atlas	_	
67-12	14307-14310	for	_	
67-13	14311-14318	further	_	
67-14	14319-14327	analysis	_	
67-15	14328-14331	and	_	
67-16	14332-14336	seed	_	
67-17	14337-14346	placement	_	
67-18	14346-14347	.	_	

#Text=To examine networks involved in the maintenance of abstinence from alcohol, spherical seeds with 3.5 mm radii were placed at left and right nucleus accumbens (NAcc) based on the Talaraich Daemon atlas from AFNI (MNI coordinates: x = ± 12, y = 10, z = − 1).
68-1	14348-14350	To	_	
68-2	14351-14358	examine	_	
68-3	14359-14367	networks	_	
68-4	14368-14376	involved	_	
68-5	14377-14379	in	_	
68-6	14380-14383	the	_	
68-7	14384-14395	maintenance	_	
68-8	14396-14398	of	_	
68-9	14399-14409	abstinence	_	
68-10	14410-14414	from	_	
68-11	14415-14422	alcohol	_	
68-12	14422-14423	,	_	
68-13	14424-14433	spherical	_	
68-14	14434-14439	seeds	_	
68-15	14440-14444	with	_	
68-16	14445-14448	3.5	_	
68-17	14448-14449	 	_	
68-18	14449-14451	mm	_	
68-19	14452-14457	radii	_	
68-20	14458-14462	were	_	
68-21	14463-14469	placed	_	
68-22	14470-14472	at	_	
68-23	14473-14477	left	_	
68-24	14478-14481	and	_	
68-25	14482-14487	right	_	
68-26	14488-14495	nucleus	_	
68-27	14496-14505	accumbens	_	
68-28	14506-14507	(	_	
68-29	14507-14511	NAcc	_	
68-30	14511-14512	)	_	
68-31	14513-14518	based	_	
68-32	14519-14521	on	_	
68-33	14522-14525	the	_	
68-34	14526-14535	Talaraich	_	
68-35	14536-14542	Daemon	_	
68-36	14543-14548	atlas	_	
68-37	14549-14553	from	_	
68-38	14554-14558	AFNI	_	
68-39	14559-14560	(	_	
68-40	14560-14563	MNI	_	
68-41	14564-14575	coordinates	_	
68-42	14575-14576	:	_	
68-43	14577-14578	x	_	
68-44	14578-14579	 	_	
68-45	14579-14580	=	_	
68-46	14580-14581	 	_	
68-47	14581-14582	±	_	
68-48	14582-14583	 	_	
68-49	14583-14585	12	_	
68-50	14585-14586	,	_	
68-51	14587-14588	y	_	
68-52	14588-14589	 	_	
68-53	14589-14590	=	_	
68-54	14590-14591	 	_	
68-55	14591-14593	10	_	
68-56	14593-14594	,	_	
68-57	14595-14596	z	_	
68-58	14596-14597	 	_	
68-59	14597-14598	=	_	
68-60	14598-14599	 	_	
68-61	14599-14600	−	_	
68-62	14600-14601	 	_	
68-63	14601-14602	1	_	
68-64	14602-14603	)	_	
68-65	14603-14604	.	_	

#Text=As described in, we originally examined left and right NAcc separately, but because results were highly similar (r = 0.81, p = 7.47 × 10− 12), they were combined.
69-1	14605-14607	As	_	
69-2	14608-14617	described	_	
69-3	14618-14620	in	_	
69-4	14620-14621	,	_	
69-5	14622-14624	we	_	
69-6	14625-14635	originally	_	
69-7	14636-14644	examined	_	
69-8	14645-14649	left	_	
69-9	14650-14653	and	_	
69-10	14654-14659	right	_	
69-11	14660-14664	NAcc	_	
69-12	14665-14675	separately	_	
69-13	14675-14676	,	_	
69-14	14677-14680	but	_	
69-15	14681-14688	because	_	
69-16	14689-14696	results	_	
69-17	14697-14701	were	_	
69-18	14702-14708	highly	_	
69-19	14709-14716	similar	_	
69-20	14717-14718	(	_	
69-21	14718-14719	r	_	
69-22	14719-14720	 	_	
69-23	14720-14721	=	_	
69-24	14721-14722	 	_	
69-25	14722-14726	0.81	_	
69-26	14726-14727	,	_	
69-27	14728-14729	p	_	
69-28	14729-14730	 	_	
69-29	14730-14731	=	_	
69-30	14731-14732	 	_	
69-31	14732-14736	7.47	_	
69-32	14736-14737	 	_	
69-33	14737-14738	×	_	
69-34	14738-14739	 	_	
69-35	14739-14741	10	_	
69-36	14741-14742	−	_	
69-37	14742-14743	 	_	
69-38	14743-14745	12	_	
69-39	14745-14746	)	_	
69-40	14746-14747	,	_	
69-41	14748-14752	they	_	
69-42	14753-14757	were	_	
69-43	14758-14766	combined	_	
69-44	14766-14767	.	_	

#Text=For each participant, a multiple regression analysis (FSL-FEAT, see) on the denoised data was performed.
70-1	14768-14771	For	_	
70-2	14772-14776	each	_	
70-3	14777-14788	participant	_	
70-4	14788-14789	,	_	
70-5	14790-14791	a	_	
70-6	14792-14800	multiple	_	
70-7	14801-14811	regression	_	
70-8	14812-14820	analysis	_	
70-9	14821-14822	(	_	
70-10	14822-14830	FSL-FEAT	_	
70-11	14830-14831	,	_	
70-12	14832-14835	see	_	
70-13	14835-14836	)	_	
70-14	14837-14839	on	_	
70-15	14840-14843	the	_	
70-16	14844-14852	denoised	_	
70-17	14853-14857	data	_	
70-18	14858-14861	was	_	
70-19	14862-14871	performed	_	
70-20	14871-14872	.	_	

#Text=This analysis generated a map of statistical parameter estimates for each voxel, for each individual.
71-1	14873-14877	This	_	
71-2	14878-14886	analysis	_	
71-3	14887-14896	generated	_	
71-4	14897-14898	a	_	
71-5	14899-14902	map	_	
71-6	14903-14905	of	_	
71-7	14906-14917	statistical	_	
71-8	14918-14927	parameter	_	
71-9	14928-14937	estimates	_	
71-10	14938-14941	for	_	
71-11	14942-14946	each	_	
71-12	14947-14952	voxel	_	
71-13	14952-14953	,	_	
71-14	14954-14957	for	_	
71-15	14958-14962	each	_	
71-16	14963-14973	individual	_	
71-17	14973-14974	.	_	

#Text=All voxels in the maps showed the degree of positive or negative correlations with the average time-series (over the left and right NAcc seeds) for each participant.
72-1	14975-14978	All	_	
72-2	14979-14985	voxels	_	
72-3	14986-14988	in	_	
72-4	14989-14992	the	_	
72-5	14993-14997	maps	_	
72-6	14998-15004	showed	_	
72-7	15005-15008	the	_	
72-8	15009-15015	degree	_	
72-9	15016-15018	of	_	
72-10	15019-15027	positive	_	
72-11	15028-15030	or	_	
72-12	15031-15039	negative	_	
72-13	15040-15052	correlations	_	
72-14	15053-15057	with	_	
72-15	15058-15061	the	_	
72-16	15062-15069	average	_	
72-17	15070-15081	time-series	_	
72-18	15082-15083	(	_	
72-19	15083-15087	over	_	
72-20	15088-15091	the	_	
72-21	15092-15096	left	_	
72-22	15097-15100	and	_	
72-23	15101-15106	right	_	
72-24	15107-15111	NAcc	_	
72-25	15112-15117	seeds	_	
72-26	15117-15118	)	_	
72-27	15119-15122	for	_	
72-28	15123-15127	each	_	
72-29	15128-15139	participant	_	
72-30	15139-15140	.	_	

#Text=Correlation values at each voxel were transformed to z-scores.
73-1	15141-15152	Correlation	_	
73-2	15153-15159	values	_	
73-3	15160-15162	at	_	
73-4	15163-15167	each	_	
73-5	15168-15173	voxel	_	
73-6	15174-15178	were	_	
73-7	15179-15190	transformed	_	
73-8	15191-15193	to	_	
73-9	15194-15202	z-scores	_	
73-10	15202-15203	.	_	

#Text=In our previous work, dorsolateral prefrontal cortex (DLPFC) regions of the executive control network showed greater RSS with NAcc; thalamic nuclei (anterior and medial dorsal) and inferior parietal regions of the appetitive drive network showed lesser RSS with NAcc in LTAA compared to controls.
74-1	15204-15206	In	_	
74-2	15207-15210	our	_	
74-3	15211-15219	previous	_	
74-4	15220-15224	work	_	
74-5	15224-15225	,	_	
74-6	15226-15238	dorsolateral	_	
74-7	15239-15249	prefrontal	_	
74-8	15250-15256	cortex	_	
74-9	15257-15258	(	_	
74-10	15258-15263	DLPFC	_	
74-11	15263-15264	)	_	
74-12	15265-15272	regions	_	
74-13	15273-15275	of	_	
74-14	15276-15279	the	_	
74-15	15280-15289	executive	_	
74-16	15290-15297	control	_	
74-17	15298-15305	network	_	
74-18	15306-15312	showed	_	
74-19	15313-15320	greater	_	
74-20	15321-15324	RSS	_	
74-21	15325-15329	with	_	
74-22	15330-15334	NAcc	_	
74-23	15334-15335	;	_	
74-24	15336-15344	thalamic	_	
74-25	15345-15351	nuclei	_	
74-26	15352-15353	(	_	
74-27	15353-15361	anterior	_	
74-28	15362-15365	and	_	
74-29	15366-15372	medial	_	
74-30	15373-15379	dorsal	_	
74-31	15379-15380	)	_	
74-32	15381-15384	and	_	
74-33	15385-15393	inferior	_	
74-34	15394-15402	parietal	_	
74-35	15403-15410	regions	_	
74-36	15411-15413	of	_	
74-37	15414-15417	the	_	
74-38	15418-15428	appetitive	_	
74-39	15429-15434	drive	_	
74-40	15435-15442	network	_	
74-41	15443-15449	showed	_	
74-42	15450-15456	lesser	_	
74-43	15457-15460	RSS	_	
74-44	15461-15465	with	_	
74-45	15466-15470	NAcc	_	
74-46	15471-15473	in	_	
74-47	15474-15478	LTAA	_	
74-48	15479-15487	compared	_	
74-49	15488-15490	to	_	
74-50	15491-15499	controls	_	
74-51	15499-15500	.	_	

#Text=EEG acquisition and processing
#Text=We recorded 64-channel resting eyes-open EEGs using the SynAmps2 amplifier and Scan 4.3 acquisition software (Compumedics Neuroscan Inc., Charlotte NC).
75-1	15501-15504	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
75-2	15505-15516	acquisition	_	
75-3	15517-15520	and	_	
75-4	15521-15531	processing	_	
75-5	15532-15534	We	_	
75-6	15535-15543	recorded	_	
75-7	15544-15546	64	_	
75-8	15546-15547	-	_	
75-9	15547-15554	channel	_	
75-10	15555-15562	resting	_	
75-11	15563-15572	eyes-open	_	
75-12	15573-15577	EEGs	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
75-13	15578-15583	using	_	
75-14	15584-15587	the	_	
75-15	15588-15596	SynAmps2	_	
75-16	15597-15606	amplifier	_	
75-17	15607-15610	and	_	
75-18	15611-15615	Scan	_	
75-19	15616-15619	4.3	_	
75-20	15620-15631	acquisition	_	
75-21	15632-15640	software	_	
75-22	15641-15642	(	_	
75-23	15642-15653	Compumedics	_	
75-24	15654-15663	Neuroscan	_	
75-25	15664-15667	Inc	_	
75-26	15667-15668	.	_	
75-27	15668-15669	,	_	
75-28	15670-15679	Charlotte	_	
75-29	15680-15682	NC	_	
75-30	15682-15683	)	_	
75-31	15683-15684	.	_	

#Text=The EEG signal was referenced to an electrode between Cz and CPz for online recording, and then re-referenced to the right ear offline.
76-1	15685-15688	The	_	
76-2	15689-15692	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[39]|http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[40]	
76-3	15693-15699	signal	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[39]	
76-4	15700-15703	was	_	
76-5	15704-15714	referenced	_	
76-6	15715-15717	to	_	
76-7	15718-15720	an	_	
76-8	15721-15730	electrode	_	
76-9	15731-15738	between	_	
76-10	15739-15741	Cz	_	
76-11	15742-15745	and	_	
76-12	15746-15749	CPz	_	
76-13	15750-15753	for	_	
76-14	15754-15760	online	_	
76-15	15761-15770	recording	_	
76-16	15770-15771	,	_	
76-17	15772-15775	and	_	
76-18	15776-15780	then	_	
76-19	15781-15794	re-referenced	_	
76-20	15795-15797	to	_	
76-21	15798-15801	the	_	
76-22	15802-15807	right	_	
76-23	15808-15811	ear	_	
76-24	15812-15819	offline	_	
76-25	15819-15820	.	_	

#Text=The ground electrode was placed 8 cm above the nasion.
77-1	15821-15824	The	_	
77-2	15825-15831	ground	_	
77-3	15832-15841	electrode	_	
77-4	15842-15845	was	_	
77-5	15846-15852	placed	_	
77-6	15853-15854	8	_	
77-7	15854-15855	 	_	
77-8	15855-15857	cm	_	
77-9	15858-15863	above	_	
77-10	15864-15867	the	_	
77-11	15868-15874	nasion	_	
77-12	15874-15875	.	_	

#Text=Electrode impedances were maintained below 10 kΩ.
78-1	15876-15885	Electrode	_	
78-2	15886-15896	impedances	_	
78-3	15897-15901	were	_	
78-4	15902-15912	maintained	_	
78-5	15913-15918	below	_	
78-6	15919-15921	10	_	
78-7	15922-15924	kΩ	_	
78-8	15924-15925	.	_	

#Text=The sampling rate was 250 Hz, analog filters were 0.3–70 Hz, and 7–8 min of data were recorded.
79-1	15926-15929	The	_	
79-2	15930-15938	sampling	_	
79-3	15939-15943	rate	_	
79-4	15944-15947	was	_	
79-5	15948-15951	250	_	
79-6	15951-15952	 	_	
79-7	15952-15954	Hz	_	
79-8	15954-15955	,	_	
79-9	15956-15962	analog	_	
79-10	15963-15970	filters	_	
79-11	15971-15975	were	_	
79-12	15976-15979	0.3	_	
79-13	15979-15980	–	_	
79-14	15980-15982	70	_	
79-15	15982-15983	 	_	
79-16	15983-15985	Hz	_	
79-17	15985-15986	,	_	
79-18	15987-15990	and	_	
79-19	15991-15992	7	_	
79-20	15992-15993	–	_	
79-21	15993-15994	8	_	
79-22	15994-15995	 	_	
79-23	15995-15998	min	_	
79-24	15999-16001	of	_	
79-25	16002-16006	data	_	
79-26	16007-16011	were	_	
79-27	16012-16020	recorded	_	
79-28	16020-16021	.	_	

#Text=EEG recordings were processed offline using the Edit program in Scan 4.3.
80-1	16022-16025	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[41]|http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[42]	
80-2	16026-16036	recordings	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[41]	
80-3	16037-16041	were	_	
80-4	16042-16051	processed	_	
80-5	16052-16059	offline	_	
80-6	16060-16065	using	_	
80-7	16066-16069	the	_	
80-8	16070-16074	Edit	_	
80-9	16075-16082	program	_	
80-10	16083-16085	in	_	
80-11	16086-16090	Scan	_	
80-12	16091-16094	4.3	_	
80-13	16094-16095	.	_	

#Text=Artifacts from eye movements were removed using the ocular artifact reduction algorithm (ARTCOR procedure) in Scan 4.3.
81-1	16096-16105	Artifacts	_	
81-2	16106-16110	from	_	
81-3	16111-16114	eye	_	
81-4	16115-16124	movements	_	
81-5	16125-16129	were	_	
81-6	16130-16137	removed	_	
81-7	16138-16143	using	_	
81-8	16144-16147	the	_	
81-9	16148-16154	ocular	_	
81-10	16155-16163	artifact	_	
81-11	16164-16173	reduction	_	
81-12	16174-16183	algorithm	_	
81-13	16184-16185	(	_	
81-14	16185-16191	ARTCOR	_	
81-15	16192-16201	procedure	_	
81-16	16201-16202	)	_	
81-17	16203-16205	in	_	
81-18	16206-16210	Scan	_	
81-19	16211-16214	4.3	_	
81-20	16214-16215	.	_	

#Text=The resulting EEG was unusable for three LTAA participants and two NSAC participants due to excessive noise and voltages out of range.
82-1	16216-16219	The	_	
82-2	16220-16229	resulting	_	
82-3	16230-16233	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
82-4	16234-16237	was	_	
82-5	16238-16246	unusable	_	
82-6	16247-16250	for	_	
82-7	16251-16256	three	_	
82-8	16257-16261	LTAA	_	
82-9	16262-16274	participants	_	
82-10	16275-16278	and	_	
82-11	16279-16282	two	_	
82-12	16283-16287	NSAC	_	
82-13	16288-16300	participants	_	
82-14	16301-16304	due	_	
82-15	16305-16307	to	_	
82-16	16308-16317	excessive	_	
82-17	16318-16323	noise	_	
82-18	16324-16327	and	_	
82-19	16328-16336	voltages	_	
82-20	16337-16340	out	_	
82-21	16341-16343	of	_	
82-22	16344-16349	range	_	
82-23	16349-16350	.	_	

#Text=Coherence between all pairs of channels was computed as follows: 1) the first 20 s of each recording was discarded, to allow electrode impedances to settle, 2) the magnitude squared coherence was estimated over the next 4 min of data using Welch's averaged, modified periodogram method, using 2 s epochs with 50% overlap, 3) coherence estimates were then averaged within frequency bands for delta (1–3 Hz), theta (4–7 Hz), alpha1 (8–9 Hz), alpha2 (10–12 Hz), beta1 (13–17 Hz), beta2 (18–30 Hz), gamma1 (31–40 Hz), and gamma2 (41–50 Hz).
83-1	16351-16360	Coherence	_	
83-2	16361-16368	between	_	
83-3	16369-16372	all	_	
83-4	16373-16378	pairs	_	
83-5	16379-16381	of	_	
83-6	16382-16390	channels	_	
83-7	16391-16394	was	_	
83-8	16395-16403	computed	_	
83-9	16404-16406	as	_	
83-10	16407-16414	follows	_	
83-11	16414-16415	:	_	
83-12	16416-16417	1	_	
83-13	16417-16418	)	_	
83-14	16419-16422	the	_	
83-15	16423-16428	first	_	
83-16	16429-16431	20	_	
83-17	16431-16432	 	_	
83-18	16432-16433	s	_	
83-19	16434-16436	of	_	
83-20	16437-16441	each	_	
83-21	16442-16451	recording	_	
83-22	16452-16455	was	_	
83-23	16456-16465	discarded	_	
83-24	16465-16466	,	_	
83-25	16467-16469	to	_	
83-26	16470-16475	allow	_	
83-27	16476-16485	electrode	_	
83-28	16486-16496	impedances	_	
83-29	16497-16499	to	_	
83-30	16500-16506	settle	_	
83-31	16506-16507	,	_	
83-32	16508-16509	2	_	
83-33	16509-16510	)	_	
83-34	16511-16514	the	_	
83-35	16515-16524	magnitude	_	
83-36	16525-16532	squared	_	
83-37	16533-16542	coherence	_	
83-38	16543-16546	was	_	
83-39	16547-16556	estimated	_	
83-40	16557-16561	over	_	
83-41	16562-16565	the	_	
83-42	16566-16570	next	_	
83-43	16571-16572	4	_	
83-44	16572-16573	 	_	
83-45	16573-16576	min	_	
83-46	16577-16579	of	_	
83-47	16580-16584	data	_	
83-48	16585-16590	using	_	
83-49	16591-16598	Welch's	_	
83-50	16599-16607	averaged	_	
83-51	16607-16608	,	_	
83-52	16609-16617	modified	_	
83-53	16618-16629	periodogram	_	
83-54	16630-16636	method	_	
83-55	16636-16637	,	_	
83-56	16638-16643	using	_	
83-57	16644-16645	2	_	
83-58	16645-16646	 	_	
83-59	16646-16647	s	_	
83-60	16648-16654	epochs	_	
83-61	16655-16659	with	_	
83-62	16660-16663	50%	_	
83-63	16664-16671	overlap	_	
83-64	16671-16672	,	_	
83-65	16673-16674	3	_	
83-66	16674-16675	)	_	
83-67	16676-16685	coherence	_	
83-68	16686-16695	estimates	_	
83-69	16696-16700	were	_	
83-70	16701-16705	then	_	
83-71	16706-16714	averaged	_	
83-72	16715-16721	within	_	
83-73	16722-16731	frequency	_	
83-74	16732-16737	bands	_	
83-75	16738-16741	for	_	
83-76	16742-16747	delta	_	
83-77	16748-16749	(	_	
83-78	16749-16750	1	_	
83-79	16750-16751	–	_	
83-80	16751-16752	3	_	
83-81	16752-16753	 	_	
83-82	16753-16755	Hz	_	
83-83	16755-16756	)	_	
83-84	16756-16757	,	_	
83-85	16758-16763	theta	_	
83-86	16764-16765	(	_	
83-87	16765-16766	4	_	
83-88	16766-16767	–	_	
83-89	16767-16768	7	_	
83-90	16768-16769	 	_	
83-91	16769-16771	Hz	_	
83-92	16771-16772	)	_	
83-93	16772-16773	,	_	
83-94	16774-16780	alpha1	_	
83-95	16781-16782	(	_	
83-96	16782-16783	8	_	
83-97	16783-16784	–	_	
83-98	16784-16785	9	_	
83-99	16785-16786	 	_	
83-100	16786-16788	Hz	_	
83-101	16788-16789	)	_	
83-102	16789-16790	,	_	
83-103	16791-16797	alpha2	_	
83-104	16798-16799	(	_	
83-105	16799-16801	10	_	
83-106	16801-16802	–	_	
83-107	16802-16804	12	_	
83-108	16804-16805	 	_	
83-109	16805-16807	Hz	_	
83-110	16807-16808	)	_	
83-111	16808-16809	,	_	
83-112	16810-16815	beta1	_	
83-113	16816-16817	(	_	
83-114	16817-16819	13	_	
83-115	16819-16820	–	_	
83-116	16820-16822	17	_	
83-117	16822-16823	 	_	
83-118	16823-16825	Hz	_	
83-119	16825-16826	)	_	
83-120	16826-16827	,	_	
83-121	16828-16833	beta2	_	
83-122	16834-16835	(	_	
83-123	16835-16837	18	_	
83-124	16837-16838	–	_	
83-125	16838-16840	30	_	
83-126	16840-16841	 	_	
83-127	16841-16843	Hz	_	
83-128	16843-16844	)	_	
83-129	16844-16845	,	_	
83-130	16846-16852	gamma1	_	
83-131	16853-16854	(	_	
83-132	16854-16856	31	_	
83-133	16856-16857	–	_	
83-134	16857-16859	40	_	
83-135	16859-16860	 	_	
83-136	16860-16862	Hz	_	
83-137	16862-16863	)	_	
83-138	16863-16864	,	_	
83-139	16865-16868	and	_	
83-140	16869-16875	gamma2	_	
83-141	16876-16877	(	_	
83-142	16877-16879	41	_	
83-143	16879-16880	–	_	
83-144	16880-16882	50	_	
83-145	16882-16883	 	_	
83-146	16883-16885	Hz	_	
83-147	16885-16886	)	_	
83-148	16886-16887	.	_	

#Text=EEG theta, alpha, and beta have been previously studied in neurofeedback treatments and have been shown to alter EEG resting state networks following alcohol consumption. fMRI BOLD signals are thought to arise from the summed neural activities of several oscillatory EEG networks, particularly gamma.
84-1	16888-16891	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[43]|http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[44]	
84-2	16892-16897	theta	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[43]	
84-3	16897-16898	,	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[43]	
84-4	16899-16904	alpha	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[43]	
84-5	16904-16905	,	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[43]	
84-6	16906-16909	and	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[43]	
84-7	16910-16914	beta	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[43]	
84-8	16915-16919	have	_	
84-9	16920-16924	been	_	
84-10	16925-16935	previously	_	
84-11	16936-16943	studied	_	
84-12	16944-16946	in	_	
84-13	16947-16960	neurofeedback	_	
84-14	16961-16971	treatments	_	
84-15	16972-16975	and	_	
84-16	16976-16980	have	_	
84-17	16981-16985	been	_	
84-18	16986-16991	shown	_	
84-19	16992-16994	to	_	
84-20	16995-17000	alter	_	
84-21	17001-17004	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[45]|http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[46]	
84-22	17005-17012	resting	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[45]	
84-23	17013-17018	state	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[45]	
84-24	17019-17027	networks	_	
84-25	17028-17037	following	_	
84-26	17038-17045	alcohol	_	
84-27	17046-17057	consumption	_	
84-28	17057-17058	.	_	
84-29	17059-17063	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
84-30	17064-17068	BOLD	_	
84-31	17069-17076	signals	_	
84-32	17077-17080	are	_	
84-33	17081-17088	thought	_	
84-34	17089-17091	to	_	
84-35	17092-17097	arise	_	
84-36	17098-17102	from	_	
84-37	17103-17106	the	_	
84-38	17107-17113	summed	_	
84-39	17114-17120	neural	_	
84-40	17121-17131	activities	_	
84-41	17132-17134	of	_	
84-42	17135-17142	several	_	
84-43	17143-17154	oscillatory	_	
84-44	17155-17158	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
84-45	17159-17167	networks	_	
84-46	17167-17168	,	_	
84-47	17169-17181	particularly	_	
84-48	17182-17187	gamma	_	
84-49	17187-17188	.	_	

#Text=Therefore, in this paper we focused on theta, alpha, beta, and gamma bands.
85-1	17189-17198	Therefore	_	
85-2	17198-17199	,	_	
85-3	17200-17202	in	_	
85-4	17203-17207	this	_	
85-5	17208-17213	paper	_	
85-6	17214-17216	we	_	
85-7	17217-17224	focused	_	
85-8	17225-17227	on	_	
85-9	17228-17233	theta	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[47]	
85-10	17233-17234	,	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[47]	
85-11	17235-17240	alpha	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[47]	
85-12	17240-17241	,	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[47]	
85-13	17242-17246	beta	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[47]	
85-14	17246-17247	,	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[47]	
85-15	17248-17251	and	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[47]	
85-16	17252-17257	gamma	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[47]	
85-17	17258-17263	bands	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[47]	
85-18	17263-17264	.	_	

#Text=For these bands, the upper-half of the resulting coherence matrix (excluding the diagonal) was rearranged into a single vector of length 2016 ((64 electrodes × 64 electrodes − 64)/2).
86-1	17265-17268	For	_	
86-2	17269-17274	these	_	
86-3	17275-17280	bands	_	
86-4	17280-17281	,	_	
86-5	17282-17285	the	_	
86-6	17286-17296	upper-half	_	
86-7	17297-17299	of	_	
86-8	17300-17303	the	_	
86-9	17304-17313	resulting	_	
86-10	17314-17323	coherence	_	
86-11	17324-17330	matrix	_	
86-12	17331-17332	(	_	
86-13	17332-17341	excluding	_	
86-14	17342-17345	the	_	
86-15	17346-17354	diagonal	_	
86-16	17354-17355	)	_	
86-17	17356-17359	was	_	
86-18	17360-17370	rearranged	_	
86-19	17371-17375	into	_	
86-20	17376-17377	a	_	
86-21	17378-17384	single	_	
86-22	17385-17391	vector	_	
86-23	17392-17394	of	_	
86-24	17395-17401	length	_	
86-25	17402-17406	2016	_	
86-26	17407-17408	(	_	
86-27	17408-17409	(	_	
86-28	17409-17411	64	_	
86-29	17412-17422	electrodes	_	
86-30	17422-17423	 	_	
86-31	17423-17424	×	_	
86-32	17424-17425	 	_	
86-33	17425-17427	64	_	
86-34	17428-17438	electrodes	_	
86-35	17438-17439	 	_	
86-36	17439-17440	−	_	
86-37	17440-17441	 	_	
86-38	17441-17443	64	_	
86-39	17443-17444	)	_	
86-40	17444-17445	/	_	
86-41	17445-17446	2	_	
86-42	17446-17447	)	_	
86-43	17447-17448	.	_	

#Text=Coherence vectors for the seven frequency bands of interest were concatenated to form one vector of length 14,112 reflecting coherence in the desired bands between all electrodes for input to parallel ICA.
87-1	17449-17458	Coherence	_	
87-2	17459-17466	vectors	_	
87-3	17467-17470	for	_	
87-4	17471-17474	the	_	
87-5	17475-17480	seven	_	
87-6	17481-17490	frequency	_	
87-7	17491-17496	bands	_	
87-8	17497-17499	of	_	
87-9	17500-17508	interest	_	
87-10	17509-17513	were	_	
87-11	17514-17526	concatenated	_	
87-12	17527-17529	to	_	
87-13	17530-17534	form	_	
87-14	17535-17538	one	_	
87-15	17539-17545	vector	_	
87-16	17546-17548	of	_	
87-17	17549-17555	length	_	
87-18	17556-17562	14,112	_	
87-19	17563-17573	reflecting	_	
87-20	17574-17583	coherence	_	
87-21	17584-17586	in	_	
87-22	17587-17590	the	_	
87-23	17591-17598	desired	_	
87-24	17599-17604	bands	_	
87-25	17605-17612	between	_	
87-26	17613-17616	all	_	
87-27	17617-17627	electrodes	_	
87-28	17628-17631	for	_	
87-29	17632-17637	input	_	
87-30	17638-17640	to	_	
87-31	17641-17649	parallel	_	
87-32	17650-17653	ICA	_	
87-33	17653-17654	.	_	

#Text=Parallel ICA
#Text=We analyzed rs-fMRI whole-brain seed-correlation maps and the vector of EEG-coherence jointly, taking all image voxels and coherence values into account simultaneously using parallel ICA (Fusion ICA Toolbox:).
88-1	17655-17663	Parallel	_	
88-2	17664-17667	ICA	_	
88-3	17668-17670	We	_	
88-4	17671-17679	analyzed	_	
88-5	17680-17687	rs-fMRI	_	
88-6	17688-17699	whole-brain	_	
88-7	17700-17716	seed-correlation	_	
88-8	17717-17721	maps	_	
88-9	17722-17725	and	_	
88-10	17726-17729	the	_	
88-11	17730-17736	vector	_	
88-12	17737-17739	of	_	
88-13	17740-17753	EEG-coherence	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
88-14	17754-17761	jointly	_	
88-15	17761-17762	,	_	
88-16	17763-17769	taking	_	
88-17	17770-17773	all	_	
88-18	17774-17779	image	_	
88-19	17780-17786	voxels	_	
88-20	17787-17790	and	_	
88-21	17791-17800	coherence	_	
88-22	17801-17807	values	_	
88-23	17808-17812	into	_	
88-24	17813-17820	account	_	
88-25	17821-17835	simultaneously	_	
88-26	17836-17841	using	_	
88-27	17842-17850	parallel	_	
88-28	17851-17854	ICA	_	
88-29	17855-17856	(	_	
88-30	17856-17862	Fusion	_	
88-31	17863-17866	ICA	_	
88-32	17867-17874	Toolbox	_	
88-33	17874-17875	:	_	
88-34	17875-17876	)	_	
88-35	17876-17877	.	_	

#Text=Parallel ICA is described in detail in.
89-1	17878-17886	Parallel	_	
89-2	17887-17890	ICA	_	
89-3	17891-17893	is	_	
89-4	17894-17903	described	_	
89-5	17904-17906	in	_	
89-6	17907-17913	detail	_	
89-7	17914-17916	in	_	
89-8	17916-17917	.	_	

#Text=Parallel ICA aims to identify independent components from the seed-correlation map and the EEG-coherence vector in addition to the relationship between them.
90-1	17918-17926	Parallel	_	
90-2	17927-17930	ICA	_	
90-3	17931-17935	aims	_	
90-4	17936-17938	to	_	
90-5	17939-17947	identify	_	
90-6	17948-17959	independent	_	
90-7	17960-17970	components	_	
90-8	17971-17975	from	_	
90-9	17976-17979	the	_	
90-10	17980-17996	seed-correlation	_	
90-11	17997-18000	map	_	
90-12	18001-18004	and	_	
90-13	18005-18008	the	_	
90-14	18009-18022	EEG-coherence	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
90-15	18023-18029	vector	_	
90-16	18030-18032	in	_	
90-17	18033-18041	addition	_	
90-18	18042-18044	to	_	
90-19	18045-18048	the	_	
90-20	18049-18061	relationship	_	
90-21	18062-18069	between	_	
90-22	18070-18074	them	_	
90-23	18074-18075	.	_	

#Text=Components extracted from the seed-correlation map can be interpreted as networks of brain regions with spatially similar seed-synchrony across subjects, but the strength of synchrony within each network may differ across subjects.
91-1	18076-18086	Components	_	
91-2	18087-18096	extracted	_	
91-3	18097-18101	from	_	
91-4	18102-18105	the	_	
91-5	18106-18122	seed-correlation	_	
91-6	18123-18126	map	_	
91-7	18127-18130	can	_	
91-8	18131-18133	be	_	
91-9	18134-18145	interpreted	_	
91-10	18146-18148	as	_	
91-11	18149-18157	networks	_	
91-12	18158-18160	of	_	
91-13	18161-18166	brain	_	
91-14	18167-18174	regions	_	
91-15	18175-18179	with	_	
91-16	18180-18189	spatially	_	
91-17	18190-18197	similar	_	
91-18	18198-18212	seed-synchrony	_	
91-19	18213-18219	across	_	
91-20	18220-18228	subjects	_	
91-21	18228-18229	,	_	
91-22	18230-18233	but	_	
91-23	18234-18237	the	_	
91-24	18238-18246	strength	_	
91-25	18247-18249	of	_	
91-26	18250-18259	synchrony	_	
91-27	18260-18266	within	_	
91-28	18267-18271	each	_	
91-29	18272-18279	network	_	
91-30	18280-18283	may	_	
91-31	18284-18290	differ	_	
91-32	18291-18297	across	_	
91-33	18298-18306	subjects	_	
91-34	18306-18307	.	_	

#Text=Components extracted from the scalp-recorded EEG-coherence reflect frequency-specific EEG oscillations within networks, which are also expressed to different degrees across subjects.
92-1	18308-18318	Components	_	
92-2	18319-18328	extracted	_	
92-3	18329-18333	from	_	
92-4	18334-18337	the	_	
92-5	18338-18352	scalp-recorded	_	
92-6	18353-18366	EEG-coherence	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
92-7	18367-18374	reflect	_	
92-8	18375-18393	frequency-specific	_	
92-9	18394-18397	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
92-10	18398-18410	oscillations	_	
92-11	18411-18417	within	_	
92-12	18418-18426	networks	_	
92-13	18426-18427	,	_	
92-14	18428-18433	which	_	
92-15	18434-18437	are	_	
92-16	18438-18442	also	_	
92-17	18443-18452	expressed	_	
92-18	18453-18455	to	_	
92-19	18456-18465	different	_	
92-20	18466-18473	degrees	_	
92-21	18474-18480	across	_	
92-22	18481-18489	subjects	_	
92-23	18489-18490	.	_	

#Text=Extracted components are not sparse; components extracted from the seed-correlation map will have a contribution from every voxel in the map, and components extracted from the EEG-coherence will have a contribution from every electrode pair within every frequency band.
93-1	18491-18500	Extracted	_	
93-2	18501-18511	components	_	
93-3	18512-18515	are	_	
93-4	18516-18519	not	_	
93-5	18520-18526	sparse	_	
93-6	18526-18527	;	_	
93-7	18528-18538	components	_	
93-8	18539-18548	extracted	_	
93-9	18549-18553	from	_	
93-10	18554-18557	the	_	
93-11	18558-18574	seed-correlation	_	
93-12	18575-18578	map	_	
93-13	18579-18583	will	_	
93-14	18584-18588	have	_	
93-15	18589-18590	a	_	
93-16	18591-18603	contribution	_	
93-17	18604-18608	from	_	
93-18	18609-18614	every	_	
93-19	18615-18620	voxel	_	
93-20	18621-18623	in	_	
93-21	18624-18627	the	_	
93-22	18628-18631	map	_	
93-23	18631-18632	,	_	
93-24	18633-18636	and	_	
93-25	18637-18647	components	_	
93-26	18648-18657	extracted	_	
93-27	18658-18662	from	_	
93-28	18663-18666	the	_	
93-29	18667-18680	EEG-coherence	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
93-30	18681-18685	will	_	
93-31	18686-18690	have	_	
93-32	18691-18692	a	_	
93-33	18693-18705	contribution	_	
93-34	18706-18710	from	_	
93-35	18711-18716	every	_	
93-36	18717-18726	electrode	_	
93-37	18727-18731	pair	_	
93-38	18732-18738	within	_	
93-39	18739-18744	every	_	
93-40	18745-18754	frequency	_	
93-41	18755-18759	band	_	
93-42	18759-18760	.	_	

#Text=The loading parameters for each component reflect the contribution of each network to that subject's whole brain seed-correlation map or EEG-coherence.
94-1	18761-18764	The	_	
94-2	18765-18772	loading	_	
94-3	18773-18783	parameters	_	
94-4	18784-18787	for	_	
94-5	18788-18792	each	_	
94-6	18793-18802	component	_	
94-7	18803-18810	reflect	_	
94-8	18811-18814	the	_	
94-9	18815-18827	contribution	_	
94-10	18828-18830	of	_	
94-11	18831-18835	each	_	
94-12	18836-18843	network	_	
94-13	18844-18846	to	_	
94-14	18847-18851	that	_	
94-15	18852-18861	subject's	_	
94-16	18862-18867	whole	_	
94-17	18868-18873	brain	_	
94-18	18874-18890	seed-correlation	_	
94-19	18891-18894	map	_	
94-20	18895-18897	or	_	
94-21	18898-18911	EEG-coherence	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
94-22	18911-18912	.	_	

#Text=Parallel ICA also models the relationship between the components estimated from each modality, such that the loading parameters between an estimated EEG-coherence component and a seed-correlation map component are correlated across all participants if they reflect the same underlying network.
95-1	18913-18921	Parallel	_	
95-2	18922-18925	ICA	_	
95-3	18926-18930	also	_	
95-4	18931-18937	models	_	
95-5	18938-18941	the	_	
95-6	18942-18954	relationship	_	
95-7	18955-18962	between	_	
95-8	18963-18966	the	_	
95-9	18967-18977	components	_	
95-10	18978-18987	estimated	_	
95-11	18988-18992	from	_	
95-12	18993-18997	each	_	
95-13	18998-19006	modality	_	
95-14	19006-19007	,	_	
95-15	19008-19012	such	_	
95-16	19013-19017	that	_	
95-17	19018-19021	the	_	
95-18	19022-19029	loading	_	
95-19	19030-19040	parameters	_	
95-20	19041-19048	between	_	
95-21	19049-19051	an	_	
95-22	19052-19061	estimated	_	
95-23	19062-19075	EEG-coherence	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
95-24	19076-19085	component	_	
95-25	19086-19089	and	_	
95-26	19090-19091	a	_	
95-27	19092-19108	seed-correlation	_	
95-28	19109-19112	map	_	
95-29	19113-19122	component	_	
95-30	19123-19126	are	_	
95-31	19127-19137	correlated	_	
95-32	19138-19144	across	_	
95-33	19145-19148	all	_	
95-34	19149-19161	participants	_	
95-35	19162-19164	if	_	
95-36	19165-19169	they	_	
95-37	19170-19177	reflect	_	
95-38	19178-19181	the	_	
95-39	19182-19186	same	_	
95-40	19187-19197	underlying	_	
95-41	19198-19205	network	_	
95-42	19205-19206	.	_	

#Text=In the parallel ICA model, we specified two groups (LTAA and NSAC) and two modalities (rs-fMRI NAcc seed correlation maps and EEG-coherence vectors).
96-1	19207-19209	In	_	
96-2	19210-19213	the	_	
96-3	19214-19222	parallel	_	
96-4	19223-19226	ICA	_	
96-5	19227-19232	model	_	
96-6	19232-19233	,	_	
96-7	19234-19236	we	_	
96-8	19237-19246	specified	_	
96-9	19247-19250	two	_	
96-10	19251-19257	groups	_	
96-11	19258-19259	(	_	
96-12	19259-19263	LTAA	_	
96-13	19264-19267	and	_	
96-14	19268-19272	NSAC	_	
96-15	19272-19273	)	_	
96-16	19274-19277	and	_	
96-17	19278-19281	two	_	
96-18	19282-19292	modalities	_	
96-19	19293-19294	(	_	
96-20	19294-19301	rs-fMRI	_	
96-21	19302-19306	NAcc	_	
96-22	19307-19311	seed	_	
96-23	19312-19323	correlation	_	
96-24	19324-19328	maps	_	
96-25	19329-19332	and	_	
96-26	19333-19346	EEG-coherence	_	
96-27	19347-19354	vectors	_	
96-28	19354-19355	)	_	
96-29	19355-19356	.	_	

#Text=We chose to use the default mask for the imaging data (only voxels with non-zero values for all subjects were included in the analysis) and the number of estimated components was restricted to 8 for each modality.
97-1	19357-19359	We	_	
97-2	19360-19365	chose	_	
97-3	19366-19368	to	_	
97-4	19369-19372	use	_	
97-5	19373-19376	the	_	
97-6	19377-19384	default	_	
97-7	19385-19389	mask	_	
97-8	19390-19393	for	_	
97-9	19394-19397	the	_	
97-10	19398-19405	imaging	_	
97-11	19406-19410	data	_	
97-12	19411-19412	(	_	
97-13	19412-19416	only	_	
97-14	19417-19423	voxels	_	
97-15	19424-19428	with	_	
97-16	19429-19437	non-zero	_	
97-17	19438-19444	values	_	
97-18	19445-19448	for	_	
97-19	19449-19452	all	_	
97-20	19453-19461	subjects	_	
97-21	19462-19466	were	_	
97-22	19467-19475	included	_	
97-23	19476-19478	in	_	
97-24	19479-19482	the	_	
97-25	19483-19491	analysis	_	
97-26	19491-19492	)	_	
97-27	19493-19496	and	_	
97-28	19497-19500	the	_	
97-29	19501-19507	number	_	
97-30	19508-19510	of	_	
97-31	19511-19520	estimated	_	
97-32	19521-19531	components	_	
97-33	19532-19535	was	_	
97-34	19536-19546	restricted	_	
97-35	19547-19549	to	_	
97-36	19550-19551	8	_	
97-37	19552-19555	for	_	
97-38	19556-19560	each	_	
97-39	19561-19569	modality	_	
97-40	19569-19570	.	_	

#Text=Since data were from different modalities and the units of measurement were different, data were scaled to unit standard deviation, yielding z-scores.
98-1	19571-19576	Since	_	
98-2	19577-19581	data	_	
98-3	19582-19586	were	_	
98-4	19587-19591	from	_	
98-5	19592-19601	different	_	
98-6	19602-19612	modalities	_	
98-7	19613-19616	and	_	
98-8	19617-19620	the	_	
98-9	19621-19626	units	_	
98-10	19627-19629	of	_	
98-11	19630-19641	measurement	_	
98-12	19642-19646	were	_	
98-13	19647-19656	different	_	
98-14	19656-19657	,	_	
98-15	19658-19662	data	_	
98-16	19663-19667	were	_	
98-17	19668-19674	scaled	_	
98-18	19675-19677	to	_	
98-19	19678-19682	unit	_	
98-20	19683-19691	standard	_	
98-21	19692-19701	deviation	_	
98-22	19701-19702	,	_	
98-23	19703-19711	yielding	_	
98-24	19712-19720	z-scores	_	
98-25	19720-19721	.	_	

#Text=We optimized the parallel ICA using the correlation between mixing coefficients of the two modalities.
99-1	19722-19724	We	_	
99-2	19725-19734	optimized	_	
99-3	19735-19738	the	_	
99-4	19739-19747	parallel	_	
99-5	19748-19751	ICA	_	
99-6	19752-19757	using	_	
99-7	19758-19761	the	_	
99-8	19762-19773	correlation	_	
99-9	19774-19781	between	_	
99-10	19782-19788	mixing	_	
99-11	19789-19801	coefficients	_	
99-12	19802-19804	of	_	
99-13	19805-19808	the	_	
99-14	19809-19812	two	_	
99-15	19813-19823	modalities	_	
99-16	19823-19824	.	_	

#Text=Using Bonferroni correction, the correlation between seed-correlation and EEG-coherence components were considered significant for p < 0.05/64 = 0.0008 (there are 8 × 8 = 64 possible correlations between estimated ICA components).
100-1	19825-19830	Using	_	
100-2	19831-19841	Bonferroni	_	
100-3	19842-19852	correction	_	
100-4	19852-19853	,	_	
100-5	19854-19857	the	_	
100-6	19858-19869	correlation	_	
100-7	19870-19877	between	_	
100-8	19878-19894	seed-correlation	_	
100-9	19895-19898	and	_	
100-10	19899-19912	EEG-coherence	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
100-11	19913-19923	components	_	
100-12	19924-19928	were	_	
100-13	19929-19939	considered	_	
100-14	19940-19951	significant	_	
100-15	19952-19955	for	_	
100-16	19956-19957	p	_	
100-17	19957-19958	 	_	
100-18	19958-19959	<	_	
100-19	19959-19960	 	_	
100-20	19960-19964	0.05	_	
100-21	19964-19965	/	_	
100-22	19965-19967	64	_	
100-23	19967-19968	 	_	
100-24	19968-19969	=	_	
100-25	19969-19970	 	_	
100-26	19970-19976	0.0008	_	
100-27	19977-19978	(	_	
100-28	19978-19983	there	_	
100-29	19984-19987	are	_	
100-30	19988-19989	8	_	
100-31	19989-19990	 	_	
100-32	19990-19991	×	_	
100-33	19991-19992	 	_	
100-34	19992-19993	8	_	
100-35	19993-19994	 	_	
100-36	19994-19995	=	_	
100-37	19995-19996	 	_	
100-38	19996-19998	64	_	
100-39	19999-20007	possible	_	
100-40	20008-20020	correlations	_	
100-41	20021-20028	between	_	
100-42	20029-20038	estimated	_	
100-43	20039-20042	ICA	_	
100-44	20043-20053	components	_	
100-45	20053-20054	)	_	
100-46	20054-20055	.	_	

#Text=Similarly, using Bonferroni correction, group differences in the loading parameters for components were considered significant for p < 0.05/8 = 0.006 (group differences tested for 8 possible EEG or seed-correlation components).
101-1	20056-20065	Similarly	_	
101-2	20065-20066	,	_	
101-3	20067-20072	using	_	
101-4	20073-20083	Bonferroni	_	
101-5	20084-20094	correction	_	
101-6	20094-20095	,	_	
101-7	20096-20101	group	_	
101-8	20102-20113	differences	_	
101-9	20114-20116	in	_	
101-10	20117-20120	the	_	
101-11	20121-20128	loading	_	
101-12	20129-20139	parameters	_	
101-13	20140-20143	for	_	
101-14	20144-20154	components	_	
101-15	20155-20159	were	_	
101-16	20160-20170	considered	_	
101-17	20171-20182	significant	_	
101-18	20183-20186	for	_	
101-19	20187-20188	p	_	
101-20	20188-20189	 	_	
101-21	20189-20190	<	_	
101-22	20190-20191	 	_	
101-23	20191-20195	0.05	_	
101-24	20195-20196	/	_	
101-25	20196-20197	8	_	
101-26	20197-20198	 	_	
101-27	20198-20199	=	_	
101-28	20199-20200	 	_	
101-29	20200-20205	0.006	_	
101-30	20206-20207	(	_	
101-31	20207-20212	group	_	
101-32	20213-20224	differences	_	
101-33	20225-20231	tested	_	
101-34	20232-20235	for	_	
101-35	20236-20237	8	_	
101-36	20238-20246	possible	_	
101-37	20247-20250	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
101-38	20251-20253	or	_	
101-39	20254-20270	seed-correlation	_	
101-40	20271-20281	components	_	
101-41	20281-20282	)	_	
101-42	20282-20283	.	_	

#Text=Although the loading parameters estimate the overall contribution of every voxel or coherence of an estimated component to each subject's seed-correlation or coherence map, many of the voxels or coherences have relatively very small magnitude contribution to the component, although they can be presumed to covary jointly.
102-1	20284-20292	Although	_	
102-2	20293-20296	the	_	
102-3	20297-20304	loading	_	
102-4	20305-20315	parameters	_	
102-5	20316-20324	estimate	_	
102-6	20325-20328	the	_	
102-7	20329-20336	overall	_	
102-8	20337-20349	contribution	_	
102-9	20350-20352	of	_	
102-10	20353-20358	every	_	
102-11	20359-20364	voxel	_	
102-12	20365-20367	or	_	
102-13	20368-20377	coherence	_	
102-14	20378-20380	of	_	
102-15	20381-20383	an	_	
102-16	20384-20393	estimated	_	
102-17	20394-20403	component	_	
102-18	20404-20406	to	_	
102-19	20407-20411	each	_	
102-20	20412-20421	subject's	_	
102-21	20422-20438	seed-correlation	_	
102-22	20439-20441	or	_	
102-23	20442-20451	coherence	_	
102-24	20452-20455	map	_	
102-25	20455-20456	,	_	
102-26	20457-20461	many	_	
102-27	20462-20464	of	_	
102-28	20465-20468	the	_	
102-29	20469-20475	voxels	_	
102-30	20476-20478	or	_	
102-31	20479-20489	coherences	_	
102-32	20490-20494	have	_	
102-33	20495-20505	relatively	_	
102-34	20506-20510	very	_	
102-35	20511-20516	small	_	
102-36	20517-20526	magnitude	_	
102-37	20527-20539	contribution	_	
102-38	20540-20542	to	_	
102-39	20543-20546	the	_	
102-40	20547-20556	component	_	
102-41	20556-20557	,	_	
102-42	20558-20566	although	_	
102-43	20567-20571	they	_	
102-44	20572-20575	can	_	
102-45	20576-20578	be	_	
102-46	20579-20587	presumed	_	
102-47	20588-20590	to	_	
102-48	20591-20597	covary	_	
102-49	20598-20605	jointly	_	
102-50	20605-20606	.	_	

#Text=Therefore, to aid in visualization, each component was scaled to unit standard deviation, yielding z-score “networks”, then thresholded at | z | > 1.96, highlighting the largest magnitude contributions to each component.
103-1	20607-20616	Therefore	_	
103-2	20616-20617	,	_	
103-3	20618-20620	to	_	
103-4	20621-20624	aid	_	
103-5	20625-20627	in	_	
103-6	20628-20641	visualization	_	
103-7	20641-20642	,	_	
103-8	20643-20647	each	_	
103-9	20648-20657	component	_	
103-10	20658-20661	was	_	
103-11	20662-20668	scaled	_	
103-12	20669-20671	to	_	
103-13	20672-20676	unit	_	
103-14	20677-20685	standard	_	
103-15	20686-20695	deviation	_	
103-16	20695-20696	,	_	
103-17	20697-20705	yielding	_	
103-18	20706-20713	z-score	_	
103-19	20714-20715	“	_	
103-20	20715-20723	networks	_	
103-21	20723-20724	”	_	
103-22	20724-20725	,	_	
103-23	20726-20730	then	_	
103-24	20731-20742	thresholded	_	
103-25	20743-20745	at	_	
103-26	20746-20747	|	_	
103-27	20747-20748	 	_	
103-28	20748-20749	z	_	
103-29	20749-20750	 	_	
103-30	20750-20751	|	_	
103-31	20751-20752	 	_	
103-32	20752-20753	>	_	
103-33	20753-20754	 	_	
103-34	20754-20758	1.96	_	
103-35	20758-20759	,	_	
103-36	20760-20772	highlighting	_	
103-37	20773-20776	the	_	
103-38	20777-20784	largest	_	
103-39	20785-20794	magnitude	_	
103-40	20795-20808	contributions	_	
103-41	20809-20811	to	_	
103-42	20812-20816	each	_	
103-43	20817-20826	component	_	
103-44	20826-20827	.	_	

#Text=Results
#Text=Demographics and psychological measures
#Text=Demographics, alcohol/drug use measures, time between EEG and fMRI acquisition, and psychological measures of Non-Substance Abusing Control (NSAC) and Long-Term Abstinent Alcoholic (LTAA) participants.
104-1	20828-20835	Results	_	
104-2	20836-20848	Demographics	_	
104-3	20849-20852	and	_	
104-4	20853-20866	psychological	_	
104-5	20867-20875	measures	_	
104-6	20876-20888	Demographics	_	
104-7	20888-20889	,	_	
104-8	20890-20897	alcohol	_	
104-9	20897-20898	/	_	
104-10	20898-20902	drug	_	
104-11	20903-20906	use	_	
104-12	20907-20915	measures	_	
104-13	20915-20916	,	_	
104-14	20917-20921	time	_	
104-15	20922-20929	between	_	
104-16	20930-20933	EEG	_	
104-17	20934-20937	and	_	
104-18	20938-20942	fMRI	_	
104-19	20943-20954	acquisition	_	
104-20	20954-20955	,	_	
104-21	20956-20959	and	_	
104-22	20960-20973	psychological	_	
104-23	20974-20982	measures	_	
104-24	20983-20985	of	_	
104-25	20986-20999	Non-Substance	_	
104-26	21000-21007	Abusing	_	
104-27	21008-21015	Control	_	
104-28	21016-21017	(	_	
104-29	21017-21021	NSAC	_	
104-30	21021-21022	)	_	
104-31	21023-21026	and	_	
104-32	21027-21036	Long-Term	_	
104-33	21037-21046	Abstinent	_	
104-34	21047-21056	Alcoholic	_	
104-35	21057-21058	(	_	
104-36	21058-21062	LTAA	_	
104-37	21062-21063	)	_	
104-38	21064-21076	participants	_	
104-39	21076-21077	.	_	

#Text=Table 1.
105-1	21078-21083	Table	_	
105-2	21084-21085	1	_	
105-3	21085-21086	.	_	

#Text=Characteristic/measure\tNSAC (n = 21)\tLTAA (n = 20)\tEffect size partial η2(% variance)\tOdds ratio\t \tMean or n\tSD or %\tMean or n\tSD or %\t \tDemographics\t\t\t\t\t\t\t \tAge (yrs)\t47.33\t6.64\t47.20\t6.95\t0.00\t\t \tEducation (yrs)\t15.48\t2.16\t13.85\t2.03\t13.6⁎\t\t \tFemale, n (%)\t7\t33.33%\t7\t35%\t\t1.08\t \tWeeks between EEG and fMRI\t6.57\t8.24\t4.65\t9.48\t1.2\t\t \tAlcohol/drug use\t\t\t\t\t\t\t \tLifetime average drinks/month\t10.76\t8.53\t189.07\t165.36\t38.5⁎⁎, a\t\t \tPeak use drinks/month\t17.86\t15.04\t334.10\t263.15\t43.7⁎⁎, a\t\t \tLength of abstinence (days)\t–\t–\t2749.35\t2933.62\t–\t\t \tLifetime nicotine Use, n (%)\t3\t14.29%\t12\t60%\t\t9⁎\t \tCannabis use, n (%)\t2b\t9.52%\t2b\t10%\t\t1.06\t \tCocaine use, n (%)\t1b\t4.76%\t0\t0%\t\t0\t \tPsychological measures\t\t\t\t\t\t\t \tMMPI psychopathic deviance scale\t6.57\t8.24\t4.65\t9.48\t31.9⁎⁎⁎\t\t \tEysenck impulsivity scale\t3.38\t2.78\t9.05\t4.58\t37.3⁎⁎⁎\t\t \tCPI socialization scale\t22.24\t3.83\t17.10\t4.28\t29.7⁎⁎⁎\t\t \tASPD lifetime symptoms\t3.00\t3.07\t7.60\t4.82\t25.6⁎⁎\t\t \tASPD current symptoms\t0.67\t0.97\t1.25\t1.80\t4.2\t\t \t
#Text=p < 0.05.
#Text=p < 0.001.
#Text=p < 0.0001.
106-1	21090-21104	Characteristic	_	
106-2	21104-21105	/	_	
106-3	21105-21112	measure	_	
106-4	21113-21117	NSAC	_	
106-5	21118-21119	(	_	
106-6	21119-21120	n	_	
106-7	21120-21121	 	_	
106-8	21121-21122	=	_	
106-9	21122-21123	 	_	
106-10	21123-21125	21	_	
106-11	21125-21126	)	_	
106-12	21127-21131	LTAA	_	
106-13	21132-21133	(	_	
106-14	21133-21134	n	_	
106-15	21134-21135	 	_	
106-16	21135-21136	=	_	
106-17	21136-21137	 	_	
106-18	21137-21139	20	_	
106-19	21139-21140	)	_	
106-20	21141-21147	Effect	_	
106-21	21148-21152	size	_	
106-22	21153-21160	partial	_	
106-23	21161-21163	η2	_	
106-24	21163-21164	(	_	
106-25	21164-21165	%	_	
106-26	21166-21174	variance	_	
106-27	21174-21175	)	_	
106-28	21176-21180	Odds	_	
106-29	21181-21186	ratio	_	
106-30	21189-21193	Mean	_	
106-31	21194-21196	or	_	
106-32	21197-21198	n	_	
106-33	21199-21201	SD	_	
106-34	21202-21204	or	_	
106-35	21205-21206	%	_	
106-36	21207-21211	Mean	_	
106-37	21212-21214	or	_	
106-38	21215-21216	n	_	
106-39	21217-21219	SD	_	
106-40	21220-21222	or	_	
106-41	21223-21224	%	_	
106-42	21227-21239	Demographics	_	
106-43	21248-21251	Age	_	
106-44	21252-21253	(	_	
106-45	21253-21256	yrs	_	
106-46	21256-21257	)	_	
106-47	21258-21263	47.33	_	
106-48	21264-21268	6.64	_	
106-49	21269-21274	47.20	_	
106-50	21275-21279	6.95	_	
106-51	21280-21284	0.00	_	
106-52	21288-21297	Education	_	
106-53	21298-21299	(	_	
106-54	21299-21302	yrs	_	
106-55	21302-21303	)	_	
106-56	21304-21309	15.48	_	
106-57	21310-21314	2.16	_	
106-58	21315-21320	13.85	_	
106-59	21321-21325	2.03	_	
106-60	21326-21330	13.6	_	
106-61	21330-21331	⁎	_	
106-62	21335-21341	Female	_	
106-63	21341-21342	,	_	
106-64	21343-21344	n	_	
106-65	21345-21346	(	_	
106-66	21346-21347	%	_	
106-67	21347-21348	)	_	
106-68	21349-21350	7	_	
106-69	21351-21357	33.33%	_	
106-70	21358-21359	7	_	
106-71	21360-21363	35%	_	
106-72	21365-21369	1.08	_	
106-73	21372-21377	Weeks	_	
106-74	21378-21385	between	_	
106-75	21386-21389	EEG	_	
106-76	21390-21393	and	_	
106-77	21394-21398	fMRI	_	
106-78	21399-21403	6.57	_	
106-79	21404-21408	8.24	_	
106-80	21409-21413	4.65	_	
106-81	21414-21418	9.48	_	
106-82	21419-21422	1.2	_	
106-83	21426-21433	Alcohol	_	
106-84	21433-21434	/	_	
106-85	21434-21438	drug	_	
106-86	21439-21442	use	_	
106-87	21451-21459	Lifetime	_	
106-88	21460-21467	average	_	
106-89	21468-21474	drinks	_	
106-90	21474-21475	/	_	
106-91	21475-21480	month	_	
106-92	21481-21486	10.76	_	
106-93	21487-21491	8.53	_	
106-94	21492-21498	189.07	_	
106-95	21499-21505	165.36	_	
106-96	21506-21510	38.5	_	
106-97	21510-21511	⁎	_	
106-98	21511-21512	⁎	_	
106-99	21512-21513	,	_	
106-100	21514-21515	a	_	
106-101	21519-21523	Peak	_	
106-102	21524-21527	use	_	
106-103	21528-21534	drinks	_	
106-104	21534-21535	/	_	
106-105	21535-21540	month	_	
106-106	21541-21546	17.86	_	
106-107	21547-21552	15.04	_	
106-108	21553-21559	334.10	_	
106-109	21560-21566	263.15	_	
106-110	21567-21571	43.7	_	
106-111	21571-21572	⁎	_	
106-112	21572-21573	⁎	_	
106-113	21573-21574	,	_	
106-114	21575-21576	a	_	
106-115	21580-21586	Length	_	
106-116	21587-21589	of	_	
106-117	21590-21600	abstinence	_	
106-118	21601-21602	(	_	
106-119	21602-21606	days	_	
106-120	21606-21607	)	_	
106-121	21608-21609	–	_	
106-122	21610-21611	–	_	
106-123	21612-21619	2749.35	_	
106-124	21620-21627	2933.62	_	
106-125	21628-21629	–	_	
106-126	21633-21641	Lifetime	_	
106-127	21642-21650	nicotine	_	
106-128	21651-21654	Use	_	
106-129	21654-21655	,	_	
106-130	21656-21657	n	_	
106-131	21658-21659	(	_	
106-132	21659-21660	%	_	
106-133	21660-21661	)	_	
106-134	21662-21663	3	_	
106-135	21664-21670	14.29%	_	
106-136	21671-21673	12	_	
106-137	21674-21677	60%	_	
106-138	21679-21680	9	_	
106-139	21680-21681	⁎	_	
106-140	21684-21692	Cannabis	_	
106-141	21693-21696	use	_	
106-142	21696-21697	,	_	
106-143	21698-21699	n	_	
106-144	21700-21701	(	_	
106-145	21701-21702	%	_	
106-146	21702-21703	)	_	
106-147	21704-21706	2b	_	
106-148	21707-21712	9.52%	_	
106-149	21713-21715	2b	_	
106-150	21716-21719	10%	_	
106-151	21721-21725	1.06	_	
106-152	21728-21735	Cocaine	_	
106-153	21736-21739	use	_	
106-154	21739-21740	,	_	
106-155	21741-21742	n	_	
106-156	21743-21744	(	_	
106-157	21744-21745	%	_	
106-158	21745-21746	)	_	
106-159	21747-21749	1b	_	
106-160	21750-21755	4.76%	_	
106-161	21756-21757	0	_	
106-162	21758-21760	0%	_	
106-163	21762-21763	0	_	
106-164	21766-21779	Psychological	_	
106-165	21780-21788	measures	_	
106-166	21797-21801	MMPI	_	
106-167	21802-21814	psychopathic	_	
106-168	21815-21823	deviance	_	
106-169	21824-21829	scale	_	
106-170	21830-21834	6.57	_	
106-171	21835-21839	8.24	_	
106-172	21840-21844	4.65	_	
106-173	21845-21849	9.48	_	
106-174	21850-21854	31.9	_	
106-175	21854-21855	⁎	_	
106-176	21855-21856	⁎	_	
106-177	21856-21857	⁎	_	
106-178	21861-21868	Eysenck	_	
106-179	21869-21880	impulsivity	_	
106-180	21881-21886	scale	_	
106-181	21887-21891	3.38	_	
106-182	21892-21896	2.78	_	
106-183	21897-21901	9.05	_	
106-184	21902-21906	4.58	_	
106-185	21907-21911	37.3	_	
106-186	21911-21912	⁎	_	
106-187	21912-21913	⁎	_	
106-188	21913-21914	⁎	_	
106-189	21918-21921	CPI	_	
106-190	21922-21935	socialization	_	
106-191	21936-21941	scale	_	
106-192	21942-21947	22.24	_	
106-193	21948-21952	3.83	_	
106-194	21953-21958	17.10	_	
106-195	21959-21963	4.28	_	
106-196	21964-21968	29.7	_	
106-197	21968-21969	⁎	_	
106-198	21969-21970	⁎	_	
106-199	21970-21971	⁎	_	
106-200	21975-21979	ASPD	_	
106-201	21980-21988	lifetime	_	
106-202	21989-21997	symptoms	_	
106-203	21998-22002	3.00	_	
106-204	22003-22007	3.07	_	
106-205	22008-22012	7.60	_	
106-206	22013-22017	4.82	_	
106-207	22018-22022	25.6	_	
106-208	22022-22023	⁎	_	
106-209	22023-22024	⁎	_	
106-210	22028-22032	ASPD	_	
106-211	22033-22040	current	_	
106-212	22041-22049	symptoms	_	
106-213	22050-22054	0.67	_	
106-214	22055-22059	0.97	_	
106-215	22060-22064	1.25	_	
106-216	22065-22069	1.80	_	
106-217	22070-22073	4.2	_	
106-218	22078-22079	p	_	
106-219	22079-22080	 	_	
106-220	22080-22081	<	_	
106-221	22081-22082	 	_	
106-222	22082-22086	0.05	_	
106-223	22086-22087	.	_	
106-224	22088-22089	p	_	
106-225	22089-22090	 	_	
106-226	22090-22091	<	_	
106-227	22091-22092	 	_	
106-228	22092-22097	0.001	_	
106-229	22097-22098	.	_	
106-230	22099-22100	p	_	
106-231	22100-22101	 	_	
106-232	22101-22102	<	_	
106-233	22102-22103	 	_	
106-234	22103-22109	0.0001	_	
106-235	22109-22110	.	_	

#Text=Statistical comparisons are inappropriate since the variable is related to selection criteria.
107-1	22111-22122	Statistical	_	
107-2	22123-22134	comparisons	_	
107-3	22135-22138	are	_	
107-4	22139-22152	inappropriate	_	
107-5	22153-22158	since	_	
107-6	22159-22162	the	_	
107-7	22163-22171	variable	_	
107-8	22172-22174	is	_	
107-9	22175-22182	related	_	
107-10	22183-22185	to	_	
107-11	22186-22195	selection	_	
107-12	22196-22204	criteria	_	
107-13	22204-22205	.	_	

#Text=Recreational substance use only, no subjects met criteria for abuse or dependence; subjects had been abstinent from these substances for an average of 18 years at the time of assessments.
108-1	22206-22218	Recreational	_	
108-2	22219-22228	substance	_	
108-3	22229-22232	use	_	
108-4	22233-22237	only	_	
108-5	22237-22238	,	_	
108-6	22239-22241	no	_	
108-7	22242-22250	subjects	_	
108-8	22251-22254	met	_	
108-9	22255-22263	criteria	_	
108-10	22264-22267	for	_	
108-11	22268-22273	abuse	_	
108-12	22274-22276	or	_	
108-13	22277-22287	dependence	_	
108-14	22287-22288	;	_	
108-15	22289-22297	subjects	_	
108-16	22298-22301	had	_	
108-17	22302-22306	been	_	
108-18	22307-22316	abstinent	_	
108-19	22317-22321	from	_	
108-20	22322-22327	these	_	
108-21	22328-22338	substances	_	
108-22	22339-22342	for	_	
108-23	22343-22345	an	_	
108-24	22346-22353	average	_	
108-25	22354-22356	of	_	
108-26	22357-22359	18	_	
108-27	22359-22360	 	_	
108-28	22360-22365	years	_	
108-29	22366-22368	at	_	
108-30	22369-22372	the	_	
108-31	22373-22377	time	_	
108-32	22378-22380	of	_	
108-33	22381-22392	assessments	_	
108-34	22392-22393	.	_	

#Text=Table 1 shows demographics, alcohol/drug use measures, and psychological measures for NSAC and LTAA.
109-1	22394-22399	Table	_	
109-2	22400-22401	1	_	
109-3	22402-22407	shows	_	
109-4	22408-22420	demographics	_	
109-5	22420-22421	,	_	
109-6	22422-22429	alcohol	_	
109-7	22429-22430	/	_	
109-8	22430-22434	drug	_	
109-9	22435-22438	use	_	
109-10	22439-22447	measures	_	
109-11	22447-22448	,	_	
109-12	22449-22452	and	_	
109-13	22453-22466	psychological	_	
109-14	22467-22475	measures	_	
109-15	22476-22479	for	_	
109-16	22480-22484	NSAC	_	
109-17	22485-22488	and	_	
109-18	22489-22493	LTAA	_	
109-19	22493-22494	.	_	

#Text=NSAC and LTAA did not differ by age or proportion of women in each group.
110-1	22495-22499	NSAC	_	
110-2	22500-22503	and	_	
110-3	22504-22508	LTAA	_	
110-4	22509-22512	did	_	
110-5	22513-22516	not	_	
110-6	22517-22523	differ	_	
110-7	22524-22526	by	_	
110-8	22527-22530	age	_	
110-9	22531-22533	or	_	
110-10	22534-22544	proportion	_	
110-11	22545-22547	of	_	
110-12	22548-22553	women	_	
110-13	22554-22556	in	_	
110-14	22557-22561	each	_	
110-15	22562-22567	group	_	
110-16	22567-22568	.	_	

#Text=NSAC had slightly more years of education compared to LTAA (15 vs. 14 yrs, η2 = 13.6, p = 0.02) and not surprisingly there were more LTAA with a lifetime history of smoking (12/20 vs. 3/21, odds ratio = 9, p = 0.005).
111-1	22569-22573	NSAC	_	
111-2	22574-22577	had	_	
111-3	22578-22586	slightly	_	
111-4	22587-22591	more	_	
111-5	22592-22597	years	_	
111-6	22598-22600	of	_	
111-7	22601-22610	education	_	
111-8	22611-22619	compared	_	
111-9	22620-22622	to	_	
111-10	22623-22627	LTAA	_	
111-11	22628-22629	(	_	
111-12	22629-22631	15	_	
111-13	22632-22634	vs	_	
111-14	22634-22635	.	_	
111-15	22636-22638	14	_	
111-16	22638-22639	 	_	
111-17	22639-22642	yrs	_	
111-18	22642-22643	,	_	
111-19	22644-22646	η2	_	
111-20	22646-22647	 	_	
111-21	22647-22648	=	_	
111-22	22648-22649	 	_	
111-23	22649-22653	13.6	_	
111-24	22653-22654	,	_	
111-25	22655-22656	p	_	
111-26	22656-22657	 	_	
111-27	22657-22658	=	_	
111-28	22658-22659	 	_	
111-29	22659-22663	0.02	_	
111-30	22663-22664	)	_	
111-31	22665-22668	and	_	
111-32	22669-22672	not	_	
111-33	22673-22685	surprisingly	_	
111-34	22686-22691	there	_	
111-35	22692-22696	were	_	
111-36	22697-22701	more	_	
111-37	22702-22706	LTAA	_	
111-38	22707-22711	with	_	
111-39	22712-22713	a	_	
111-40	22714-22722	lifetime	_	
111-41	22723-22730	history	_	
111-42	22731-22733	of	_	
111-43	22734-22741	smoking	_	
111-44	22742-22743	(	_	
111-45	22743-22745	12	_	
111-46	22745-22746	/	_	
111-47	22746-22748	20	_	
111-48	22749-22751	vs	_	
111-49	22751-22752	.	_	
111-50	22753-22754	3	_	
111-51	22754-22755	/	_	
111-52	22755-22757	21	_	
111-53	22757-22758	,	_	
111-54	22759-22763	odds	_	
111-55	22764-22769	ratio	_	
111-56	22769-22770	 	_	
111-57	22770-22771	=	_	
111-58	22771-22772	 	_	
111-59	22772-22773	9	_	
111-60	22773-22774	,	_	
111-61	22775-22776	p	_	
111-62	22776-22777	 	_	
111-63	22777-22778	=	_	
111-64	22778-22779	 	_	
111-65	22779-22784	0.005	_	
111-66	22784-22785	)	_	
111-67	22785-22786	.	_	

#Text=LTAA drank an average of 189 ± 165 standard drinks/month over their lifetime with a peak use of 334 ± 263 drinks/month.
112-1	22787-22791	LTAA	_	
112-2	22792-22797	drank	_	
112-3	22798-22800	an	_	
112-4	22801-22808	average	_	
112-5	22809-22811	of	_	
112-6	22812-22815	189	_	
112-7	22815-22816	 	_	
112-8	22816-22817	±	_	
112-9	22817-22818	 	_	
112-10	22818-22821	165	_	
112-11	22821-22822	 	_	
112-12	22822-22830	standard	_	
112-13	22831-22837	drinks	_	
112-14	22837-22838	/	_	
112-15	22838-22843	month	_	
112-16	22844-22848	over	_	
112-17	22849-22854	their	_	
112-18	22855-22863	lifetime	_	
112-19	22864-22868	with	_	
112-20	22869-22870	a	_	
112-21	22871-22875	peak	_	
112-22	22876-22879	use	_	
112-23	22880-22882	of	_	
112-24	22883-22886	334	_	
112-25	22886-22887	 	_	
112-26	22887-22888	±	_	
112-27	22888-22889	 	_	
112-28	22889-22892	263	_	
112-29	22892-22893	 	_	
112-30	22893-22899	drinks	_	
112-31	22899-22900	/	_	
112-32	22900-22905	month	_	
112-33	22905-22906	.	_	

#Text=LTAA had been abstinent an average of 2749 ± 2933 days (about 7.5 yrs, min/max 1.6/32 yrs).
113-1	22907-22911	LTAA	_	
113-2	22912-22915	had	_	
113-3	22916-22920	been	_	
113-4	22921-22930	abstinent	_	
113-5	22931-22933	an	_	
113-6	22934-22941	average	_	
113-7	22942-22944	of	_	
113-8	22945-22949	2749	_	
113-9	22949-22950	 	_	
113-10	22950-22951	±	_	
113-11	22951-22952	 	_	
113-12	22952-22956	2933	_	
113-13	22956-22957	 	_	
113-14	22957-22961	days	_	
113-15	22962-22963	(	_	
113-16	22963-22968	about	_	
113-17	22969-22972	7.5	_	
113-18	22972-22973	 	_	
113-19	22973-22976	yrs	_	
113-20	22976-22977	,	_	
113-21	22978-22981	min	_	
113-22	22981-22982	/	_	
113-23	22982-22985	max	_	
113-24	22986-22989	1.6	_	
113-25	22989-22990	/	_	
113-26	22990-22992	32	_	
113-27	22992-22993	 	_	
113-28	22993-22996	yrs	_	
113-29	22996-22997	)	_	
113-30	22997-22998	.	_	

#Text=EEG and fMRI testing sessions were 6.56 ± 8.24 weeks apart for NSAC, and 4.65 ± 9.48 weeks for LTAA (η2 = 1.2, NS), with a range of 0–34 weeks between sessions.
114-1	22999-23002	EEG	_	
114-2	23003-23006	and	_	
114-3	23007-23011	fMRI	_	
114-4	23012-23019	testing	_	
114-5	23020-23028	sessions	_	
114-6	23029-23033	were	_	
114-7	23034-23038	6.56	_	
114-8	23038-23039	 	_	
114-9	23039-23040	±	_	
114-10	23040-23041	 	_	
114-11	23041-23045	8.24	_	
114-12	23045-23046	 	_	
114-13	23046-23051	weeks	_	
114-14	23052-23057	apart	_	
114-15	23058-23061	for	_	
114-16	23062-23066	NSAC	_	
114-17	23066-23067	,	_	
114-18	23068-23071	and	_	
114-19	23072-23076	4.65	_	
114-20	23076-23077	 	_	
114-21	23077-23078	±	_	
114-22	23078-23079	 	_	
114-23	23079-23083	9.48	_	
114-24	23083-23084	 	_	
114-25	23084-23089	weeks	_	
114-26	23090-23093	for	_	
114-27	23094-23098	LTAA	_	
114-28	23099-23100	(	_	
114-29	23100-23102	η2	_	
114-30	23102-23103	 	_	
114-31	23103-23104	=	_	
114-32	23104-23105	 	_	
114-33	23105-23108	1.2	_	
114-34	23108-23109	,	_	
114-35	23110-23112	NS	_	
114-36	23112-23113	)	_	
114-37	23113-23114	,	_	
114-38	23115-23119	with	_	
114-39	23120-23121	a	_	
114-40	23122-23127	range	_	
114-41	23128-23130	of	_	
114-42	23131-23132	0	_	
114-43	23132-23133	–	_	
114-44	23133-23135	34	_	
114-45	23135-23136	 	_	
114-46	23136-23141	weeks	_	
114-47	23142-23149	between	_	
114-48	23150-23158	sessions	_	
114-49	23158-23159	.	_	

#Text=LTAA were more prone to social deviance as evidenced by lower CPI-sociability scores (17 vs. 22, η2 = 29.7, p < 0.0001), were more impulsive (9 vs. 3, η2 = 37.3, p < 0.0001), and had greater antisocial disposition (23 vs. 16, η2 = 31.9, p < 0.0001).
115-1	23160-23164	LTAA	_	
115-2	23165-23169	were	_	
115-3	23170-23174	more	_	
115-4	23175-23180	prone	_	
115-5	23181-23183	to	_	
115-6	23184-23190	social	_	
115-7	23191-23199	deviance	_	
115-8	23200-23202	as	_	
115-9	23203-23212	evidenced	_	
115-10	23213-23215	by	_	
115-11	23216-23221	lower	_	
115-12	23222-23237	CPI-sociability	_	
115-13	23238-23244	scores	_	
115-14	23245-23246	(	_	
115-15	23246-23248	17	_	
115-16	23249-23251	vs	_	
115-17	23251-23252	.	_	
115-18	23253-23255	22	_	
115-19	23255-23256	,	_	
115-20	23257-23259	η2	_	
115-21	23259-23260	 	_	
115-22	23260-23261	=	_	
115-23	23261-23262	 	_	
115-24	23262-23266	29.7	_	
115-25	23266-23267	,	_	
115-26	23268-23269	p	_	
115-27	23269-23270	 	_	
115-28	23270-23271	<	_	
115-29	23271-23272	 	_	
115-30	23272-23278	0.0001	_	
115-31	23278-23279	)	_	
115-32	23279-23280	,	_	
115-33	23281-23285	were	_	
115-34	23286-23290	more	_	
115-35	23291-23300	impulsive	_	
115-36	23301-23302	(	_	
115-37	23302-23303	9	_	
115-38	23304-23306	vs	_	
115-39	23306-23307	.	_	
115-40	23308-23309	3	_	
115-41	23309-23310	,	_	
115-42	23311-23313	η2	_	
115-43	23313-23314	 	_	
115-44	23314-23315	=	_	
115-45	23315-23316	 	_	
115-46	23316-23320	37.3	_	
115-47	23320-23321	,	_	
115-48	23322-23323	p	_	
115-49	23323-23324	 	_	
115-50	23324-23325	<	_	
115-51	23325-23326	 	_	
115-52	23326-23332	0.0001	_	
115-53	23332-23333	)	_	
115-54	23333-23334	,	_	
115-55	23335-23338	and	_	
115-56	23339-23342	had	_	
115-57	23343-23350	greater	_	
115-58	23351-23361	antisocial	_	
115-59	23362-23373	disposition	_	
115-60	23374-23375	(	_	
115-61	23375-23377	23	_	
115-62	23378-23380	vs	_	
115-63	23380-23381	.	_	
115-64	23382-23384	16	_	
115-65	23384-23385	,	_	
115-66	23386-23388	η2	_	
115-67	23388-23389	 	_	
115-68	23389-23390	=	_	
115-69	23390-23391	 	_	
115-70	23391-23395	31.9	_	
115-71	23395-23396	,	_	
115-72	23397-23398	p	_	
115-73	23398-23399	 	_	
115-74	23399-23400	<	_	
115-75	23400-23401	 	_	
115-76	23401-23407	0.0001	_	
115-77	23407-23408	)	_	
115-78	23408-23409	.	_	

#Text=LTAA also had higher ASPD lifetime symptoms counts (7.6 vs. 3.0, η2 = 25.6, p = 0.001) but comparable current ASPD symptom counts (1.25 vs. 0.67, η2 = 4.2, NS).
116-1	23410-23414	LTAA	_	
116-2	23415-23419	also	_	
116-3	23420-23423	had	_	
116-4	23424-23430	higher	_	
116-5	23431-23435	ASPD	_	
116-6	23436-23444	lifetime	_	
116-7	23445-23453	symptoms	_	
116-8	23454-23460	counts	_	
116-9	23461-23462	(	_	
116-10	23462-23465	7.6	_	
116-11	23466-23468	vs	_	
116-12	23468-23469	.	_	
116-13	23470-23473	3.0	_	
116-14	23473-23474	,	_	
116-15	23475-23477	η2	_	
116-16	23477-23478	 	_	
116-17	23478-23479	=	_	
116-18	23479-23480	 	_	
116-19	23480-23484	25.6	_	
116-20	23484-23485	,	_	
116-21	23486-23487	p	_	
116-22	23487-23488	 	_	
116-23	23488-23489	=	_	
116-24	23489-23490	 	_	
116-25	23490-23495	0.001	_	
116-26	23495-23496	)	_	
116-27	23497-23500	but	_	
116-28	23501-23511	comparable	_	
116-29	23512-23519	current	_	
116-30	23520-23524	ASPD	_	
116-31	23525-23532	symptom	_	
116-32	23533-23539	counts	_	
116-33	23540-23541	(	_	
116-34	23541-23545	1.25	_	
116-35	23546-23548	vs	_	
116-36	23548-23549	.	_	
116-37	23550-23554	0.67	_	
116-38	23554-23555	,	_	
116-39	23556-23558	η2	_	
116-40	23558-23559	 	_	
116-41	23559-23560	=	_	
116-42	23560-23561	 	_	
116-43	23561-23564	4.2	_	
116-44	23564-23565	,	_	
116-45	23566-23568	NS	_	
116-46	23568-23569	)	_	
116-47	23569-23570	.	_	

#Text=These results imply that LTAA were able to inhibit their antisocial behavior despite an unchanged antisocial disposition.
117-1	23571-23576	These	_	
117-2	23577-23584	results	_	
117-3	23585-23590	imply	_	
117-4	23591-23595	that	_	
117-5	23596-23600	LTAA	_	
117-6	23601-23605	were	_	
117-7	23606-23610	able	_	
117-8	23611-23613	to	_	
117-9	23614-23621	inhibit	_	
117-10	23622-23627	their	_	
117-11	23628-23638	antisocial	_	
117-12	23639-23647	behavior	_	
117-13	23648-23655	despite	_	
117-14	23656-23658	an	_	
117-15	23659-23668	unchanged	_	
117-16	23669-23679	antisocial	_	
117-17	23680-23691	disposition	_	
117-18	23691-23692	.	_	

#Text=Parallel ICA
#Text=The rs-fMRI seed-correlation map component that differentiates between LTAA and NSAC and is linked to EEG coherence is shown, after converting to z-scores and thresholding at | z | > 1.96.
118-1	23693-23701	Parallel	_	
118-2	23702-23705	ICA	_	
118-3	23706-23709	The	_	
118-4	23710-23717	rs-fMRI	_	
118-5	23718-23734	seed-correlation	_	
118-6	23735-23738	map	_	
118-7	23739-23748	component	_	
118-8	23749-23753	that	_	
118-9	23754-23768	differentiates	_	
118-10	23769-23776	between	_	
118-11	23777-23781	LTAA	_	
118-12	23782-23785	and	_	
118-13	23786-23790	NSAC	_	
118-14	23791-23794	and	_	
118-15	23795-23797	is	_	
118-16	23798-23804	linked	_	
118-17	23805-23807	to	_	
118-18	23808-23811	EEG	_	
118-19	23812-23821	coherence	_	
118-20	23822-23824	is	_	
118-21	23825-23830	shown	_	
118-22	23830-23831	,	_	
118-23	23832-23837	after	_	
118-24	23838-23848	converting	_	
118-25	23849-23851	to	_	
118-26	23852-23860	z-scores	_	
118-27	23861-23864	and	_	
118-28	23865-23877	thresholding	_	
118-29	23878-23880	at	_	
118-30	23881-23882	|	_	
118-31	23882-23883	 	_	
118-32	23883-23884	z	_	
118-33	23884-23885	 	_	
118-34	23885-23886	|	_	
118-35	23886-23887	 	_	
118-36	23887-23888	>	_	
118-37	23888-23889	 	_	
118-38	23889-23893	1.96	_	
118-39	23893-23894	.	_	

#Text=The component encompasses regions involved in executive control and appetitive drive networks and shows higher (voxels shaded red) NAcc seed-correlation in the dorsolateral prefrontal cortex (DLPFC) and lower (voxels shaded blue) seed-correlation in the thalamus for LTAA vs.
119-1	23895-23898	The	_	
119-2	23899-23908	component	_	
119-3	23909-23920	encompasses	_	
119-4	23921-23928	regions	_	
119-5	23929-23937	involved	_	
119-6	23938-23940	in	_	
119-7	23941-23950	executive	_	
119-8	23951-23958	control	_	
119-9	23959-23962	and	_	
119-10	23963-23973	appetitive	_	
119-11	23974-23979	drive	_	
119-12	23980-23988	networks	_	
119-13	23989-23992	and	_	
119-14	23993-23998	shows	_	
119-15	23999-24005	higher	_	
119-16	24006-24007	(	_	
119-17	24007-24013	voxels	_	
119-18	24014-24020	shaded	_	
119-19	24021-24024	red	_	
119-20	24024-24025	)	_	
119-21	24026-24030	NAcc	_	
119-22	24031-24047	seed-correlation	_	
119-23	24048-24050	in	_	
119-24	24051-24054	the	_	
119-25	24055-24067	dorsolateral	_	
119-26	24068-24078	prefrontal	_	
119-27	24079-24085	cortex	_	
119-28	24086-24087	(	_	
119-29	24087-24092	DLPFC	_	
119-30	24092-24093	)	_	
119-31	24094-24097	and	_	
119-32	24098-24103	lower	_	
119-33	24104-24105	(	_	
119-34	24105-24111	voxels	_	
119-35	24112-24118	shaded	_	
119-36	24119-24123	blue	_	
119-37	24123-24124	)	_	
119-38	24125-24141	seed-correlation	_	
119-39	24142-24144	in	_	
119-40	24145-24148	the	_	
119-41	24149-24157	thalamus	_	
119-42	24158-24161	for	_	
119-43	24162-24166	LTAA	_	
119-44	24167-24169	vs	_	
119-45	24169-24170	.	_	

#Text=NSAC.
120-1	24171-24175	NSAC	_	
120-2	24175-24176	.	_	

#Text=The component also shows higher seed-correlation in the anterior cingulate (AC), bilateral inferior frontal regions extending posteriorly, and lower seed correlation in the insula.
121-1	24177-24180	The	_	
121-2	24181-24190	component	_	
121-3	24191-24195	also	_	
121-4	24196-24201	shows	_	
121-5	24202-24208	higher	_	
121-6	24209-24225	seed-correlation	_	
121-7	24226-24228	in	_	
121-8	24229-24232	the	_	
121-9	24233-24241	anterior	_	
121-10	24242-24251	cingulate	_	
121-11	24252-24253	(	_	
121-12	24253-24255	AC	_	
121-13	24255-24256	)	_	
121-14	24256-24257	,	_	
121-15	24258-24267	bilateral	_	
121-16	24268-24276	inferior	_	
121-17	24277-24284	frontal	_	
121-18	24285-24292	regions	_	
121-19	24293-24302	extending	_	
121-20	24303-24314	posteriorly	_	
121-21	24314-24315	,	_	
121-22	24316-24319	and	_	
121-23	24320-24325	lower	_	
121-24	24326-24330	seed	_	
121-25	24331-24342	correlation	_	
121-26	24343-24345	in	_	
121-27	24346-24349	the	_	
121-28	24350-24356	insula	_	
121-29	24356-24357	.	_	

#Text=Fig. 1.
122-1	24358-24361	Fig	_	
122-2	24361-24362	.	_	
122-3	24363-24364	1	_	
122-4	24364-24365	.	_	

#Text=Parallel ICA revealed 3 sets of significantly correlated seed-correlation/EEG-coherence components.
123-1	24366-24374	Parallel	_	
123-2	24375-24378	ICA	_	
123-3	24379-24387	revealed	_	
123-4	24388-24389	3	_	
123-5	24390-24394	sets	_	
123-6	24395-24397	of	_	
123-7	24398-24411	significantly	_	
123-8	24412-24422	correlated	_	
123-9	24423-24439	seed-correlation	_	
123-10	24439-24440	/	_	
123-11	24440-24453	EEG-coherence	_	
123-12	24454-24464	components	_	
123-13	24464-24465	.	_	

#Text=Of these 3 sets, however, only one was comprised of components that were also significantly different between LTAA and NSAC.
124-1	24466-24468	Of	_	
124-2	24469-24474	these	_	
124-3	24475-24476	3	_	
124-4	24477-24481	sets	_	
124-5	24481-24482	,	_	
124-6	24483-24490	however	_	
124-7	24490-24491	,	_	
124-8	24492-24496	only	_	
124-9	24497-24500	one	_	
124-10	24501-24504	was	_	
124-11	24505-24514	comprised	_	
124-12	24515-24517	of	_	
124-13	24518-24528	components	_	
124-14	24529-24533	that	_	
124-15	24534-24538	were	_	
124-16	24539-24543	also	_	
124-17	24544-24557	significantly	_	
124-18	24558-24567	different	_	
124-19	24568-24575	between	_	
124-20	24576-24580	LTAA	_	
124-21	24581-24584	and	_	
124-22	24585-24589	NSAC	_	
124-23	24589-24590	.	_	

#Text=This pair of components had a correlation coefficient of r = − 0.60 (t39 = − 4.71, corrected p = 0.002).
125-1	24591-24595	This	_	
125-2	24596-24600	pair	_	
125-3	24601-24603	of	_	
125-4	24604-24614	components	_	
125-5	24615-24618	had	_	
125-6	24619-24620	a	_	
125-7	24621-24632	correlation	_	
125-8	24633-24644	coefficient	_	
125-9	24645-24647	of	_	
125-10	24648-24649	r	_	
125-11	24649-24650	 	_	
125-12	24650-24651	=	_	
125-13	24651-24652	 	_	
125-14	24652-24653	−	_	
125-15	24653-24654	 	_	
125-16	24654-24658	0.60	_	
125-17	24659-24660	(	_	
125-18	24660-24663	t39	_	
125-19	24663-24664	 	_	
125-20	24664-24665	=	_	
125-21	24665-24666	 	_	
125-22	24666-24667	−	_	
125-23	24667-24668	 	_	
125-24	24668-24672	4.71	_	
125-25	24672-24673	,	_	
125-26	24674-24683	corrected	_	
125-27	24684-24685	p	_	
125-28	24685-24686	 	_	
125-29	24686-24687	=	_	
125-30	24687-24688	 	_	
125-31	24688-24693	0.002	_	
125-32	24693-24694	)	_	
125-33	24694-24695	.	_	

#Text=A two-sample t-test computed on the loading parameters for the seed-correlation map showed group difference with corrected p = 0.0004 (t39 = 4.54), with LTAA having higher loading than NSAC.
126-1	24696-24697	A	_	
126-2	24698-24708	two-sample	_	
126-3	24709-24715	t-test	_	
126-4	24716-24724	computed	_	
126-5	24725-24727	on	_	
126-6	24728-24731	the	_	
126-7	24732-24739	loading	_	
126-8	24740-24750	parameters	_	
126-9	24751-24754	for	_	
126-10	24755-24758	the	_	
126-11	24759-24775	seed-correlation	_	
126-12	24776-24779	map	_	
126-13	24780-24786	showed	_	
126-14	24787-24792	group	_	
126-15	24793-24803	difference	_	
126-16	24804-24808	with	_	
126-17	24809-24818	corrected	_	
126-18	24819-24820	p	_	
126-19	24820-24821	 	_	
126-20	24821-24822	=	_	
126-21	24822-24823	 	_	
126-22	24823-24829	0.0004	_	
126-23	24830-24831	(	_	
126-24	24831-24834	t39	_	
126-25	24834-24835	 	_	
126-26	24835-24836	=	_	
126-27	24836-24837	 	_	
126-28	24837-24841	4.54	_	
126-29	24841-24842	)	_	
126-30	24842-24843	,	_	
126-31	24844-24848	with	_	
126-32	24849-24853	LTAA	_	
126-33	24854-24860	having	_	
126-34	24861-24867	higher	_	
126-35	24868-24875	loading	_	
126-36	24876-24880	than	_	
126-37	24881-24885	NSAC	_	
126-38	24885-24886	.	_	

#Text=Because LTAA had more lifetime smokers and fewer years of education, we compared the loading parameters for the seed-correlation maps using a linear model, covarying for smoking and education.
127-1	24887-24894	Because	_	
127-2	24895-24899	LTAA	_	
127-3	24900-24903	had	_	
127-4	24904-24908	more	_	
127-5	24909-24917	lifetime	_	
127-6	24918-24925	smokers	_	
127-7	24926-24929	and	_	
127-8	24930-24935	fewer	_	
127-9	24936-24941	years	_	
127-10	24942-24944	of	_	
127-11	24945-24954	education	_	
127-12	24954-24955	,	_	
127-13	24956-24958	we	_	
127-14	24959-24967	compared	_	
127-15	24968-24971	the	_	
127-16	24972-24979	loading	_	
127-17	24980-24990	parameters	_	
127-18	24991-24994	for	_	
127-19	24995-24998	the	_	
127-20	24999-25015	seed-correlation	_	
127-21	25016-25020	maps	_	
127-22	25021-25026	using	_	
127-23	25027-25028	a	_	
127-24	25029-25035	linear	_	
127-25	25036-25041	model	_	
127-26	25041-25042	,	_	
127-27	25043-25052	covarying	_	
127-28	25053-25056	for	_	
127-29	25057-25064	smoking	_	
127-30	25065-25068	and	_	
127-31	25069-25078	education	_	
127-32	25078-25079	.	_	

#Text=This analysis showed a group difference with p = 0.005 (t37 = 2.97), so smoking and education could not explain all of the group difference.
128-1	25080-25084	This	_	
128-2	25085-25093	analysis	_	
128-3	25094-25100	showed	_	
128-4	25101-25102	a	_	
128-5	25103-25108	group	_	
128-6	25109-25119	difference	_	
128-7	25120-25124	with	_	
128-8	25125-25126	p	_	
128-9	25126-25127	 	_	
128-10	25127-25128	=	_	
128-11	25128-25129	 	_	
128-12	25129-25134	0.005	_	
128-13	25135-25136	(	_	
128-14	25136-25139	t37	_	
128-15	25139-25140	 	_	
128-16	25140-25141	=	_	
128-17	25141-25142	 	_	
128-18	25142-25146	2.97	_	
128-19	25146-25147	)	_	
128-20	25147-25148	,	_	
128-21	25149-25151	so	_	
128-22	25152-25159	smoking	_	
128-23	25160-25163	and	_	
128-24	25164-25173	education	_	
128-25	25174-25179	could	_	
128-26	25180-25183	not	_	
128-27	25184-25191	explain	_	
128-28	25192-25195	all	_	
128-29	25196-25198	of	_	
128-30	25199-25202	the	_	
128-31	25203-25208	group	_	
128-32	25209-25219	difference	_	
128-33	25219-25220	.	_	

#Text=Examination of the rs-fMRI seed-correlation map component, after converting to z-scores and thresholding at | z | > 1.96, shows higher NAcc seed-correlation in the dorsolateral prefrontal cortex bilaterally but more pronounced on the left (consistent with a bigger effect for inhibitory control vs. emotion regulation executive control networks), and lower seed-correlation in the thalamus (see Fig. 1, voxels shaded red show higher correlation for LTAA, voxels shaded blue show lower correlation for LTAA) for LTAA vs.
129-1	25221-25232	Examination	_	
129-2	25233-25235	of	_	
129-3	25236-25239	the	_	
129-4	25240-25247	rs-fMRI	_	
129-5	25248-25264	seed-correlation	_	
129-6	25265-25268	map	_	
129-7	25269-25278	component	_	
129-8	25278-25279	,	_	
129-9	25280-25285	after	_	
129-10	25286-25296	converting	_	
129-11	25297-25299	to	_	
129-12	25300-25308	z-scores	_	
129-13	25309-25312	and	_	
129-14	25313-25325	thresholding	_	
129-15	25326-25328	at	_	
129-16	25329-25330	|	_	
129-17	25330-25331	 	_	
129-18	25331-25332	z	_	
129-19	25332-25333	 	_	
129-20	25333-25334	|	_	
129-21	25334-25335	 	_	
129-22	25335-25336	>	_	
129-23	25336-25337	 	_	
129-24	25337-25341	1.96	_	
129-25	25341-25342	,	_	
129-26	25343-25348	shows	_	
129-27	25349-25355	higher	_	
129-28	25356-25360	NAcc	_	
129-29	25361-25377	seed-correlation	_	
129-30	25378-25380	in	_	
129-31	25381-25384	the	_	
129-32	25385-25397	dorsolateral	_	
129-33	25398-25408	prefrontal	_	
129-34	25409-25415	cortex	_	
129-35	25416-25427	bilaterally	_	
129-36	25428-25431	but	_	
129-37	25432-25436	more	_	
129-38	25437-25447	pronounced	_	
129-39	25448-25450	on	_	
129-40	25451-25454	the	_	
129-41	25455-25459	left	_	
129-42	25460-25461	(	_	
129-43	25461-25471	consistent	_	
129-44	25472-25476	with	_	
129-45	25477-25478	a	_	
129-46	25479-25485	bigger	_	
129-47	25486-25492	effect	_	
129-48	25493-25496	for	_	
129-49	25497-25507	inhibitory	_	
129-50	25508-25515	control	_	
129-51	25516-25518	vs	_	
129-52	25518-25519	.	_	
129-53	25520-25527	emotion	_	
129-54	25528-25538	regulation	_	
129-55	25539-25548	executive	_	
129-56	25549-25556	control	_	
129-57	25557-25565	networks	_	
129-58	25565-25566	)	_	
129-59	25566-25567	,	_	
129-60	25568-25571	and	_	
129-61	25572-25577	lower	_	
129-62	25578-25594	seed-correlation	_	
129-63	25595-25597	in	_	
129-64	25598-25601	the	_	
129-65	25602-25610	thalamus	_	
129-66	25611-25612	(	_	
129-67	25612-25615	see	_	
129-68	25616-25619	Fig	_	
129-69	25619-25620	.	_	
129-70	25621-25622	1	_	
129-71	25622-25623	,	_	
129-72	25624-25630	voxels	_	
129-73	25631-25637	shaded	_	
129-74	25638-25641	red	_	
129-75	25642-25646	show	_	
129-76	25647-25653	higher	_	
129-77	25654-25665	correlation	_	
129-78	25666-25669	for	_	
129-79	25670-25674	LTAA	_	
129-80	25674-25675	,	_	
129-81	25676-25682	voxels	_	
129-82	25683-25689	shaded	_	
129-83	25690-25694	blue	_	
129-84	25695-25699	show	_	
129-85	25700-25705	lower	_	
129-86	25706-25717	correlation	_	
129-87	25718-25721	for	_	
129-88	25722-25726	LTAA	_	
129-89	25726-25727	)	_	
129-90	25728-25731	for	_	
129-91	25732-25736	LTAA	_	
129-92	25737-25739	vs	_	
129-93	25739-25740	.	_	

#Text=NSAC.
130-1	25741-25745	NSAC	_	
130-2	25745-25746	.	_	

#Text=The component also shows higher seed-correlation in the anterior cingulate, bilateral inferior frontal regions extending posteriorly, and lower seed correlation in the insula.
131-1	25747-25750	The	_	
131-2	25751-25760	component	_	
131-3	25761-25765	also	_	
131-4	25766-25771	shows	_	
131-5	25772-25778	higher	_	
131-6	25779-25795	seed-correlation	_	
131-7	25796-25798	in	_	
131-8	25799-25802	the	_	
131-9	25803-25811	anterior	_	
131-10	25812-25821	cingulate	_	
131-11	25821-25822	,	_	
131-12	25823-25832	bilateral	_	
131-13	25833-25841	inferior	_	
131-14	25842-25849	frontal	_	
131-15	25850-25857	regions	_	
131-16	25858-25867	extending	_	
131-17	25868-25879	posteriorly	_	
131-18	25879-25880	,	_	
131-19	25881-25884	and	_	
131-20	25885-25890	lower	_	
131-21	25891-25895	seed	_	
131-22	25896-25907	correlation	_	
131-23	25908-25910	in	_	
131-24	25911-25914	the	_	
131-25	25915-25921	insula	_	
131-26	25921-25922	.	_	

#Text=This single component thus encompasses the executive control and appetitive drive networks, consistent with our previous rs-fMRI results.
132-1	25923-25927	This	_	
132-2	25928-25934	single	_	
132-3	25935-25944	component	_	
132-4	25945-25949	thus	_	
132-5	25950-25961	encompasses	_	
132-6	25962-25965	the	_	
132-7	25966-25975	executive	_	
132-8	25976-25983	control	_	
132-9	25984-25987	and	_	
132-10	25988-25998	appetitive	_	
132-11	25999-26004	drive	_	
132-12	26005-26013	networks	_	
132-13	26013-26014	,	_	
132-14	26015-26025	consistent	_	
132-15	26026-26030	with	_	
132-16	26031-26034	our	_	
132-17	26035-26043	previous	_	
132-18	26044-26051	rs-fMRI	_	
132-19	26052-26059	results	_	
132-20	26059-26060	.	_	

#Text=The unthresholded seed-correlation map component is included as supplemental 3D neuroimaging data for this manuscript.
133-1	26061-26064	The	_	
133-2	26065-26078	unthresholded	_	
133-3	26079-26095	seed-correlation	_	
133-4	26096-26099	map	_	
133-5	26100-26109	component	_	
133-6	26110-26112	is	_	
133-7	26113-26121	included	_	
133-8	26122-26124	as	_	
133-9	26125-26137	supplemental	_	
133-10	26138-26140	3D	_	
133-11	26141-26153	neuroimaging	_	
133-12	26154-26158	data	_	
133-13	26159-26162	for	_	
133-14	26163-26167	this	_	
133-15	26168-26178	manuscript	_	
133-16	26178-26179	.	_	

#Text=The contributions of theta (panel a) and alpha (panels b and c) to the EEG coherence component that differentiates between LTAA and NSAC and is linked to the rs-fMRI seed correlation map are shown within a matrix.
134-1	26180-26183	The	_	
134-2	26184-26197	contributions	_	
134-3	26198-26200	of	_	
134-4	26201-26206	theta	_	
134-5	26207-26208	(	_	
134-6	26208-26213	panel	_	
134-7	26214-26215	a	_	
134-8	26215-26216	)	_	
134-9	26217-26220	and	_	
134-10	26221-26226	alpha	_	
134-11	26227-26228	(	_	
134-12	26228-26234	panels	_	
134-13	26235-26236	b	_	
134-14	26237-26240	and	_	
134-15	26241-26242	c	_	
134-16	26242-26243	)	_	
134-17	26244-26246	to	_	
134-18	26247-26250	the	_	
134-19	26251-26254	EEG	_	
134-20	26255-26264	coherence	_	
134-21	26265-26274	component	_	
134-22	26275-26279	that	_	
134-23	26280-26294	differentiates	_	
134-24	26295-26302	between	_	
134-25	26303-26307	LTAA	_	
134-26	26308-26311	and	_	
134-27	26312-26316	NSAC	_	
134-28	26317-26320	and	_	
134-29	26321-26323	is	_	
134-30	26324-26330	linked	_	
134-31	26331-26333	to	_	
134-32	26334-26337	the	_	
134-33	26338-26345	rs-fMRI	_	
134-34	26346-26350	seed	_	
134-35	26351-26362	correlation	_	
134-36	26363-26366	map	_	
134-37	26367-26370	are	_	
134-38	26371-26376	shown	_	
134-39	26377-26383	within	_	
134-40	26384-26385	a	_	
134-41	26386-26392	matrix	_	
134-42	26392-26393	.	_	

#Text=Each element of the component vector has been converted to a z-score and only elements with | z | > 1.96 are displayed, where green shows pairs with | z | < 1.96, red shows higher coherence in NSAC vs.
135-1	26394-26398	Each	_	
135-2	26399-26406	element	_	
135-3	26407-26409	of	_	
135-4	26410-26413	the	_	
135-5	26414-26423	component	_	
135-6	26424-26430	vector	_	
135-7	26431-26434	has	_	
135-8	26435-26439	been	_	
135-9	26440-26449	converted	_	
135-10	26450-26452	to	_	
135-11	26453-26454	a	_	
135-12	26455-26462	z-score	_	
135-13	26463-26466	and	_	
135-14	26467-26471	only	_	
135-15	26472-26480	elements	_	
135-16	26481-26485	with	_	
135-17	26486-26487	|	_	
135-18	26487-26488	 	_	
135-19	26488-26489	z	_	
135-20	26489-26490	 	_	
135-21	26490-26491	|	_	
135-22	26491-26492	 	_	
135-23	26492-26493	>	_	
135-24	26493-26494	 	_	
135-25	26494-26498	1.96	_	
135-26	26499-26502	are	_	
135-27	26503-26512	displayed	_	
135-28	26512-26513	,	_	
135-29	26514-26519	where	_	
135-30	26520-26525	green	_	
135-31	26526-26531	shows	_	
135-32	26532-26537	pairs	_	
135-33	26538-26542	with	_	
135-34	26543-26544	|	_	
135-35	26544-26545	 	_	
135-36	26545-26546	z	_	
135-37	26546-26547	 	_	
135-38	26547-26548	|	_	
135-39	26548-26549	 	_	
135-40	26549-26550	<	_	
135-41	26550-26551	 	_	
135-42	26551-26555	1.96	_	
135-43	26555-26556	,	_	
135-44	26557-26560	red	_	
135-45	26561-26566	shows	_	
135-46	26567-26573	higher	_	
135-47	26574-26583	coherence	_	
135-48	26584-26586	in	_	
135-49	26587-26591	NSAC	_	
135-50	26592-26594	vs	_	
135-51	26594-26595	.	_	

#Text=LTAA, and blue shows lower coherence in NSAC vs.
136-1	26596-26600	LTAA	_	
136-2	26600-26601	,	_	
136-3	26602-26605	and	_	
136-4	26606-26610	blue	_	
136-5	26611-26616	shows	_	
136-6	26617-26622	lower	_	
136-7	26623-26632	coherence	_	
136-8	26633-26635	in	_	
136-9	26636-26640	NSAC	_	
136-10	26641-26643	vs	_	
136-11	26643-26644	.	_	

#Text=LTAA.
137-1	26645-26649	LTAA	_	
137-2	26649-26650	.	_	

#Text=The position within the matrix denote identifies the contributing electrode pair (see the corresponding row and column labels at the top and right side of map).
138-1	26651-26654	The	_	
138-2	26655-26663	position	_	
138-3	26664-26670	within	_	
138-4	26671-26674	the	_	
138-5	26675-26681	matrix	_	
138-6	26682-26688	denote	_	
138-7	26689-26699	identifies	_	
138-8	26700-26703	the	_	
138-9	26704-26716	contributing	_	
138-10	26717-26726	electrode	_	
138-11	26727-26731	pair	_	
138-12	26732-26733	(	_	
138-13	26733-26736	see	_	
138-14	26737-26740	the	_	
138-15	26741-26754	corresponding	_	
138-16	26755-26758	row	_	
138-17	26759-26762	and	_	
138-18	26763-26769	column	_	
138-19	26770-26776	labels	_	
138-20	26777-26779	at	_	
138-21	26780-26783	the	_	
138-22	26784-26787	top	_	
138-23	26788-26791	and	_	
138-24	26792-26797	right	_	
138-25	26798-26802	side	_	
138-26	26803-26805	of	_	
138-27	26806-26809	map	_	
138-28	26809-26810	)	_	
138-29	26810-26811	.	_	

#Text=Overall, the figure shows higher theta and alpha coherence in LTAA compared to NSAC.
139-1	26812-26819	Overall	_	
139-2	26819-26820	,	_	
139-3	26821-26824	the	_	
139-4	26825-26831	figure	_	
139-5	26832-26837	shows	_	
139-6	26838-26844	higher	_	
139-7	26845-26850	theta	_	
139-8	26851-26854	and	_	
139-9	26855-26860	alpha	_	
139-10	26861-26870	coherence	_	
139-11	26871-26873	in	_	
139-12	26874-26878	LTAA	_	
139-13	26879-26887	compared	_	
139-14	26888-26890	to	_	
139-15	26891-26895	NSAC	_	
139-16	26895-26896	.	_	

#Text=Fig. 2.
140-1	26897-26900	Fig	_	
140-2	26900-26901	.	_	
140-3	26902-26903	2	_	
140-4	26903-26904	.	_	

#Text=The contributions of beta (panels a and b) and gamma (panels c and d) to the EEG coherence component that differentiates between LTAA and NSAC and is linked to the rs-fMRI seed correlation map are shown within a matrix.
141-1	26905-26908	The	_	
141-2	26909-26922	contributions	_	
141-3	26923-26925	of	_	
141-4	26926-26930	beta	_	
141-5	26931-26932	(	_	
141-6	26932-26938	panels	_	
141-7	26939-26940	a	_	
141-8	26941-26944	and	_	
141-9	26945-26946	b	_	
141-10	26946-26947	)	_	
141-11	26948-26951	and	_	
141-12	26952-26957	gamma	_	
141-13	26958-26959	(	_	
141-14	26959-26965	panels	_	
141-15	26966-26967	c	_	
141-16	26968-26971	and	_	
141-17	26972-26973	d	_	
141-18	26973-26974	)	_	
141-19	26975-26977	to	_	
141-20	26978-26981	the	_	
141-21	26982-26985	EEG	_	
141-22	26986-26995	coherence	_	
141-23	26996-27005	component	_	
141-24	27006-27010	that	_	
141-25	27011-27025	differentiates	_	
141-26	27026-27033	between	_	
141-27	27034-27038	LTAA	_	
141-28	27039-27042	and	_	
141-29	27043-27047	NSAC	_	
141-30	27048-27051	and	_	
141-31	27052-27054	is	_	
141-32	27055-27061	linked	_	
141-33	27062-27064	to	_	
141-34	27065-27068	the	_	
141-35	27069-27076	rs-fMRI	_	
141-36	27077-27081	seed	_	
141-37	27082-27093	correlation	_	
141-38	27094-27097	map	_	
141-39	27098-27101	are	_	
141-40	27102-27107	shown	_	
141-41	27108-27114	within	_	
141-42	27115-27116	a	_	
141-43	27117-27123	matrix	_	
141-44	27123-27124	.	_	

#Text=Each element of the component vector has been converted to a z-score and only elements with | z | > 1.96 are displayed, where green shows pairs with | z | < 1.96, red shows higher coherence in NSAC vs.
142-1	27125-27129	Each	_	
142-2	27130-27137	element	_	
142-3	27138-27140	of	_	
142-4	27141-27144	the	_	
142-5	27145-27154	component	_	
142-6	27155-27161	vector	_	
142-7	27162-27165	has	_	
142-8	27166-27170	been	_	
142-9	27171-27180	converted	_	
142-10	27181-27183	to	_	
142-11	27184-27185	a	_	
142-12	27186-27193	z-score	_	
142-13	27194-27197	and	_	
142-14	27198-27202	only	_	
142-15	27203-27211	elements	_	
142-16	27212-27216	with	_	
142-17	27217-27218	|	_	
142-18	27218-27219	 	_	
142-19	27219-27220	z	_	
142-20	27220-27221	 	_	
142-21	27221-27222	|	_	
142-22	27222-27223	 	_	
142-23	27223-27224	>	_	
142-24	27224-27225	 	_	
142-25	27225-27229	1.96	_	
142-26	27230-27233	are	_	
142-27	27234-27243	displayed	_	
142-28	27243-27244	,	_	
142-29	27245-27250	where	_	
142-30	27251-27256	green	_	
142-31	27257-27262	shows	_	
142-32	27263-27268	pairs	_	
142-33	27269-27273	with	_	
142-34	27274-27275	|	_	
142-35	27275-27276	 	_	
142-36	27276-27277	z	_	
142-37	27277-27278	 	_	
142-38	27278-27279	|	_	
142-39	27279-27280	 	_	
142-40	27280-27281	<	_	
142-41	27281-27282	 	_	
142-42	27282-27286	1.96	_	
142-43	27286-27287	,	_	
142-44	27288-27291	red	_	
142-45	27292-27297	shows	_	
142-46	27298-27304	higher	_	
142-47	27305-27314	coherence	_	
142-48	27315-27317	in	_	
142-49	27318-27322	NSAC	_	
142-50	27323-27325	vs	_	
142-51	27325-27326	.	_	

#Text=LTAA, and blue shows lower coherence in NSAC vs.
143-1	27327-27331	LTAA	_	
143-2	27331-27332	,	_	
143-3	27333-27336	and	_	
143-4	27337-27341	blue	_	
143-5	27342-27347	shows	_	
143-6	27348-27353	lower	_	
143-7	27354-27363	coherence	_	
143-8	27364-27366	in	_	
143-9	27367-27371	NSAC	_	
143-10	27372-27374	vs	_	
143-11	27374-27375	.	_	

#Text=LTAA.
144-1	27376-27380	LTAA	_	
144-2	27380-27381	.	_	

#Text=The position within the matrix denote identifies the contributing electrode pair (see the corresponding row and column labels at the top and right side of map).
145-1	27382-27385	The	_	
145-2	27386-27394	position	_	
145-3	27395-27401	within	_	
145-4	27402-27405	the	_	
145-5	27406-27412	matrix	_	
145-6	27413-27419	denote	_	
145-7	27420-27430	identifies	_	
145-8	27431-27434	the	_	
145-9	27435-27447	contributing	_	
145-10	27448-27457	electrode	_	
145-11	27458-27462	pair	_	
145-12	27463-27464	(	_	
145-13	27464-27467	see	_	
145-14	27468-27471	the	_	
145-15	27472-27485	corresponding	_	
145-16	27486-27489	row	_	
145-17	27490-27493	and	_	
145-18	27494-27500	column	_	
145-19	27501-27507	labels	_	
145-20	27508-27510	at	_	
145-21	27511-27514	the	_	
145-22	27515-27518	top	_	
145-23	27519-27522	and	_	
145-24	27523-27528	right	_	
145-25	27529-27533	side	_	
145-26	27534-27536	of	_	
145-27	27537-27540	map	_	
145-28	27540-27541	)	_	
145-29	27541-27542	.	_	

#Text=Overall, the figure shows little contribution of beta to the component and mostly lower gamma coherence in LTAA compared to NSAC.
146-1	27543-27550	Overall	_	
146-2	27550-27551	,	_	
146-3	27552-27555	the	_	
146-4	27556-27562	figure	_	
146-5	27563-27568	shows	_	
146-6	27569-27575	little	_	
146-7	27576-27588	contribution	_	
146-8	27589-27591	of	_	
146-9	27592-27596	beta	_	
146-10	27597-27599	to	_	
146-11	27600-27603	the	_	
146-12	27604-27613	component	_	
146-13	27614-27617	and	_	
146-14	27618-27624	mostly	_	
146-15	27625-27630	lower	_	
146-16	27631-27636	gamma	_	
146-17	27637-27646	coherence	_	
146-18	27647-27649	in	_	
146-19	27650-27654	LTAA	_	
146-20	27655-27663	compared	_	
146-21	27664-27666	to	_	
146-22	27667-27671	NSAC	_	
146-23	27671-27672	.	_	

#Text=Fig. 3.
147-1	27673-27676	Fig	_	
147-2	27676-27677	.	_	
147-3	27678-27679	3	_	
147-4	27679-27680	.	_	

#Text=The two-sample t-test computed on the loading parameters for the correlated EEG-coherence component showed a group difference with corrected p = 0.0016 (t39 = 4.10), with LTAA having lower loading than NSAC (thus the negative correlation coefficient with the NAcc seed-correlation component, where LTAA had higher loading than NSAC).
148-1	27681-27684	The	_	
148-2	27685-27695	two-sample	_	
148-3	27696-27702	t-test	_	
148-4	27703-27711	computed	_	
148-5	27712-27714	on	_	
148-6	27715-27718	the	_	
148-7	27719-27726	loading	_	
148-8	27727-27737	parameters	_	
148-9	27738-27741	for	_	
148-10	27742-27745	the	_	
148-11	27746-27756	correlated	_	
148-12	27757-27770	EEG-coherence	_	
148-13	27771-27780	component	_	
148-14	27781-27787	showed	_	
148-15	27788-27789	a	_	
148-16	27790-27795	group	_	
148-17	27796-27806	difference	_	
148-18	27807-27811	with	_	
148-19	27812-27821	corrected	_	
148-20	27822-27823	p	_	
148-21	27823-27824	 	_	
148-22	27824-27825	=	_	
148-23	27825-27826	 	_	
148-24	27826-27832	0.0016	_	
148-25	27833-27834	(	_	
148-26	27834-27837	t39	_	
148-27	27837-27838	 	_	
148-28	27838-27839	=	_	
148-29	27839-27840	 	_	
148-30	27840-27844	4.10	_	
148-31	27844-27845	)	_	
148-32	27845-27846	,	_	
148-33	27847-27851	with	_	
148-34	27852-27856	LTAA	_	
148-35	27857-27863	having	_	
148-36	27864-27869	lower	_	
148-37	27870-27877	loading	_	
148-38	27878-27882	than	_	
148-39	27883-27887	NSAC	_	
148-40	27888-27889	(	_	
148-41	27889-27893	thus	_	
148-42	27894-27897	the	_	
148-43	27898-27906	negative	_	
148-44	27907-27918	correlation	_	
148-45	27919-27930	coefficient	_	
148-46	27931-27935	with	_	
148-47	27936-27939	the	_	
148-48	27940-27944	NAcc	_	
148-49	27945-27961	seed-correlation	_	
148-50	27962-27971	component	_	
148-51	27971-27972	,	_	
148-52	27973-27978	where	_	
148-53	27979-27983	LTAA	_	
148-54	27984-27987	had	_	
148-55	27988-27994	higher	_	
148-56	27995-28002	loading	_	
148-57	28003-28007	than	_	
148-58	28008-28012	NSAC	_	
148-59	28012-28013	)	_	
148-60	28013-28014	.	_	

#Text=We also compared the loading parameters for the EEG coherence component using a linear model, covarying for smoking and education.
149-1	28015-28017	We	_	
149-2	28018-28022	also	_	
149-3	28023-28031	compared	_	
149-4	28032-28035	the	_	
149-5	28036-28043	loading	_	
149-6	28044-28054	parameters	_	
149-7	28055-28058	for	_	
149-8	28059-28062	the	_	
149-9	28063-28066	EEG	_	
149-10	28067-28076	coherence	_	
149-11	28077-28086	component	_	
149-12	28087-28092	using	_	
149-13	28093-28094	a	_	
149-14	28095-28101	linear	_	
149-15	28102-28107	model	_	
149-16	28107-28108	,	_	
149-17	28109-28118	covarying	_	
149-18	28119-28122	for	_	
149-19	28123-28130	smoking	_	
149-20	28131-28134	and	_	
149-21	28135-28144	education	_	
149-22	28144-28145	.	_	

#Text=This analysis showed a group difference with p = 0.01 (t37 = 2.73), so smoking and education could not explain all of the group difference.
150-1	28146-28150	This	_	
150-2	28151-28159	analysis	_	
150-3	28160-28166	showed	_	
150-4	28167-28168	a	_	
150-5	28169-28174	group	_	
150-6	28175-28185	difference	_	
150-7	28186-28190	with	_	
150-8	28191-28192	p	_	
150-9	28192-28193	 	_	
150-10	28193-28194	=	_	
150-11	28194-28195	 	_	
150-12	28195-28199	0.01	_	
150-13	28200-28201	(	_	
150-14	28201-28204	t37	_	
150-15	28204-28205	 	_	
150-16	28205-28206	=	_	
150-17	28206-28207	 	_	
150-18	28207-28211	2.73	_	
150-19	28211-28212	)	_	
150-20	28212-28213	,	_	
150-21	28214-28216	so	_	
150-22	28217-28224	smoking	_	
150-23	28225-28228	and	_	
150-24	28229-28238	education	_	
150-25	28239-28244	could	_	
150-26	28245-28248	not	_	
150-27	28249-28256	explain	_	
150-28	28257-28260	all	_	
150-29	28261-28263	of	_	
150-30	28264-28267	the	_	
150-31	28268-28273	group	_	
150-32	28274-28284	difference	_	
150-33	28284-28285	.	_	

#Text=Fig. 2, Fig. 3 illustrate the EEG-coherence component in a series of maps.
151-1	28286-28289	Fig	_	
151-2	28289-28290	.	_	
151-3	28291-28292	2	_	
151-4	28292-28293	,	_	
151-5	28294-28297	Fig	_	
151-6	28297-28298	.	_	
151-7	28299-28300	3	_	
151-8	28301-28311	illustrate	_	
151-9	28312-28315	the	_	
151-10	28316-28329	EEG-coherence	_	
151-11	28330-28339	component	_	
151-12	28340-28342	in	_	
151-13	28343-28344	a	_	
151-14	28345-28351	series	_	
151-15	28352-28354	of	_	
151-16	28355-28359	maps	_	
151-17	28359-28360	.	_	

#Text=For higher resolution viewing, MATLAB .fig files are included as supplemental data.
152-1	28361-28364	For	_	
152-2	28365-28371	higher	_	
152-3	28372-28382	resolution	_	
152-4	28383-28390	viewing	_	
152-5	28390-28391	,	_	
152-6	28392-28398	MATLAB	_	
152-7	28399-28400	.	_	
152-8	28400-28403	fig	_	
152-9	28404-28409	files	_	
152-10	28410-28413	are	_	
152-11	28414-28422	included	_	
152-12	28423-28425	as	_	
152-13	28426-28438	supplemental	_	
152-14	28439-28443	data	_	
152-15	28443-28444	.	_	

#Text=As each element of the component corresponds to the contribution to coherence between a pair of electrodes within one of the frequency bands (theta, alpha1, alpha2, beta1, beta2, gamma1, gamma2), the magnitude of its contribution can be visualized within a matrix where its position denotes the electrode pair (i.e., the row and column labels correspond to the electrode pair), with separate matrices for each band.
153-1	28445-28447	As	_	
153-2	28448-28452	each	_	
153-3	28453-28460	element	_	
153-4	28461-28463	of	_	
153-5	28464-28467	the	_	
153-6	28468-28477	component	_	
153-7	28478-28489	corresponds	_	
153-8	28490-28492	to	_	
153-9	28493-28496	the	_	
153-10	28497-28509	contribution	_	
153-11	28510-28512	to	_	
153-12	28513-28522	coherence	_	
153-13	28523-28530	between	_	
153-14	28531-28532	a	_	
153-15	28533-28537	pair	_	
153-16	28538-28540	of	_	
153-17	28541-28551	electrodes	_	
153-18	28552-28558	within	_	
153-19	28559-28562	one	_	
153-20	28563-28565	of	_	
153-21	28566-28569	the	_	
153-22	28570-28579	frequency	_	
153-23	28580-28585	bands	_	
153-24	28586-28587	(	_	
153-25	28587-28592	theta	_	
153-26	28592-28593	,	_	
153-27	28594-28600	alpha1	_	
153-28	28600-28601	,	_	
153-29	28602-28608	alpha2	_	
153-30	28608-28609	,	_	
153-31	28610-28615	beta1	_	
153-32	28615-28616	,	_	
153-33	28617-28622	beta2	_	
153-34	28622-28623	,	_	
153-35	28624-28630	gamma1	_	
153-36	28630-28631	,	_	
153-37	28632-28638	gamma2	_	
153-38	28638-28639	)	_	
153-39	28639-28640	,	_	
153-40	28641-28644	the	_	
153-41	28645-28654	magnitude	_	
153-42	28655-28657	of	_	
153-43	28658-28661	its	_	
153-44	28662-28674	contribution	_	
153-45	28675-28678	can	_	
153-46	28679-28681	be	_	
153-47	28682-28692	visualized	_	
153-48	28693-28699	within	_	
153-49	28700-28701	a	_	
153-50	28702-28708	matrix	_	
153-51	28709-28714	where	_	
153-52	28715-28718	its	_	
153-53	28719-28727	position	_	
153-54	28728-28735	denotes	_	
153-55	28736-28739	the	_	
153-56	28740-28749	electrode	_	
153-57	28750-28754	pair	_	
153-58	28755-28756	(	_	
153-59	28756-28759	i.e	_	
153-60	28759-28760	.	_	
153-61	28760-28761	,	_	
153-62	28762-28765	the	_	
153-63	28766-28769	row	_	
153-64	28770-28773	and	_	
153-65	28774-28780	column	_	
153-66	28781-28787	labels	_	
153-67	28788-28798	correspond	_	
153-68	28799-28801	to	_	
153-69	28802-28805	the	_	
153-70	28806-28815	electrode	_	
153-71	28816-28820	pair	_	
153-72	28820-28821	)	_	
153-73	28821-28822	,	_	
153-74	28823-28827	with	_	
153-75	28828-28836	separate	_	
153-76	28837-28845	matrices	_	
153-77	28846-28849	for	_	
153-78	28850-28854	each	_	
153-79	28855-28859	band	_	
153-80	28859-28860	.	_	

#Text=Each element of the component vector has been converted to a z-score and only elements with | z | > 1.96 are displayed, where green shows pairs with | z | < 1.96, red shows higher coherence in NSAC vs.
154-1	28861-28865	Each	_	
154-2	28866-28873	element	_	
154-3	28874-28876	of	_	
154-4	28877-28880	the	_	
154-5	28881-28890	component	_	
154-6	28891-28897	vector	_	
154-7	28898-28901	has	_	
154-8	28902-28906	been	_	
154-9	28907-28916	converted	_	
154-10	28917-28919	to	_	
154-11	28920-28921	a	_	
154-12	28922-28929	z-score	_	
154-13	28930-28933	and	_	
154-14	28934-28938	only	_	
154-15	28939-28947	elements	_	
154-16	28948-28952	with	_	
154-17	28953-28954	|	_	
154-18	28954-28955	 	_	
154-19	28955-28956	z	_	
154-20	28956-28957	 	_	
154-21	28957-28958	|	_	
154-22	28958-28959	 	_	
154-23	28959-28960	>	_	
154-24	28960-28961	 	_	
154-25	28961-28965	1.96	_	
154-26	28966-28969	are	_	
154-27	28970-28979	displayed	_	
154-28	28979-28980	,	_	
154-29	28981-28986	where	_	
154-30	28987-28992	green	_	
154-31	28993-28998	shows	_	
154-32	28999-29004	pairs	_	
154-33	29005-29009	with	_	
154-34	29010-29011	|	_	
154-35	29011-29012	 	_	
154-36	29012-29013	z	_	
154-37	29013-29014	 	_	
154-38	29014-29015	|	_	
154-39	29015-29016	 	_	
154-40	29016-29017	<	_	
154-41	29017-29018	 	_	
154-42	29018-29022	1.96	_	
154-43	29022-29023	,	_	
154-44	29024-29027	red	_	
154-45	29028-29033	shows	_	
154-46	29034-29040	higher	_	
154-47	29041-29050	coherence	_	
154-48	29051-29053	in	_	
154-49	29054-29058	NSAC	_	
154-50	29059-29061	vs	_	
154-51	29061-29062	.	_	

#Text=LTAA, and blue shows lower coherence in NSAC vs.
155-1	29063-29067	LTAA	_	
155-2	29067-29068	,	_	
155-3	29069-29072	and	_	
155-4	29073-29077	blue	_	
155-5	29078-29083	shows	_	
155-6	29084-29089	lower	_	
155-7	29090-29099	coherence	_	
155-8	29100-29102	in	_	
155-9	29103-29107	NSAC	_	
155-10	29108-29110	vs	_	
155-11	29110-29111	.	_	

#Text=LTAA.
156-1	29112-29116	LTAA	_	
156-2	29116-29117	.	_	

#Text=Examination of these maps showed higher theta coherence between midline (Cz, FCz, Fz, CPz) and mostly left ipsilateral electrodes (Fp1, PO5, PO7, CB1, O1, AF3, PO3, FC2, CP2, AF4) and lower coherence between most electrodes with Fp2, F6, and T8 (see Fig. 2) in NSAC vs.
157-1	29118-29129	Examination	_	
157-2	29130-29132	of	_	
157-3	29133-29138	these	_	
157-4	29139-29143	maps	_	
157-5	29144-29150	showed	_	
157-6	29151-29157	higher	_	
157-7	29158-29163	theta	_	
157-8	29164-29173	coherence	_	
157-9	29174-29181	between	_	
157-10	29182-29189	midline	_	
157-11	29190-29191	(	_	
157-12	29191-29193	Cz	_	
157-13	29193-29194	,	_	
157-14	29195-29198	FCz	_	
157-15	29198-29199	,	_	
157-16	29200-29202	Fz	_	
157-17	29202-29203	,	_	
157-18	29204-29207	CPz	_	
157-19	29207-29208	)	_	
157-20	29209-29212	and	_	
157-21	29213-29219	mostly	_	
157-22	29220-29224	left	_	
157-23	29225-29236	ipsilateral	_	
157-24	29237-29247	electrodes	_	
157-25	29248-29249	(	_	
157-26	29249-29252	Fp1	_	
157-27	29252-29253	,	_	
157-28	29254-29257	PO5	_	
157-29	29257-29258	,	_	
157-30	29259-29262	PO7	_	
157-31	29262-29263	,	_	
157-32	29264-29267	CB1	_	
157-33	29267-29268	,	_	
157-34	29269-29271	O1	_	
157-35	29271-29272	,	_	
157-36	29273-29276	AF3	_	
157-37	29276-29277	,	_	
157-38	29278-29281	PO3	_	
157-39	29281-29282	,	_	
157-40	29283-29286	FC2	_	
157-41	29286-29287	,	_	
157-42	29288-29291	CP2	_	
157-43	29291-29292	,	_	
157-44	29293-29296	AF4	_	
157-45	29296-29297	)	_	
157-46	29298-29301	and	_	
157-47	29302-29307	lower	_	
157-48	29308-29317	coherence	_	
157-49	29318-29325	between	_	
157-50	29326-29330	most	_	
157-51	29331-29341	electrodes	_	
157-52	29342-29346	with	_	
157-53	29347-29350	Fp2	_	
157-54	29350-29351	,	_	
157-55	29352-29354	F6	_	
157-56	29354-29355	,	_	
157-57	29356-29359	and	_	
157-58	29360-29362	T8	_	
157-59	29363-29364	(	_	
157-60	29364-29367	see	_	
157-61	29368-29371	Fig	_	
157-62	29371-29372	.	_	
157-63	29373-29374	2	_	
157-64	29374-29375	)	_	
157-65	29376-29378	in	_	
157-66	29379-29383	NSAC	_	
157-67	29384-29386	vs	_	
157-68	29386-29387	.	_	

#Text=LTAA.
158-1	29388-29392	LTAA	_	
158-2	29392-29393	.	_	

#Text=Fig. 2 also shows lower alpha1 coherence between most electrodes with CPz and Fp2 with some lower coherence also between left frontal/parietal regions (Fp1 with PO7 and PO5), and a similar but more extensive pattern of lower alpha2 coherence in NSAC vs.
159-1	29394-29397	Fig	_	
159-2	29397-29398	.	_	
159-3	29399-29400	2	_	
159-4	29401-29405	also	_	
159-5	29406-29411	shows	_	
159-6	29412-29417	lower	_	
159-7	29418-29424	alpha1	_	
159-8	29425-29434	coherence	_	
159-9	29435-29442	between	_	
159-10	29443-29447	most	_	
159-11	29448-29458	electrodes	_	
159-12	29459-29463	with	_	
159-13	29464-29467	CPz	_	
159-14	29468-29471	and	_	
159-15	29472-29475	Fp2	_	
159-16	29476-29480	with	_	
159-17	29481-29485	some	_	
159-18	29486-29491	lower	_	
159-19	29492-29501	coherence	_	
159-20	29502-29506	also	_	
159-21	29507-29514	between	_	
159-22	29515-29519	left	_	
159-23	29520-29527	frontal	_	
159-24	29527-29528	/	_	
159-25	29528-29536	parietal	_	
159-26	29537-29544	regions	_	
159-27	29545-29546	(	_	
159-28	29546-29549	Fp1	_	
159-29	29550-29554	with	_	
159-30	29555-29558	PO7	_	
159-31	29559-29562	and	_	
159-32	29563-29566	PO5	_	
159-33	29566-29567	)	_	
159-34	29567-29568	,	_	
159-35	29569-29572	and	_	
159-36	29573-29574	a	_	
159-37	29575-29582	similar	_	
159-38	29583-29586	but	_	
159-39	29587-29591	more	_	
159-40	29592-29601	extensive	_	
159-41	29602-29609	pattern	_	
159-42	29610-29612	of	_	
159-43	29613-29618	lower	_	
159-44	29619-29625	alpha2	_	
159-45	29626-29635	coherence	_	
159-46	29636-29638	in	_	
159-47	29639-29643	NSAC	_	
159-48	29644-29646	vs	_	
159-49	29646-29647	.	_	

#Text=LTAA.
160-1	29648-29652	LTAA	_	
160-2	29652-29653	.	_	

#Text=There are scattered examples of both higher and lower beta1 coherence (see Fig. 3), but a more spatially distinct pattern of higher beta2 coherence on the left involving F7, CP5, F5, P5, PO7, F3, P3, CB1, O1, AF3, FT7, and T7 in NSAC vs.
161-1	29654-29659	There	_	
161-2	29660-29663	are	_	
161-3	29664-29673	scattered	_	
161-4	29674-29682	examples	_	
161-5	29683-29685	of	_	
161-6	29686-29690	both	_	
161-7	29691-29697	higher	_	
161-8	29698-29701	and	_	
161-9	29702-29707	lower	_	
161-10	29708-29713	beta1	_	
161-11	29714-29723	coherence	_	
161-12	29724-29725	(	_	
161-13	29725-29728	see	_	
161-14	29729-29732	Fig	_	
161-15	29732-29733	.	_	
161-16	29734-29735	3	_	
161-17	29735-29736	)	_	
161-18	29736-29737	,	_	
161-19	29738-29741	but	_	
161-20	29742-29743	a	_	
161-21	29744-29748	more	_	
161-22	29749-29758	spatially	_	
161-23	29759-29767	distinct	_	
161-24	29768-29775	pattern	_	
161-25	29776-29778	of	_	
161-26	29779-29785	higher	_	
161-27	29786-29791	beta2	_	
161-28	29792-29801	coherence	_	
161-29	29802-29804	on	_	
161-30	29805-29808	the	_	
161-31	29809-29813	left	_	
161-32	29814-29823	involving	_	
161-33	29824-29826	F7	_	
161-34	29826-29827	,	_	
161-35	29828-29831	CP5	_	
161-36	29831-29832	,	_	
161-37	29833-29835	F5	_	
161-38	29835-29836	,	_	
161-39	29837-29839	P5	_	
161-40	29839-29840	,	_	
161-41	29841-29844	PO7	_	
161-42	29844-29845	,	_	
161-43	29846-29848	F3	_	
161-44	29848-29849	,	_	
161-45	29850-29852	P3	_	
161-46	29852-29853	,	_	
161-47	29854-29857	CB1	_	
161-48	29857-29858	,	_	
161-49	29859-29861	O1	_	
161-50	29861-29862	,	_	
161-51	29863-29866	AF3	_	
161-52	29866-29867	,	_	
161-53	29868-29871	FT7	_	
161-54	29871-29872	,	_	
161-55	29873-29876	and	_	
161-56	29877-29879	T7	_	
161-57	29880-29882	in	_	
161-58	29883-29887	NSAC	_	
161-59	29888-29890	vs	_	
161-60	29890-29891	.	_	

#Text=LTAA.
162-1	29892-29896	LTAA	_	
162-2	29896-29897	.	_	

#Text=As seen in Fig. 3, the coherence matrices for gamma1 and gamma2 are nearly identical, and show higher gamma coherency in NSAC vs.
163-1	29898-29900	As	_	
163-2	29901-29905	seen	_	
163-3	29906-29908	in	_	
163-4	29909-29912	Fig	_	
163-5	29912-29913	.	_	
163-6	29914-29915	3	_	
163-7	29915-29916	,	_	
163-8	29917-29920	the	_	
163-9	29921-29930	coherence	_	
163-10	29931-29939	matrices	_	
163-11	29940-29943	for	_	
163-12	29944-29950	gamma1	_	
163-13	29951-29954	and	_	
163-14	29955-29961	gamma2	_	
163-15	29962-29965	are	_	
163-16	29966-29972	nearly	_	
163-17	29973-29982	identical	_	
163-18	29982-29983	,	_	
163-19	29984-29987	and	_	
163-20	29988-29992	show	_	
163-21	29993-29999	higher	_	
163-22	30000-30005	gamma	_	
163-23	30006-30015	coherency	_	
163-24	30016-30018	in	_	
163-25	30019-30023	NSAC	_	
163-26	30024-30026	vs	_	
163-27	30026-30027	.	_	

#Text=LTAA among left ipsilateral electrodes (including FT7, TP7, F7, FC5, CP5, F5, P5, PO7, F3, P3, CB1, O1, AF3, FPz, and Fz) and P8 with most electrodes, with some lower coherency between PO4 and mostly ipsilateral electrodes.
164-1	30028-30032	LTAA	_	
164-2	30033-30038	among	_	
164-3	30039-30043	left	_	
164-4	30044-30055	ipsilateral	_	
164-5	30056-30066	electrodes	_	
164-6	30067-30068	(	_	
164-7	30068-30077	including	_	
164-8	30078-30081	FT7	_	
164-9	30081-30082	,	_	
164-10	30083-30086	TP7	_	
164-11	30086-30087	,	_	
164-12	30088-30090	F7	_	
164-13	30090-30091	,	_	
164-14	30092-30095	FC5	_	
164-15	30095-30096	,	_	
164-16	30097-30100	CP5	_	
164-17	30100-30101	,	_	
164-18	30102-30104	F5	_	
164-19	30104-30105	,	_	
164-20	30106-30108	P5	_	
164-21	30108-30109	,	_	
164-22	30110-30113	PO7	_	
164-23	30113-30114	,	_	
164-24	30115-30117	F3	_	
164-25	30117-30118	,	_	
164-26	30119-30121	P3	_	
164-27	30121-30122	,	_	
164-28	30123-30126	CB1	_	
164-29	30126-30127	,	_	
164-30	30128-30130	O1	_	
164-31	30130-30131	,	_	
164-32	30132-30135	AF3	_	
164-33	30135-30136	,	_	
164-34	30137-30140	FPz	_	
164-35	30140-30141	,	_	
164-36	30142-30145	and	_	
164-37	30146-30148	Fz	_	
164-38	30148-30149	)	_	
164-39	30150-30153	and	_	
164-40	30154-30156	P8	_	
164-41	30157-30161	with	_	
164-42	30162-30166	most	_	
164-43	30167-30177	electrodes	_	
164-44	30177-30178	,	_	
164-45	30179-30183	with	_	
164-46	30184-30188	some	_	
164-47	30189-30194	lower	_	
164-48	30195-30204	coherency	_	
164-49	30205-30212	between	_	
164-50	30213-30216	PO4	_	
164-51	30217-30220	and	_	
164-52	30221-30227	mostly	_	
164-53	30228-30239	ipsilateral	_	
164-54	30240-30250	electrodes	_	
164-55	30250-30251	.	_	

#Text=Overall, the matrices shown in Fig. 2, Fig. 3 give the impression of mostly higher theta and alpha coherence in LTAA compared to NSAC, and lower gamma coherence in LTAA compared to NSAC.
165-1	30252-30259	Overall	_	
165-2	30259-30260	,	_	
165-3	30261-30264	the	_	
165-4	30265-30273	matrices	_	
165-5	30274-30279	shown	_	
165-6	30280-30282	in	_	
165-7	30283-30286	Fig	_	
165-8	30286-30287	.	_	
165-9	30288-30289	2	_	
165-10	30289-30290	,	_	
165-11	30291-30294	Fig	_	
165-12	30294-30295	.	_	
165-13	30296-30297	3	_	
165-14	30298-30302	give	_	
165-15	30303-30306	the	_	
165-16	30307-30317	impression	_	
165-17	30318-30320	of	_	
165-18	30321-30327	mostly	_	
165-19	30328-30334	higher	_	
165-20	30335-30340	theta	_	
165-21	30341-30344	and	_	
165-22	30345-30350	alpha	_	
165-23	30351-30360	coherence	_	
165-24	30361-30363	in	_	
165-25	30364-30368	LTAA	_	
165-26	30369-30377	compared	_	
165-27	30378-30380	to	_	
165-28	30381-30385	NSAC	_	
165-29	30385-30386	,	_	
165-30	30387-30390	and	_	
165-31	30391-30396	lower	_	
165-32	30397-30402	gamma	_	
165-33	30403-30412	coherence	_	
165-34	30413-30415	in	_	
165-35	30416-30420	LTAA	_	
165-36	30421-30429	compared	_	
165-37	30430-30432	to	_	
165-38	30433-30437	NSAC	_	
165-39	30437-30438	.	_	

#Text=In LTAA only, we computed correlations between loading parameters for the EEG coherence component and NAcc seed-correlation map component with average number of drinks/month over the lifetime, average number of drinks/month during peak use, length of abstinence, number of lifetime ASPD symptoms, and number of current ASPD symptoms.
166-1	30439-30441	In	_	
166-2	30442-30446	LTAA	_	
166-3	30447-30451	only	_	
166-4	30451-30452	,	_	
166-5	30453-30455	we	_	
166-6	30456-30464	computed	_	
166-7	30465-30477	correlations	_	
166-8	30478-30485	between	_	
166-9	30486-30493	loading	_	
166-10	30494-30504	parameters	_	
166-11	30505-30508	for	_	
166-12	30509-30512	the	_	
166-13	30513-30516	EEG	_	
166-14	30517-30526	coherence	_	
166-15	30527-30536	component	_	
166-16	30537-30540	and	_	
166-17	30541-30545	NAcc	_	
166-18	30546-30562	seed-correlation	_	
166-19	30563-30566	map	_	
166-20	30567-30576	component	_	
166-21	30577-30581	with	_	
166-22	30582-30589	average	_	
166-23	30590-30596	number	_	
166-24	30597-30599	of	_	
166-25	30600-30606	drinks	_	
166-26	30606-30607	/	_	
166-27	30607-30612	month	_	
166-28	30613-30617	over	_	
166-29	30618-30621	the	_	
166-30	30622-30630	lifetime	_	
166-31	30630-30631	,	_	
166-32	30632-30639	average	_	
166-33	30640-30646	number	_	
166-34	30647-30649	of	_	
166-35	30650-30656	drinks	_	
166-36	30656-30657	/	_	
166-37	30657-30662	month	_	
166-38	30663-30669	during	_	
166-39	30670-30674	peak	_	
166-40	30675-30678	use	_	
166-41	30678-30679	,	_	
166-42	30680-30686	length	_	
166-43	30687-30689	of	_	
166-44	30690-30700	abstinence	_	
166-45	30700-30701	,	_	
166-46	30702-30708	number	_	
166-47	30709-30711	of	_	
166-48	30712-30720	lifetime	_	
166-49	30721-30725	ASPD	_	
166-50	30726-30734	symptoms	_	
166-51	30734-30735	,	_	
166-52	30736-30739	and	_	
166-53	30740-30746	number	_	
166-54	30747-30749	of	_	
166-55	30750-30757	current	_	
166-56	30758-30762	ASPD	_	
166-57	30763-30771	symptoms	_	
166-58	30771-30772	.	_	

#Text=No significant correlations were observed.
167-1	30773-30775	No	_	
167-2	30776-30787	significant	_	
167-3	30788-30800	correlations	_	
167-4	30801-30805	were	_	
167-5	30806-30814	observed	_	
167-6	30814-30815	.	_	

#Text=Even though groups were sex-matched, we recomputed the correlation on the loading components to ensure that no sex-differences existed.
168-1	30816-30820	Even	_	
168-2	30821-30827	though	_	
168-3	30828-30834	groups	_	
168-4	30835-30839	were	_	
168-5	30840-30851	sex-matched	_	
168-6	30851-30852	,	_	
168-7	30853-30855	we	_	
168-8	30856-30866	recomputed	_	
168-9	30867-30870	the	_	
168-10	30871-30882	correlation	_	
168-11	30883-30885	on	_	
168-12	30886-30889	the	_	
168-13	30890-30897	loading	_	
168-14	30898-30908	components	_	
168-15	30909-30911	to	_	
168-16	30912-30918	ensure	_	
168-17	30919-30923	that	_	
168-18	30924-30926	no	_	
168-19	30927-30942	sex-differences	_	
168-20	30943-30950	existed	_	
168-21	30950-30951	.	_	

#Text=In women only, the correlation between the EEG-coherence and NAcc seed-correlation components was r = − 0.56 (uncorrected p = 0.037), and in men only the correlation was r = − 0.60 (uncorrected p = 0.001).
169-1	30952-30954	In	_	
169-2	30955-30960	women	_	
169-3	30961-30965	only	_	
169-4	30965-30966	,	_	
169-5	30967-30970	the	_	
169-6	30971-30982	correlation	_	
169-7	30983-30990	between	_	
169-8	30991-30994	the	_	
169-9	30995-31008	EEG-coherence	_	
169-10	31009-31012	and	_	
169-11	31013-31017	NAcc	_	
169-12	31018-31034	seed-correlation	_	
169-13	31035-31045	components	_	
169-14	31046-31049	was	_	
169-15	31050-31051	r	_	
169-16	31051-31052	 	_	
169-17	31052-31053	=	_	
169-18	31053-31054	 	_	
169-19	31054-31055	−	_	
169-20	31055-31056	 	_	
169-21	31056-31060	0.56	_	
169-22	31061-31062	(	_	
169-23	31062-31073	uncorrected	_	
169-24	31074-31075	p	_	
169-25	31075-31076	 	_	
169-26	31076-31077	=	_	
169-27	31077-31078	 	_	
169-28	31078-31083	0.037	_	
169-29	31083-31084	)	_	
169-30	31084-31085	,	_	
169-31	31086-31089	and	_	
169-32	31090-31092	in	_	
169-33	31093-31096	men	_	
169-34	31097-31101	only	_	
169-35	31102-31105	the	_	
169-36	31106-31117	correlation	_	
169-37	31118-31121	was	_	
169-38	31122-31123	r	_	
169-39	31123-31124	 	_	
169-40	31124-31125	=	_	
169-41	31125-31126	 	_	
169-42	31126-31127	−	_	
169-43	31127-31128	 	_	
169-44	31128-31132	0.60	_	
169-45	31133-31134	(	_	
169-46	31134-31145	uncorrected	_	
169-47	31146-31147	p	_	
169-48	31147-31148	 	_	
169-49	31148-31149	=	_	
169-50	31149-31150	 	_	
169-51	31150-31155	0.001	_	
169-52	31155-31156	)	_	
169-53	31156-31157	.	_	

#Text=Due to the smaller sample sizes, the correlations no longer reached corrected significance, but we found no evidence for sex-differences in the relationship between the fMRI network and EEG coherence networks estimated.
170-1	31158-31161	Due	_	
170-2	31162-31164	to	_	
170-3	31165-31168	the	_	
170-4	31169-31176	smaller	_	
170-5	31177-31183	sample	_	
170-6	31184-31189	sizes	_	
170-7	31189-31190	,	_	
170-8	31191-31194	the	_	
170-9	31195-31207	correlations	_	
170-10	31208-31210	no	_	
170-11	31211-31217	longer	_	
170-12	31218-31225	reached	_	
170-13	31226-31235	corrected	_	
170-14	31236-31248	significance	_	
170-15	31248-31249	,	_	
170-16	31250-31253	but	_	
170-17	31254-31256	we	_	
170-18	31257-31262	found	_	
170-19	31263-31265	no	_	
170-20	31266-31274	evidence	_	
170-21	31275-31278	for	_	
170-22	31279-31294	sex-differences	_	
170-23	31295-31297	in	_	
170-24	31298-31301	the	_	
170-25	31302-31314	relationship	_	
170-26	31315-31322	between	_	
170-27	31323-31326	the	_	
170-28	31327-31331	fMRI	_	
170-29	31332-31339	network	_	
170-30	31340-31343	and	_	
170-31	31344-31347	EEG	_	
170-32	31348-31357	coherence	_	
170-33	31358-31366	networks	_	
170-34	31367-31376	estimated	_	
170-35	31376-31377	.	_	

#Text=The 2 sets of seed-correlation/EEG-coherence components that were significantly correlated but did not differentiate between LTAA and NSAC were comprised of two seed-correlation components that each correlated to the same EEG-coherence component.
171-1	31378-31381	The	_	
171-2	31382-31383	2	_	
171-3	31384-31388	sets	_	
171-4	31389-31391	of	_	
171-5	31392-31408	seed-correlation	_	
171-6	31408-31409	/	_	
171-7	31409-31422	EEG-coherence	_	
171-8	31423-31433	components	_	
171-9	31434-31438	that	_	
171-10	31439-31443	were	_	
171-11	31444-31457	significantly	_	
171-12	31458-31468	correlated	_	
171-13	31469-31472	but	_	
171-14	31473-31476	did	_	
171-15	31477-31480	not	_	
171-16	31481-31494	differentiate	_	
171-17	31495-31502	between	_	
171-18	31503-31507	LTAA	_	
171-19	31508-31511	and	_	
171-20	31512-31516	NSAC	_	
171-21	31517-31521	were	_	
171-22	31522-31531	comprised	_	
171-23	31532-31534	of	_	
171-24	31535-31538	two	_	
171-25	31539-31555	seed-correlation	_	
171-26	31556-31566	components	_	
171-27	31567-31571	that	_	
171-28	31572-31576	each	_	
171-29	31577-31587	correlated	_	
171-30	31588-31590	to	_	
171-31	31591-31594	the	_	
171-32	31595-31599	same	_	
171-33	31600-31613	EEG-coherence	_	
171-34	31614-31623	component	_	
171-35	31623-31624	.	_	

#Text=This EEG-coherence component that was equally represented in NSAC and LTAA was dominated by high alpha2 coherence between central, parietal, and occipital electrodes bilaterally, and likely reflects normal alpha rhythms in both groups.
172-1	31625-31629	This	_	
172-2	31630-31643	EEG-coherence	_	
172-3	31644-31653	component	_	
172-4	31654-31658	that	_	
172-5	31659-31662	was	_	
172-6	31663-31670	equally	_	
172-7	31671-31682	represented	_	
172-8	31683-31685	in	_	
172-9	31686-31690	NSAC	_	
172-10	31691-31694	and	_	
172-11	31695-31699	LTAA	_	
172-12	31700-31703	was	_	
172-13	31704-31713	dominated	_	
172-14	31714-31716	by	_	
172-15	31717-31721	high	_	
172-16	31722-31728	alpha2	_	
172-17	31729-31738	coherence	_	
172-18	31739-31746	between	_	
172-19	31747-31754	central	_	
172-20	31754-31755	,	_	
172-21	31756-31764	parietal	_	
172-22	31764-31765	,	_	
172-23	31766-31769	and	_	
172-24	31770-31779	occipital	_	
172-25	31780-31790	electrodes	_	
172-26	31791-31802	bilaterally	_	
172-27	31802-31803	,	_	
172-28	31804-31807	and	_	
172-29	31808-31814	likely	_	
172-30	31815-31823	reflects	_	
172-31	31824-31830	normal	_	
172-32	31831-31836	alpha	_	
172-33	31837-31844	rhythms	_	
172-34	31845-31847	in	_	
172-35	31848-31852	both	_	
172-36	31853-31859	groups	_	
172-37	31859-31860	.	_	

#Text=This alpha-dominated component was negatively correlated with a seed-correlation component (r = − 0.57, t39 = − 4.30, corrected p = 0.007) that had no distinguishing features, and positively correlated with a seed-correlation component (r = 0.53, t39 = 3.93, corrected p = 0.003) that showed high synchrony between NAcc and medial frontal cortex and low synchrony between NAcc and the vicinity of the brainstem (perhaps pons, ventral tegmental area, or reticular nuclei).
173-1	31861-31865	This	_	
173-2	31866-31881	alpha-dominated	_	
173-3	31882-31891	component	_	
173-4	31892-31895	was	_	
173-5	31896-31906	negatively	_	
173-6	31907-31917	correlated	_	
173-7	31918-31922	with	_	
173-8	31923-31924	a	_	
173-9	31925-31941	seed-correlation	_	
173-10	31942-31951	component	_	
173-11	31952-31953	(	_	
173-12	31953-31954	r	_	
173-13	31954-31955	 	_	
173-14	31955-31956	=	_	
173-15	31956-31957	 	_	
173-16	31957-31958	−	_	
173-17	31958-31959	 	_	
173-18	31959-31963	0.57	_	
173-19	31963-31964	,	_	
173-20	31965-31968	t39	_	
173-21	31968-31969	 	_	
173-22	31969-31970	=	_	
173-23	31970-31971	 	_	
173-24	31971-31972	−	_	
173-25	31972-31973	 	_	
173-26	31973-31977	4.30	_	
173-27	31977-31978	,	_	
173-28	31979-31988	corrected	_	
173-29	31989-31990	p	_	
173-30	31990-31991	 	_	
173-31	31991-31992	=	_	
173-32	31992-31993	 	_	
173-33	31993-31998	0.007	_	
173-34	31998-31999	)	_	
173-35	32000-32004	that	_	
173-36	32005-32008	had	_	
173-37	32009-32011	no	_	
173-38	32012-32026	distinguishing	_	
173-39	32027-32035	features	_	
173-40	32035-32036	,	_	
173-41	32037-32040	and	_	
173-42	32041-32051	positively	_	
173-43	32052-32062	correlated	_	
173-44	32063-32067	with	_	
173-45	32068-32069	a	_	
173-46	32070-32086	seed-correlation	_	
173-47	32087-32096	component	_	
173-48	32097-32098	(	_	
173-49	32098-32099	r	_	
173-50	32099-32100	 	_	
173-51	32100-32101	=	_	
173-52	32101-32102	 	_	
173-53	32102-32106	0.53	_	
173-54	32106-32107	,	_	
173-55	32108-32111	t39	_	
173-56	32111-32112	 	_	
173-57	32112-32113	=	_	
173-58	32113-32114	 	_	
173-59	32114-32118	3.93	_	
173-60	32118-32119	,	_	
173-61	32120-32129	corrected	_	
173-62	32130-32131	p	_	
173-63	32131-32132	 	_	
173-64	32132-32133	=	_	
173-65	32133-32134	 	_	
173-66	32134-32139	0.003	_	
173-67	32139-32140	)	_	
173-68	32141-32145	that	_	
173-69	32146-32152	showed	_	
173-70	32153-32157	high	_	
173-71	32158-32167	synchrony	_	
173-72	32168-32175	between	_	
173-73	32176-32180	NAcc	_	
173-74	32181-32184	and	_	
173-75	32185-32191	medial	_	
173-76	32192-32199	frontal	_	
173-77	32200-32206	cortex	_	
173-78	32207-32210	and	_	
173-79	32211-32214	low	_	
173-80	32215-32224	synchrony	_	
173-81	32225-32232	between	_	
173-82	32233-32237	NAcc	_	
173-83	32238-32241	and	_	
173-84	32242-32245	the	_	
173-85	32246-32254	vicinity	_	
173-86	32255-32257	of	_	
173-87	32258-32261	the	_	
173-88	32262-32271	brainstem	_	
173-89	32272-32273	(	_	
173-90	32273-32280	perhaps	_	
173-91	32281-32285	pons	_	
173-92	32285-32286	,	_	
173-93	32287-32294	ventral	_	
173-94	32295-32304	tegmental	_	
173-95	32305-32309	area	_	
173-96	32309-32310	,	_	
173-97	32311-32313	or	_	
173-98	32314-32323	reticular	_	
173-99	32324-32330	nuclei	_	
173-100	32330-32331	)	_	
173-101	32331-32332	.	_	

#Text=These regions represent networks where synchrony with the NAcc was either unaffected by long-term alcohol use or has completely resolved with abstinence.
174-1	32333-32338	These	_	
174-2	32339-32346	regions	_	
174-3	32347-32356	represent	_	
174-4	32357-32365	networks	_	
174-5	32366-32371	where	_	
174-6	32372-32381	synchrony	_	
174-7	32382-32386	with	_	
174-8	32387-32390	the	_	
174-9	32391-32395	NAcc	_	
174-10	32396-32399	was	_	
174-11	32400-32406	either	_	
174-12	32407-32417	unaffected	_	
174-13	32418-32420	by	_	
174-14	32421-32430	long-term	_	
174-15	32431-32438	alcohol	_	
174-16	32439-32442	use	_	
174-17	32443-32445	or	_	
174-18	32446-32449	has	_	
174-19	32450-32460	completely	_	
174-20	32461-32469	resolved	_	
174-21	32470-32474	with	_	
174-22	32475-32485	abstinence	_	
174-23	32485-32486	.	_	

#Text=Discussion
#Text=In this paper, we used parallel ICA to identify components of EEG coherence that were correlated to components of fMRI bilateral NAcc seed-correlation maps, derived from 21 NSAC and 20 LTAA.
175-1	32487-32497	Discussion	_	
175-2	32498-32500	In	_	
175-3	32501-32505	this	_	
175-4	32506-32511	paper	_	
175-5	32511-32512	,	_	
175-6	32513-32515	we	_	
175-7	32516-32520	used	_	
175-8	32521-32529	parallel	_	
175-9	32530-32533	ICA	_	
175-10	32534-32536	to	_	
175-11	32537-32545	identify	_	
175-12	32546-32556	components	_	
175-13	32557-32559	of	_	
175-14	32560-32563	EEG	_	
175-15	32564-32573	coherence	_	
175-16	32574-32578	that	_	
175-17	32579-32583	were	_	
175-18	32584-32594	correlated	_	
175-19	32595-32597	to	_	
175-20	32598-32608	components	_	
175-21	32609-32611	of	_	
175-22	32612-32616	fMRI	_	
175-23	32617-32626	bilateral	_	
175-24	32627-32631	NAcc	_	
175-25	32632-32648	seed-correlation	_	
175-26	32649-32653	maps	_	
175-27	32653-32654	,	_	
175-28	32655-32662	derived	_	
175-29	32663-32667	from	_	
175-30	32668-32670	21	_	
175-31	32671-32675	NSAC	_	
175-32	32676-32679	and	_	
175-33	32680-32682	20	_	
175-34	32683-32687	LTAA	_	
175-35	32687-32688	.	_	

#Text=Our major result was that parallel ICA identified a pair of EEG coherence and rs-fMRI seed-correlation map components that significantly separated NSAC from LTAA and were correlated with each other.
176-1	32689-32692	Our	_	
176-2	32693-32698	major	_	
176-3	32699-32705	result	_	
176-4	32706-32709	was	_	
176-5	32710-32714	that	_	
176-6	32715-32723	parallel	_	
176-7	32724-32727	ICA	_	
176-8	32728-32738	identified	_	
176-9	32739-32740	a	_	
176-10	32741-32745	pair	_	
176-11	32746-32748	of	_	
176-12	32749-32752	EEG	_	
176-13	32753-32762	coherence	_	
176-14	32763-32766	and	_	
176-15	32767-32774	rs-fMRI	_	
176-16	32775-32791	seed-correlation	_	
176-17	32792-32795	map	_	
176-18	32796-32806	components	_	
176-19	32807-32811	that	_	
176-20	32812-32825	significantly	_	
176-21	32826-32835	separated	_	
176-22	32836-32840	NSAC	_	
176-23	32841-32845	from	_	
176-24	32846-32850	LTAA	_	
176-25	32851-32854	and	_	
176-26	32855-32859	were	_	
176-27	32860-32870	correlated	_	
176-28	32871-32875	with	_	
176-29	32876-32880	each	_	
176-30	32881-32886	other	_	
176-31	32886-32887	.	_	

#Text=These results suggest that rs-fMRI synchrony is reflected in spontaneous EEG, even when the EEG and rs-fMRI are not obtained simultaneously.
177-1	32888-32893	These	_	
177-2	32894-32901	results	_	
177-3	32902-32909	suggest	_	
177-4	32910-32914	that	_	
177-5	32915-32922	rs-fMRI	_	
177-6	32923-32932	synchrony	_	
177-7	32933-32935	is	_	
177-8	32936-32945	reflected	_	
177-9	32946-32948	in	_	
177-10	32949-32960	spontaneous	_	
177-11	32961-32964	EEG	_	
177-12	32964-32965	,	_	
177-13	32966-32970	even	_	
177-14	32971-32975	when	_	
177-15	32976-32979	the	_	
177-16	32980-32983	EEG	_	
177-17	32984-32987	and	_	
177-18	32988-32995	rs-fMRI	_	
177-19	32996-32999	are	_	
177-20	33000-33003	not	_	
177-21	33004-33012	obtained	_	
177-22	33013-33027	simultaneously	_	
177-23	33027-33028	.	_	

#Text=We also showed that although these LTAA did not have a current ASPD diagnosis, psychological measures of antisocial disposition, impulsiveness, social deviance proneness, and lifetime ASPD symptoms were highly elevated in LTAA versus NSAC.
178-1	33029-33031	We	_	
178-2	33032-33036	also	_	
178-3	33037-33043	showed	_	
178-4	33044-33048	that	_	
178-5	33049-33057	although	_	
178-6	33058-33063	these	_	
178-7	33064-33068	LTAA	_	
178-8	33069-33072	did	_	
178-9	33073-33076	not	_	
178-10	33077-33081	have	_	
178-11	33082-33083	a	_	
178-12	33084-33091	current	_	
178-13	33092-33096	ASPD	_	
178-14	33097-33106	diagnosis	_	
178-15	33106-33107	,	_	
178-16	33108-33121	psychological	_	
178-17	33122-33130	measures	_	
178-18	33131-33133	of	_	
178-19	33134-33144	antisocial	_	
178-20	33145-33156	disposition	_	
178-21	33156-33157	,	_	
178-22	33158-33171	impulsiveness	_	
178-23	33171-33172	,	_	
178-24	33173-33179	social	_	
178-25	33180-33188	deviance	_	
178-26	33189-33198	proneness	_	
178-27	33198-33199	,	_	
178-28	33200-33203	and	_	
178-29	33204-33212	lifetime	_	
178-30	33213-33217	ASPD	_	
178-31	33218-33226	symptoms	_	
178-32	33227-33231	were	_	
178-33	33232-33238	highly	_	
178-34	33239-33247	elevated	_	
178-35	33248-33250	in	_	
178-36	33251-33255	LTAA	_	
178-37	33256-33262	versus	_	
178-38	33263-33267	NSAC	_	
178-39	33267-33268	.	_	

#Text=In contrast to lifetime symptoms, current ASPD symptoms were similar to controls, suggesting that LTAA are able to inhibit their deviance-prone tendencies and reduce their ASPD symptoms, consistent with a top-down model supporting extended abstinence.
179-1	33269-33271	In	_	
179-2	33272-33280	contrast	_	
179-3	33281-33283	to	_	
179-4	33284-33292	lifetime	_	
179-5	33293-33301	symptoms	_	
179-6	33301-33302	,	_	
179-7	33303-33310	current	_	
179-8	33311-33315	ASPD	_	
179-9	33316-33324	symptoms	_	
179-10	33325-33329	were	_	
179-11	33330-33337	similar	_	
179-12	33338-33340	to	_	
179-13	33341-33349	controls	_	
179-14	33349-33350	,	_	
179-15	33351-33361	suggesting	_	
179-16	33362-33366	that	_	
179-17	33367-33371	LTAA	_	
179-18	33372-33375	are	_	
179-19	33376-33380	able	_	
179-20	33381-33383	to	_	
179-21	33384-33391	inhibit	_	
179-22	33392-33397	their	_	
179-23	33398-33412	deviance-prone	_	
179-24	33413-33423	tendencies	_	
179-25	33424-33427	and	_	
179-26	33428-33434	reduce	_	
179-27	33435-33440	their	_	
179-28	33441-33445	ASPD	_	
179-29	33446-33454	symptoms	_	
179-30	33454-33455	,	_	
179-31	33456-33466	consistent	_	
179-32	33467-33471	with	_	
179-33	33472-33473	a	_	
179-34	33474-33482	top-down	_	
179-35	33483-33488	model	_	
179-36	33489-33499	supporting	_	
179-37	33500-33508	extended	_	
179-38	33509-33519	abstinence	_	
179-39	33519-33520	.	_	

#Text=In other words, long-term abstinence is associated with a dramatic reduction in general antisocial behavior despite a mostly unchanged antisocial disposition.
180-1	33521-33523	In	_	
180-2	33524-33529	other	_	
180-3	33530-33535	words	_	
180-4	33535-33536	,	_	
180-5	33537-33546	long-term	_	
180-6	33547-33557	abstinence	_	
180-7	33558-33560	is	_	
180-8	33561-33571	associated	_	
180-9	33572-33576	with	_	
180-10	33577-33578	a	_	
180-11	33579-33587	dramatic	_	
180-12	33588-33597	reduction	_	
180-13	33598-33600	in	_	
180-14	33601-33608	general	_	
180-15	33609-33619	antisocial	_	
180-16	33620-33628	behavior	_	
180-17	33629-33636	despite	_	
180-18	33637-33638	a	_	
180-19	33639-33645	mostly	_	
180-20	33646-33655	unchanged	_	
180-21	33656-33666	antisocial	_	
180-22	33667-33678	disposition	_	
180-23	33678-33679	.	_	

#Text=In previous work using the same rs-fMRI images and NAcc seed-correlation maps as used in this paper, a multiple comparison corrected voxel-wise group analysis revealed significantly higher strength of RSS in LTAA vs.
181-1	33680-33682	In	_	
181-2	33683-33691	previous	_	
181-3	33692-33696	work	_	
181-4	33697-33702	using	_	
181-5	33703-33706	the	_	
181-6	33707-33711	same	_	
181-7	33712-33719	rs-fMRI	_	
181-8	33720-33726	images	_	
181-9	33727-33730	and	_	
181-10	33731-33735	NAcc	_	
181-11	33736-33752	seed-correlation	_	
181-12	33753-33757	maps	_	
181-13	33758-33760	as	_	
181-14	33761-33765	used	_	
181-15	33766-33768	in	_	
181-16	33769-33773	this	_	
181-17	33774-33779	paper	_	
181-18	33779-33780	,	_	
181-19	33781-33782	a	_	
181-20	33783-33791	multiple	_	
181-21	33792-33802	comparison	_	
181-22	33803-33812	corrected	_	
181-23	33813-33823	voxel-wise	_	
181-24	33824-33829	group	_	
181-25	33830-33838	analysis	_	
181-26	33839-33847	revealed	_	
181-27	33848-33861	significantly	_	
181-28	33862-33868	higher	_	
181-29	33869-33877	strength	_	
181-30	33878-33880	of	_	
181-31	33881-33884	RSS	_	
181-32	33885-33887	in	_	
181-33	33888-33892	LTAA	_	
181-34	33893-33895	vs	_	
181-35	33895-33896	.	_	

#Text=NSAC between the NAcc and the DLPFC and the superior frontal gyrus, and lower strength of RSS between the NAcc and the thalamus (both anterior and medical dorsal nuclei), the postcentral gyrus, and the inferior parietal lobule.
182-1	33897-33901	NSAC	_	
182-2	33902-33909	between	_	
182-3	33910-33913	the	_	
182-4	33914-33918	NAcc	_	
182-5	33919-33922	and	_	
182-6	33923-33926	the	_	
182-7	33927-33932	DLPFC	_	
182-8	33933-33936	and	_	
182-9	33937-33940	the	_	
182-10	33941-33949	superior	_	
182-11	33950-33957	frontal	_	
182-12	33958-33963	gyrus	_	
182-13	33963-33964	,	_	
182-14	33965-33968	and	_	
182-15	33969-33974	lower	_	
182-16	33975-33983	strength	_	
182-17	33984-33986	of	_	
182-18	33987-33990	RSS	_	
182-19	33991-33998	between	_	
182-20	33999-34002	the	_	
182-21	34003-34007	NAcc	_	
182-22	34008-34011	and	_	
182-23	34012-34015	the	_	
182-24	34016-34024	thalamus	_	
182-25	34025-34026	(	_	
182-26	34026-34030	both	_	
182-27	34031-34039	anterior	_	
182-28	34040-34043	and	_	
182-29	34044-34051	medical	_	
182-30	34052-34058	dorsal	_	
182-31	34059-34065	nuclei	_	
182-32	34065-34066	)	_	
182-33	34066-34067	,	_	
182-34	34068-34071	the	_	
182-35	34072-34083	postcentral	_	
182-36	34084-34089	gyrus	_	
182-37	34089-34090	,	_	
182-38	34091-34094	and	_	
182-39	34095-34098	the	_	
182-40	34099-34107	inferior	_	
182-41	34108-34116	parietal	_	
182-42	34117-34123	lobule	_	
182-43	34123-34124	.	_	

#Text=The independent component for the seed-correlation map derived using parallel ICA also identified higher strength of RSS in the DLPFC and other frontal regions (notably the anterior cingulate and superior/inferior frontal regions) and lower strength of RSS in the thalamus and insula.
183-1	34125-34128	The	_	
183-2	34129-34140	independent	_	
183-3	34141-34150	component	_	
183-4	34151-34154	for	_	
183-5	34155-34158	the	_	
183-6	34159-34175	seed-correlation	_	
183-7	34176-34179	map	_	
183-8	34180-34187	derived	_	
183-9	34188-34193	using	_	
183-10	34194-34202	parallel	_	
183-11	34203-34206	ICA	_	
183-12	34207-34211	also	_	
183-13	34212-34222	identified	_	
183-14	34223-34229	higher	_	
183-15	34230-34238	strength	_	
183-16	34239-34241	of	_	
183-17	34242-34245	RSS	_	
183-18	34246-34248	in	_	
183-19	34249-34252	the	_	
183-20	34253-34258	DLPFC	_	
183-21	34259-34262	and	_	
183-22	34263-34268	other	_	
183-23	34269-34276	frontal	_	
183-24	34277-34284	regions	_	
183-25	34285-34286	(	_	
183-26	34286-34293	notably	_	
183-27	34294-34297	the	_	
183-28	34298-34306	anterior	_	
183-29	34307-34316	cingulate	_	
183-30	34317-34320	and	_	
183-31	34321-34329	superior	_	
183-32	34329-34330	/	_	
183-33	34330-34338	inferior	_	
183-34	34339-34346	frontal	_	
183-35	34347-34354	regions	_	
183-36	34354-34355	)	_	
183-37	34356-34359	and	_	
183-38	34360-34365	lower	_	
183-39	34366-34374	strength	_	
183-40	34375-34377	of	_	
183-41	34378-34381	RSS	_	
183-42	34382-34384	in	_	
183-43	34385-34388	the	_	
183-44	34389-34397	thalamus	_	
183-45	34398-34401	and	_	
183-46	34402-34408	insula	_	
183-47	34408-34409	.	_	

#Text=The remarkable similarity in the results from such different analysis approaches gave us confidence that parallel ICA, which can be prone to model selection errors and overfitting, was decomposing the seed-correlation map into appropriate components.
184-1	34410-34413	The	_	
184-2	34414-34424	remarkable	_	
184-3	34425-34435	similarity	_	
184-4	34436-34438	in	_	
184-5	34439-34442	the	_	
184-6	34443-34450	results	_	
184-7	34451-34455	from	_	
184-8	34456-34460	such	_	
184-9	34461-34470	different	_	
184-10	34471-34479	analysis	_	
184-11	34480-34490	approaches	_	
184-12	34491-34495	gave	_	
184-13	34496-34498	us	_	
184-14	34499-34509	confidence	_	
184-15	34510-34514	that	_	
184-16	34515-34523	parallel	_	
184-17	34524-34527	ICA	_	
184-18	34527-34528	,	_	
184-19	34529-34534	which	_	
184-20	34535-34538	can	_	
184-21	34539-34541	be	_	
184-22	34542-34547	prone	_	
184-23	34548-34550	to	_	
184-24	34551-34556	model	_	
184-25	34557-34566	selection	_	
184-26	34567-34573	errors	_	
184-27	34574-34577	and	_	
184-28	34578-34589	overfitting	_	
184-29	34589-34590	,	_	
184-30	34591-34594	was	_	
184-31	34595-34606	decomposing	_	
184-32	34607-34610	the	_	
184-33	34611-34627	seed-correlation	_	
184-34	34628-34631	map	_	
184-35	34632-34636	into	_	
184-36	34637-34648	appropriate	_	
184-37	34649-34659	components	_	
184-38	34659-34660	.	_	

#Text=The additional regions discovered with parallel ICA, the higher synchrony with the anterior cingulate and lower synchrony with the insula, are also implicated in executive control and reward processing.
185-1	34661-34664	The	_	
185-2	34665-34675	additional	_	
185-3	34676-34683	regions	_	
185-4	34684-34694	discovered	_	
185-5	34695-34699	with	_	
185-6	34700-34708	parallel	_	
185-7	34709-34712	ICA	_	
185-8	34712-34713	,	_	
185-9	34714-34717	the	_	
185-10	34718-34724	higher	_	
185-11	34725-34734	synchrony	_	
185-12	34735-34739	with	_	
185-13	34740-34743	the	_	
185-14	34744-34752	anterior	_	
185-15	34753-34762	cingulate	_	
185-16	34763-34766	and	_	
185-17	34767-34772	lower	_	
185-18	34773-34782	synchrony	_	
185-19	34783-34787	with	_	
185-20	34788-34791	the	_	
185-21	34792-34798	insula	_	
185-22	34798-34799	,	_	
185-23	34800-34803	are	_	
185-24	34804-34808	also	_	
185-25	34809-34819	implicated	_	
185-26	34820-34822	in	_	
185-27	34823-34832	executive	_	
185-28	34833-34840	control	_	
185-29	34841-34844	and	_	
185-30	34845-34851	reward	_	
185-31	34852-34862	processing	_	
185-32	34862-34863	.	_	

#Text=The anterior cingulate has connections with the nucleus accumbens and insula in a circuit involved in emotional salience and mood, and the varying strength of connections between these anatomical regions might contribute to the maintenance of abstinence in LTAA.
186-1	34864-34867	The	_	
186-2	34868-34876	anterior	_	
186-3	34877-34886	cingulate	_	
186-4	34887-34890	has	_	
186-5	34891-34902	connections	_	
186-6	34903-34907	with	_	
186-7	34908-34911	the	_	
186-8	34912-34919	nucleus	_	
186-9	34920-34929	accumbens	_	
186-10	34930-34933	and	_	
186-11	34934-34940	insula	_	
186-12	34941-34943	in	_	
186-13	34944-34945	a	_	
186-14	34946-34953	circuit	_	
186-15	34954-34962	involved	_	
186-16	34963-34965	in	_	
186-17	34966-34975	emotional	_	
186-18	34976-34984	salience	_	
186-19	34985-34988	and	_	
186-20	34989-34993	mood	_	
186-21	34993-34994	,	_	
186-22	34995-34998	and	_	
186-23	34999-35002	the	_	
186-24	35003-35010	varying	_	
186-25	35011-35019	strength	_	
186-26	35020-35022	of	_	
186-27	35023-35034	connections	_	
186-28	35035-35042	between	_	
186-29	35043-35048	these	_	
186-30	35049-35059	anatomical	_	
186-31	35060-35067	regions	_	
186-32	35068-35073	might	_	
186-33	35074-35084	contribute	_	
186-34	35085-35087	to	_	
186-35	35088-35091	the	_	
186-36	35092-35103	maintenance	_	
186-37	35104-35106	of	_	
186-38	35107-35117	abstinence	_	
186-39	35118-35120	in	_	
186-40	35121-35125	LTAA	_	
186-41	35125-35126	.	_	

#Text=The regions of the brain implicated in this and our previous fMRI analysis are concordant with other studies of alcoholism and drug abuse.
187-1	35127-35130	The	_	
187-2	35131-35138	regions	_	
187-3	35139-35141	of	_	
187-4	35142-35145	the	_	
187-5	35146-35151	brain	_	
187-6	35152-35162	implicated	_	
187-7	35163-35165	in	_	
187-8	35166-35170	this	_	
187-9	35171-35174	and	_	
187-10	35175-35178	our	_	
187-11	35179-35187	previous	_	
187-12	35188-35192	fMRI	_	
187-13	35193-35201	analysis	_	
187-14	35202-35205	are	_	
187-15	35206-35216	concordant	_	
187-16	35217-35221	with	_	
187-17	35222-35227	other	_	
187-18	35228-35235	studies	_	
187-19	35236-35238	of	_	
187-20	35239-35249	alcoholism	_	
187-21	35250-35253	and	_	
187-22	35254-35258	drug	_	
187-23	35259-35264	abuse	_	
187-24	35264-35265	.	_	

#Text=Using fMRI task-related paradigms, many observed differences in activation in the executive control and appetitive drive networks have been associated with alcohol use, abuse, and dependence, suggesting that multiple brain regions can contribute to the poor decision making and risky behaviors seen in alcoholism (for a review, see).
188-1	35266-35271	Using	_	
188-2	35272-35276	fMRI	_	
188-3	35277-35289	task-related	_	
188-4	35290-35299	paradigms	_	
188-5	35299-35300	,	_	
188-6	35301-35305	many	_	
188-7	35306-35314	observed	_	
188-8	35315-35326	differences	_	
188-9	35327-35329	in	_	
188-10	35330-35340	activation	_	
188-11	35341-35343	in	_	
188-12	35344-35347	the	_	
188-13	35348-35357	executive	_	
188-14	35358-35365	control	_	
188-15	35366-35369	and	_	
188-16	35370-35380	appetitive	_	
188-17	35381-35386	drive	_	
188-18	35387-35395	networks	_	
188-19	35396-35400	have	_	
188-20	35401-35405	been	_	
188-21	35406-35416	associated	_	
188-22	35417-35421	with	_	
188-23	35422-35429	alcohol	_	
188-24	35430-35433	use	_	
188-25	35433-35434	,	_	
188-26	35435-35440	abuse	_	
188-27	35440-35441	,	_	
188-28	35442-35445	and	_	
188-29	35446-35456	dependence	_	
188-30	35456-35457	,	_	
188-31	35458-35468	suggesting	_	
188-32	35469-35473	that	_	
188-33	35474-35482	multiple	_	
188-34	35483-35488	brain	_	
188-35	35489-35496	regions	_	
188-36	35497-35500	can	_	
188-37	35501-35511	contribute	_	
188-38	35512-35514	to	_	
188-39	35515-35518	the	_	
188-40	35519-35523	poor	_	
188-41	35524-35532	decision	_	
188-42	35533-35539	making	_	
188-43	35540-35543	and	_	
188-44	35544-35549	risky	_	
188-45	35550-35559	behaviors	_	
188-46	35560-35564	seen	_	
188-47	35565-35567	in	_	
188-48	35568-35578	alcoholism	_	
188-49	35579-35580	(	_	
188-50	35580-35583	for	_	
188-51	35584-35585	a	_	
188-52	35586-35592	review	_	
188-53	35592-35593	,	_	
188-54	35594-35597	see	_	
188-55	35597-35598	)	_	
188-56	35598-35599	.	_	

#Text=Increased activity in the amygdala and insula associated with inflexible poor decision making is found in binge drinkers, while lower activity in the dorsolateral prefrontal cortex is observed in short-term abstinent alcoholics during inhibition tasks, in adolescents with a family history of alcohol drinking during risky decision making and in adolescents without notable substance use involvement during response inhibition.
189-1	35600-35609	Increased	_	
189-2	35610-35618	activity	_	
189-3	35619-35621	in	_	
189-4	35622-35625	the	_	
189-5	35626-35634	amygdala	_	
189-6	35635-35638	and	_	
189-7	35639-35645	insula	_	
189-8	35646-35656	associated	_	
189-9	35657-35661	with	_	
189-10	35662-35672	inflexible	_	
189-11	35673-35677	poor	_	
189-12	35678-35686	decision	_	
189-13	35687-35693	making	_	
189-14	35694-35696	is	_	
189-15	35697-35702	found	_	
189-16	35703-35705	in	_	
189-17	35706-35711	binge	_	
189-18	35712-35720	drinkers	_	
189-19	35720-35721	,	_	
189-20	35722-35727	while	_	
189-21	35728-35733	lower	_	
189-22	35734-35742	activity	_	
189-23	35743-35745	in	_	
189-24	35746-35749	the	_	
189-25	35750-35762	dorsolateral	_	
189-26	35763-35773	prefrontal	_	
189-27	35774-35780	cortex	_	
189-28	35781-35783	is	_	
189-29	35784-35792	observed	_	
189-30	35793-35795	in	_	
189-31	35796-35806	short-term	_	
189-32	35807-35816	abstinent	_	
189-33	35817-35827	alcoholics	_	
189-34	35828-35834	during	_	
189-35	35835-35845	inhibition	_	
189-36	35846-35851	tasks	_	
189-37	35851-35852	,	_	
189-38	35853-35855	in	_	
189-39	35856-35867	adolescents	_	
189-40	35868-35872	with	_	
189-41	35873-35874	a	_	
189-42	35875-35881	family	_	
189-43	35882-35889	history	_	
189-44	35890-35892	of	_	
189-45	35893-35900	alcohol	_	
189-46	35901-35909	drinking	_	
189-47	35910-35916	during	_	
189-48	35917-35922	risky	_	
189-49	35923-35931	decision	_	
189-50	35932-35938	making	_	
189-51	35939-35942	and	_	
189-52	35943-35945	in	_	
189-53	35946-35957	adolescents	_	
189-54	35958-35965	without	_	
189-55	35966-35973	notable	_	
189-56	35974-35983	substance	_	
189-57	35984-35987	use	_	
189-58	35988-35999	involvement	_	
189-59	36000-36006	during	_	
189-60	36007-36015	response	_	
189-61	36016-36026	inhibition	_	
189-62	36026-36027	.	_	

#Text=Lesser activation of prefrontal executive control regions than seen in controls has been observed in alcoholics during spatial and verbal working memory tasks.
190-1	36028-36034	Lesser	_	
190-2	36035-36045	activation	_	
190-3	36046-36048	of	_	
190-4	36049-36059	prefrontal	_	
190-5	36060-36069	executive	_	
190-6	36070-36077	control	_	
190-7	36078-36085	regions	_	
190-8	36086-36090	than	_	
190-9	36091-36095	seen	_	
190-10	36096-36098	in	_	
190-11	36099-36107	controls	_	
190-12	36108-36111	has	_	
190-13	36112-36116	been	_	
190-14	36117-36125	observed	_	
190-15	36126-36128	in	_	
190-16	36129-36139	alcoholics	_	
190-17	36140-36146	during	_	
190-18	36147-36154	spatial	_	
190-19	36155-36158	and	_	
190-20	36159-36165	verbal	_	
190-21	36166-36173	working	_	
190-22	36174-36180	memory	_	
190-23	36181-36186	tasks	_	
190-24	36186-36187	.	_	

#Text=Active drinkers show enhanced BOLD activation in the ventral striatum when presented with visual alcohol cues, also supporting the notion of a stronger appetitive and reward drive in current alcohol dependence.
191-1	36188-36194	Active	_	
191-2	36195-36203	drinkers	_	
191-3	36204-36208	show	_	
191-4	36209-36217	enhanced	_	
191-5	36218-36222	BOLD	_	
191-6	36223-36233	activation	_	
191-7	36234-36236	in	_	
191-8	36237-36240	the	_	
191-9	36241-36248	ventral	_	
191-10	36249-36257	striatum	_	
191-11	36258-36262	when	_	
191-12	36263-36272	presented	_	
191-13	36273-36277	with	_	
191-14	36278-36284	visual	_	
191-15	36285-36292	alcohol	_	
191-16	36293-36297	cues	_	
191-17	36297-36298	,	_	
191-18	36299-36303	also	_	
191-19	36304-36314	supporting	_	
191-20	36315-36318	the	_	
191-21	36319-36325	notion	_	
191-22	36326-36328	of	_	
191-23	36329-36330	a	_	
191-24	36331-36339	stronger	_	
191-25	36340-36350	appetitive	_	
191-26	36351-36354	and	_	
191-27	36355-36361	reward	_	
191-28	36362-36367	drive	_	
191-29	36368-36370	in	_	
191-30	36371-36378	current	_	
191-31	36379-36386	alcohol	_	
191-32	36387-36397	dependence	_	
191-33	36397-36398	.	_	

#Text=Active drinkers with a diagnosis of alcohol dependence show higher activity in the dorsal lateral prefrontal cortex (DLPFC) regions during delayed reward decision compared to active drinkers without alcohol dependence, which may reflect alcoholics' increased demand of the executive control network when required to make decisions on behavior ruled by appetitive drive.
192-1	36399-36405	Active	_	
192-2	36406-36414	drinkers	_	
192-3	36415-36419	with	_	
192-4	36420-36421	a	_	
192-5	36422-36431	diagnosis	_	
192-6	36432-36434	of	_	
192-7	36435-36442	alcohol	_	
192-8	36443-36453	dependence	_	
192-9	36454-36458	show	_	
192-10	36459-36465	higher	_	
192-11	36466-36474	activity	_	
192-12	36475-36477	in	_	
192-13	36478-36481	the	_	
192-14	36482-36488	dorsal	_	
192-15	36489-36496	lateral	_	
192-16	36497-36507	prefrontal	_	
192-17	36508-36514	cortex	_	
192-18	36515-36516	(	_	
192-19	36516-36521	DLPFC	_	
192-20	36521-36522	)	_	
192-21	36523-36530	regions	_	
192-22	36531-36537	during	_	
192-23	36538-36545	delayed	_	
192-24	36546-36552	reward	_	
192-25	36553-36561	decision	_	
192-26	36562-36570	compared	_	
192-27	36571-36573	to	_	
192-28	36574-36580	active	_	
192-29	36581-36589	drinkers	_	
192-30	36590-36597	without	_	
192-31	36598-36605	alcohol	_	
192-32	36606-36616	dependence	_	
192-33	36616-36617	,	_	
192-34	36618-36623	which	_	
192-35	36624-36627	may	_	
192-36	36628-36635	reflect	_	
192-37	36636-36646	alcoholics	_	
192-38	36646-36647	'	_	
192-39	36648-36657	increased	_	
192-40	36658-36664	demand	_	
192-41	36665-36667	of	_	
192-42	36668-36671	the	_	
192-43	36672-36681	executive	_	
192-44	36682-36689	control	_	
192-45	36690-36697	network	_	
192-46	36698-36702	when	_	
192-47	36703-36711	required	_	
192-48	36712-36714	to	_	
192-49	36715-36719	make	_	
192-50	36720-36729	decisions	_	
192-51	36730-36732	on	_	
192-52	36733-36741	behavior	_	
192-53	36742-36747	ruled	_	
192-54	36748-36750	by	_	
192-55	36751-36761	appetitive	_	
192-56	36762-36767	drive	_	
192-57	36767-36768	.	_	

#Text=These studies demonstrate that excessive alcohol use and even the genetic vulnerability to alcoholism (observed prior to initiating alcohol use) is associated with activation patterns different than controls in brain regions that are part of the executive control and appetitive drive network.
193-1	36769-36774	These	_	
193-2	36775-36782	studies	_	
193-3	36783-36794	demonstrate	_	
193-4	36795-36799	that	_	
193-5	36800-36809	excessive	_	
193-6	36810-36817	alcohol	_	
193-7	36818-36821	use	_	
193-8	36822-36825	and	_	
193-9	36826-36830	even	_	
193-10	36831-36834	the	_	
193-11	36835-36842	genetic	_	
193-12	36843-36856	vulnerability	_	
193-13	36857-36859	to	_	
193-14	36860-36870	alcoholism	_	
193-15	36871-36872	(	_	
193-16	36872-36880	observed	_	
193-17	36881-36886	prior	_	
193-18	36887-36889	to	_	
193-19	36890-36900	initiating	_	
193-20	36901-36908	alcohol	_	
193-21	36909-36912	use	_	
193-22	36912-36913	)	_	
193-23	36914-36916	is	_	
193-24	36917-36927	associated	_	
193-25	36928-36932	with	_	
193-26	36933-36943	activation	_	
193-27	36944-36952	patterns	_	
193-28	36953-36962	different	_	
193-29	36963-36967	than	_	
193-30	36968-36976	controls	_	
193-31	36977-36979	in	_	
193-32	36980-36985	brain	_	
193-33	36986-36993	regions	_	
193-34	36994-36998	that	_	
193-35	36999-37002	are	_	
193-36	37003-37007	part	_	
193-37	37008-37010	of	_	
193-38	37011-37014	the	_	
193-39	37015-37024	executive	_	
193-40	37025-37032	control	_	
193-41	37033-37036	and	_	
193-42	37037-37047	appetitive	_	
193-43	37048-37053	drive	_	
193-44	37054-37061	network	_	
193-45	37061-37062	.	_	

#Text=Recent work has examined resting state fMRI synchrony in multiple brain networks in individuals with current AUDs.
194-1	37063-37069	Recent	_	
194-2	37070-37074	work	_	
194-3	37075-37078	has	_	
194-4	37079-37087	examined	_	
194-5	37088-37095	resting	_	
194-6	37096-37101	state	_	
194-7	37102-37106	fMRI	_	
194-8	37107-37116	synchrony	_	
194-9	37117-37119	in	_	
194-10	37120-37128	multiple	_	
194-11	37129-37134	brain	_	
194-12	37135-37143	networks	_	
194-13	37144-37146	in	_	
194-14	37147-37158	individuals	_	
194-15	37159-37163	with	_	
194-16	37164-37171	current	_	
194-17	37172-37176	AUDs	_	
194-18	37176-37177	.	_	

#Text=The fMRI time series measures of synchrony (i.e., average within network correlations of BOLD signal magnitude across the network's nodes) were computed for 14 networks in each of 422 individuals with active AUDs and 97 controls.
195-1	37178-37181	The	_	
195-2	37182-37186	fMRI	_	
195-3	37187-37191	time	_	
195-4	37192-37198	series	_	
195-5	37199-37207	measures	_	
195-6	37208-37210	of	_	
195-7	37211-37220	synchrony	_	
195-8	37221-37222	(	_	
195-9	37222-37225	i.e	_	
195-10	37225-37226	.	_	
195-11	37226-37227	,	_	
195-12	37228-37235	average	_	
195-13	37236-37242	within	_	
195-14	37243-37250	network	_	
195-15	37251-37263	correlations	_	
195-16	37264-37266	of	_	
195-17	37267-37271	BOLD	_	
195-18	37272-37278	signal	_	
195-19	37279-37288	magnitude	_	
195-20	37289-37295	across	_	
195-21	37296-37299	the	_	
195-22	37300-37309	network's	_	
195-23	37310-37315	nodes	_	
195-24	37315-37316	)	_	
195-25	37317-37321	were	_	
195-26	37322-37330	computed	_	
195-27	37331-37334	for	_	
195-28	37335-37337	14	_	
195-29	37338-37346	networks	_	
195-30	37347-37349	in	_	
195-31	37350-37354	each	_	
195-32	37355-37357	of	_	
195-33	37358-37361	422	_	
195-34	37362-37373	individuals	_	
195-35	37374-37378	with	_	
195-36	37379-37385	active	_	
195-37	37386-37390	AUDs	_	
195-38	37391-37394	and	_	
195-39	37395-37397	97	_	
195-40	37398-37406	controls	_	
195-41	37406-37407	.	_	

#Text=Network strength on average for all networks (multivariate test) was lower for AUD than controls.
196-1	37408-37415	Network	_	
196-2	37416-37424	strength	_	
196-3	37425-37427	on	_	
196-4	37428-37435	average	_	
196-5	37436-37439	for	_	
196-6	37440-37443	all	_	
196-7	37444-37452	networks	_	
196-8	37453-37454	(	_	
196-9	37454-37466	multivariate	_	
196-10	37467-37471	test	_	
196-11	37471-37472	)	_	
196-12	37473-37476	was	_	
196-13	37477-37482	lower	_	
196-14	37483-37486	for	_	
196-15	37487-37490	AUD	_	
196-16	37491-37495	than	_	
196-17	37496-37504	controls	_	
196-18	37504-37505	.	_	

#Text=Univariate tests showed lower synchrony in AUD vs. controls for the left executive control network, sensorimotor, basal ganglia, and primary visual networks.
197-1	37506-37516	Univariate	_	
197-2	37517-37522	tests	_	
197-3	37523-37529	showed	_	
197-4	37530-37535	lower	_	
197-5	37536-37545	synchrony	_	
197-6	37546-37548	in	_	
197-7	37549-37552	AUD	_	
197-8	37553-37555	vs	_	
197-9	37555-37556	.	_	
197-10	37557-37565	controls	_	
197-11	37566-37569	for	_	
197-12	37570-37573	the	_	
197-13	37574-37578	left	_	
197-14	37579-37588	executive	_	
197-15	37589-37596	control	_	
197-16	37597-37604	network	_	
197-17	37604-37605	,	_	
197-18	37606-37618	sensorimotor	_	
197-19	37618-37619	,	_	
197-20	37620-37625	basal	_	
197-21	37626-37633	ganglia	_	
197-22	37633-37634	,	_	
197-23	37635-37638	and	_	
197-24	37639-37646	primary	_	
197-25	37647-37653	visual	_	
197-26	37654-37662	networks	_	
197-27	37662-37663	.	_	

#Text=Although all frequency bands contributed significantly to the EEG-coherence ICA component related to the rs-fMRI component, an examination of Fig. 2, Fig. 3 show that coherence within the theta, alpha, and gamma bands contributed the most to the component.
198-1	37664-37672	Although	_	
198-2	37673-37676	all	_	
198-3	37677-37686	frequency	_	
198-4	37687-37692	bands	_	
198-5	37693-37704	contributed	_	
198-6	37705-37718	significantly	_	
198-7	37719-37721	to	_	
198-8	37722-37725	the	_	
198-9	37726-37739	EEG-coherence	_	
198-10	37740-37743	ICA	_	
198-11	37744-37753	component	_	
198-12	37754-37761	related	_	
198-13	37762-37764	to	_	
198-14	37765-37768	the	_	
198-15	37769-37776	rs-fMRI	_	
198-16	37777-37786	component	_	
198-17	37786-37787	,	_	
198-18	37788-37790	an	_	
198-19	37791-37802	examination	_	
198-20	37803-37805	of	_	
198-21	37806-37809	Fig	_	
198-22	37809-37810	.	_	
198-23	37811-37812	2	_	
198-24	37812-37813	,	_	
198-25	37814-37817	Fig	_	
198-26	37817-37818	.	_	
198-27	37819-37820	3	_	
198-28	37821-37825	show	_	
198-29	37826-37830	that	_	
198-30	37831-37840	coherence	_	
198-31	37841-37847	within	_	
198-32	37848-37851	the	_	
198-33	37852-37857	theta	_	
198-34	37857-37858	,	_	
198-35	37859-37864	alpha	_	
198-36	37864-37865	,	_	
198-37	37866-37869	and	_	
198-38	37870-37875	gamma	_	
198-39	37876-37881	bands	_	
198-40	37882-37893	contributed	_	
198-41	37894-37897	the	_	
198-42	37898-37902	most	_	
198-43	37903-37905	to	_	
198-44	37906-37909	the	_	
198-45	37910-37919	component	_	
198-46	37919-37920	.	_	

#Text=Gamma frequency oscillations and synchronization between neural groups have been proposed to underlie perceptual experience and cognition.
199-1	37921-37926	Gamma	_	
199-2	37927-37936	frequency	_	
199-3	37937-37949	oscillations	_	
199-4	37950-37953	and	_	
199-5	37954-37969	synchronization	_	
199-6	37970-37977	between	_	
199-7	37978-37984	neural	_	
199-8	37985-37991	groups	_	
199-9	37992-37996	have	_	
199-10	37997-38001	been	_	
199-11	38002-38010	proposed	_	
199-12	38011-38013	to	_	
199-13	38014-38022	underlie	_	
199-14	38023-38033	perceptual	_	
199-15	38034-38044	experience	_	
199-16	38045-38048	and	_	
199-17	38049-38058	cognition	_	
199-18	38058-38059	.	_	

#Text=Gamma oscillations appear to combine activity of spatially localized groups of neurons (e.g., within visual cortex; within hippocampus).
200-1	38060-38065	Gamma	_	
200-2	38066-38078	oscillations	_	
200-3	38079-38085	appear	_	
200-4	38086-38088	to	_	
200-5	38089-38096	combine	_	
200-6	38097-38105	activity	_	
200-7	38106-38108	of	_	
200-8	38109-38118	spatially	_	
200-9	38119-38128	localized	_	
200-10	38129-38135	groups	_	
200-11	38136-38138	of	_	
200-12	38139-38146	neurons	_	
200-13	38147-38148	(	_	
200-14	38148-38151	e.g	_	
200-15	38151-38152	.	_	
200-16	38152-38153	,	_	
200-17	38154-38160	within	_	
200-18	38161-38167	visual	_	
200-19	38168-38174	cortex	_	
200-20	38174-38175	;	_	
200-21	38176-38182	within	_	
200-22	38183-38194	hippocampus	_	
200-23	38194-38195	)	_	
200-24	38195-38196	.	_	

#Text=Increased gamma band synchrony between frontal and parietal regions has also been observed during recollection.
201-1	38197-38206	Increased	_	
201-2	38207-38212	gamma	_	
201-3	38213-38217	band	_	
201-4	38218-38227	synchrony	_	
201-5	38228-38235	between	_	
201-6	38236-38243	frontal	_	
201-7	38244-38247	and	_	
201-8	38248-38256	parietal	_	
201-9	38257-38264	regions	_	
201-10	38265-38268	has	_	
201-11	38269-38273	also	_	
201-12	38274-38278	been	_	
201-13	38279-38287	observed	_	
201-14	38288-38294	during	_	
201-15	38295-38307	recollection	_	
201-16	38307-38308	.	_	

#Text=Our results mostly show lower gamma coherence in the LTAA compared to NSAC within left ipsilateral regions.
202-1	38309-38312	Our	_	
202-2	38313-38320	results	_	
202-3	38321-38327	mostly	_	
202-4	38328-38332	show	_	
202-5	38333-38338	lower	_	
202-6	38339-38344	gamma	_	
202-7	38345-38354	coherence	_	
202-8	38355-38357	in	_	
202-9	38358-38361	the	_	
202-10	38362-38366	LTAA	_	
202-11	38367-38375	compared	_	
202-12	38376-38378	to	_	
202-13	38379-38383	NSAC	_	
202-14	38384-38390	within	_	
202-15	38391-38395	left	_	
202-16	38396-38407	ipsilateral	_	
202-17	38408-38415	regions	_	
202-18	38415-38416	.	_	

#Text=It is unclear how a decrease in resting gamma coherence would manifest behaviorally, although it seems likely that it would degrade performance of a network.
203-1	38417-38419	It	_	
203-2	38420-38422	is	_	
203-3	38423-38430	unclear	_	
203-4	38431-38434	how	_	
203-5	38435-38436	a	_	
203-6	38437-38445	decrease	_	
203-7	38446-38448	in	_	
203-8	38449-38456	resting	_	
203-9	38457-38462	gamma	_	
203-10	38463-38472	coherence	_	
203-11	38473-38478	would	_	
203-12	38479-38487	manifest	_	
203-13	38488-38500	behaviorally	_	
203-14	38500-38501	,	_	
203-15	38502-38510	although	_	
203-16	38511-38513	it	_	
203-17	38514-38519	seems	_	
203-18	38520-38526	likely	_	
203-19	38527-38531	that	_	
203-20	38532-38534	it	_	
203-21	38535-38540	would	_	
203-22	38541-38548	degrade	_	
203-23	38549-38560	performance	_	
203-24	38561-38563	of	_	
203-25	38564-38565	a	_	
203-26	38566-38573	network	_	
203-27	38573-38574	.	_	

#Text=The relationship of decreased gamma to our rs-fMRI results suggests that lower gamma coherence contributes to the decreased appetitive drive RSS observed in LTAA.
204-1	38575-38578	The	_	
204-2	38579-38591	relationship	_	
204-3	38592-38594	of	_	
204-4	38595-38604	decreased	_	
204-5	38605-38610	gamma	_	
204-6	38611-38613	to	_	
204-7	38614-38617	our	_	
204-8	38618-38625	rs-fMRI	_	
204-9	38626-38633	results	_	
204-10	38634-38642	suggests	_	
204-11	38643-38647	that	_	
204-12	38648-38653	lower	_	
204-13	38654-38659	gamma	_	
204-14	38660-38669	coherence	_	
204-15	38670-38681	contributes	_	
204-16	38682-38684	to	_	
204-17	38685-38688	the	_	
204-18	38689-38698	decreased	_	
204-19	38699-38709	appetitive	_	
204-20	38710-38715	drive	_	
204-21	38716-38719	RSS	_	
204-22	38720-38728	observed	_	
204-23	38729-38731	in	_	
204-24	38732-38736	LTAA	_	
204-25	38736-38737	.	_	

#Text=Fig. 2 illustrates a pattern of higher alpha coherence in the LTAA vs.
205-1	38738-38741	Fig	_	
205-2	38741-38742	.	_	
205-3	38743-38744	2	_	
205-4	38745-38756	illustrates	_	
205-5	38757-38758	a	_	
205-6	38759-38766	pattern	_	
205-7	38767-38769	of	_	
205-8	38770-38776	higher	_	
205-9	38777-38782	alpha	_	
205-10	38783-38792	coherence	_	
205-11	38793-38795	in	_	
205-12	38796-38799	the	_	
205-13	38800-38804	LTAA	_	
205-14	38805-38807	vs	_	
205-15	38807-38808	.	_	

#Text=NSAC that is related to rs-fMRI NAcc seed connectivity.
206-1	38809-38813	NSAC	_	
206-2	38814-38818	that	_	
206-3	38819-38821	is	_	
206-4	38822-38829	related	_	
206-5	38830-38832	to	_	
206-6	38833-38840	rs-fMRI	_	
206-7	38841-38845	NAcc	_	
206-8	38846-38850	seed	_	
206-9	38851-38863	connectivity	_	
206-10	38863-38864	.	_	

#Text=We also observed lower theta coherence between midline (Cz, FCz, Fz, CPz) and mostly left ipsilateral electrodes (Fp1, PO5, PO7, CB1, O1, AF3, PO3, FC2, CP2, AF4) in LTAA vs.
207-1	38865-38867	We	_	
207-2	38868-38872	also	_	
207-3	38873-38881	observed	_	
207-4	38882-38887	lower	_	
207-5	38888-38893	theta	_	
207-6	38894-38903	coherence	_	
207-7	38904-38911	between	_	
207-8	38912-38919	midline	_	
207-9	38920-38921	(	_	
207-10	38921-38923	Cz	_	
207-11	38923-38924	,	_	
207-12	38925-38928	FCz	_	
207-13	38928-38929	,	_	
207-14	38930-38932	Fz	_	
207-15	38932-38933	,	_	
207-16	38934-38937	CPz	_	
207-17	38937-38938	)	_	
207-18	38939-38942	and	_	
207-19	38943-38949	mostly	_	
207-20	38950-38954	left	_	
207-21	38955-38966	ipsilateral	_	
207-22	38967-38977	electrodes	_	
207-23	38978-38979	(	_	
207-24	38979-38982	Fp1	_	
207-25	38982-38983	,	_	
207-26	38984-38987	PO5	_	
207-27	38987-38988	,	_	
207-28	38989-38992	PO7	_	
207-29	38992-38993	,	_	
207-30	38994-38997	CB1	_	
207-31	38997-38998	,	_	
207-32	38999-39001	O1	_	
207-33	39001-39002	,	_	
207-34	39003-39006	AF3	_	
207-35	39006-39007	,	_	
207-36	39008-39011	PO3	_	
207-37	39011-39012	,	_	
207-38	39013-39016	FC2	_	
207-39	39016-39017	,	_	
207-40	39018-39021	CP2	_	
207-41	39021-39022	,	_	
207-42	39023-39026	AF4	_	
207-43	39026-39027	)	_	
207-44	39028-39030	in	_	
207-45	39031-39035	LTAA	_	
207-46	39036-39038	vs	_	
207-47	39038-39039	.	_	

#Text=NSAC, and higher coherence between most electrodes with Fp2, F6, and T8 (see Fig. 2).
208-1	39040-39044	NSAC	_	
208-2	39044-39045	,	_	
208-3	39046-39049	and	_	
208-4	39050-39056	higher	_	
208-5	39057-39066	coherence	_	
208-6	39067-39074	between	_	
208-7	39075-39079	most	_	
208-8	39080-39090	electrodes	_	
208-9	39091-39095	with	_	
208-10	39096-39099	Fp2	_	
208-11	39099-39100	,	_	
208-12	39101-39103	F6	_	
208-13	39103-39104	,	_	
208-14	39105-39108	and	_	
208-15	39109-39111	T8	_	
208-16	39112-39113	(	_	
208-17	39113-39116	see	_	
208-18	39117-39120	Fig	_	
208-19	39120-39121	.	_	
208-20	39122-39123	2	_	
208-21	39123-39124	)	_	
208-22	39124-39125	.	_	

#Text=Although alpha was once attributed to an inactive or “idling” brain, more recently the presence of alpha has been attributed to the suppression of brain responses to distractors and absence of bottom up processing.
209-1	39126-39134	Although	_	
209-2	39135-39140	alpha	_	
209-3	39141-39144	was	_	
209-4	39145-39149	once	_	
209-5	39150-39160	attributed	_	
209-6	39161-39163	to	_	
209-7	39164-39166	an	_	
209-8	39167-39175	inactive	_	
209-9	39176-39178	or	_	
209-10	39179-39180	“	_	
209-11	39180-39186	idling	_	
209-12	39186-39187	”	_	
209-13	39188-39193	brain	_	
209-14	39193-39194	,	_	
209-15	39195-39199	more	_	
209-16	39200-39208	recently	_	
209-17	39209-39212	the	_	
209-18	39213-39221	presence	_	
209-19	39222-39224	of	_	
209-20	39225-39230	alpha	_	
209-21	39231-39234	has	_	
209-22	39235-39239	been	_	
209-23	39240-39250	attributed	_	
209-24	39251-39253	to	_	
209-25	39254-39257	the	_	
209-26	39258-39269	suppression	_	
209-27	39270-39272	of	_	
209-28	39273-39278	brain	_	
209-29	39279-39288	responses	_	
209-30	39289-39291	to	_	
209-31	39292-39303	distractors	_	
209-32	39304-39307	and	_	
209-33	39308-39315	absence	_	
209-34	39316-39318	of	_	
209-35	39319-39325	bottom	_	
209-36	39326-39328	up	_	
209-37	39329-39339	processing	_	
209-38	39339-39340	.	_	

#Text=Theta-modulated gamma oscillations have been recorded and have been proposed as a model for short-term memory.
210-1	39341-39356	Theta-modulated	_	
210-2	39357-39362	gamma	_	
210-3	39363-39375	oscillations	_	
210-4	39376-39380	have	_	
210-5	39381-39385	been	_	
210-6	39386-39394	recorded	_	
210-7	39395-39398	and	_	
210-8	39399-39403	have	_	
210-9	39404-39408	been	_	
210-10	39409-39417	proposed	_	
210-11	39418-39420	as	_	
210-12	39421-39422	a	_	
210-13	39423-39428	model	_	
210-14	39429-39432	for	_	
210-15	39433-39443	short-term	_	
210-16	39444-39450	memory	_	
210-17	39450-39451	.	_	

#Text=Moreover, theta coherence between frontal and posterior association regions has been shown to increase during the retention period of working memory tasks.
211-1	39452-39460	Moreover	_	
211-2	39460-39461	,	_	
211-3	39462-39467	theta	_	
211-4	39468-39477	coherence	_	
211-5	39478-39485	between	_	
211-6	39486-39493	frontal	_	
211-7	39494-39497	and	_	
211-8	39498-39507	posterior	_	
211-9	39508-39519	association	_	
211-10	39520-39527	regions	_	
211-11	39528-39531	has	_	
211-12	39532-39536	been	_	
211-13	39537-39542	shown	_	
211-14	39543-39545	to	_	
211-15	39546-39554	increase	_	
211-16	39555-39561	during	_	
211-17	39562-39565	the	_	
211-18	39566-39575	retention	_	
211-19	39576-39582	period	_	
211-20	39583-39585	of	_	
211-21	39586-39593	working	_	
211-22	39594-39600	memory	_	
211-23	39601-39606	tasks	_	
211-24	39606-39607	.	_	

#Text=Increasing theta coherence was also found during a mental imagery task.
212-1	39608-39618	Increasing	_	
212-2	39619-39624	theta	_	
212-3	39625-39634	coherence	_	
212-4	39635-39638	was	_	
212-5	39639-39643	also	_	
212-6	39644-39649	found	_	
212-7	39650-39656	during	_	
212-8	39657-39658	a	_	
212-9	39659-39665	mental	_	
212-10	39666-39673	imagery	_	
212-11	39674-39678	task	_	
212-12	39678-39679	.	_	

#Text=These alpha and theta coherence results from the literature suggest that alpha and theta coherence might be a characteristic feature of top-down processing.
213-1	39680-39685	These	_	
213-2	39686-39691	alpha	_	
213-3	39692-39695	and	_	
213-4	39696-39701	theta	_	
213-5	39702-39711	coherence	_	
213-6	39712-39719	results	_	
213-7	39720-39724	from	_	
213-8	39725-39728	the	_	
213-9	39729-39739	literature	_	
213-10	39740-39747	suggest	_	
213-11	39748-39752	that	_	
213-12	39753-39758	alpha	_	
213-13	39759-39762	and	_	
213-14	39763-39768	theta	_	
213-15	39769-39778	coherence	_	
213-16	39779-39784	might	_	
213-17	39785-39787	be	_	
213-18	39788-39789	a	_	
213-19	39790-39804	characteristic	_	
213-20	39805-39812	feature	_	
213-21	39813-39815	of	_	
213-22	39816-39824	top-down	_	
213-23	39825-39835	processing	_	
213-24	39835-39836	.	_	

#Text=If so, the observed increase in alpha and theta coherence we observe in LTAA may actively suppress the brain's response to alcohol cues, increasing inhibitory control and emotion regulation, and reducing appetitive drive.
214-1	39837-39839	If	_	
214-2	39840-39842	so	_	
214-3	39842-39843	,	_	
214-4	39844-39847	the	_	
214-5	39848-39856	observed	_	
214-6	39857-39865	increase	_	
214-7	39866-39868	in	_	
214-8	39869-39874	alpha	_	
214-9	39875-39878	and	_	
214-10	39879-39884	theta	_	
214-11	39885-39894	coherence	_	
214-12	39895-39897	we	_	
214-13	39898-39905	observe	_	
214-14	39906-39908	in	_	
214-15	39909-39913	LTAA	_	
214-16	39914-39917	may	_	
214-17	39918-39926	actively	_	
214-18	39927-39935	suppress	_	
214-19	39936-39939	the	_	
214-20	39940-39947	brain's	_	
214-21	39948-39956	response	_	
214-22	39957-39959	to	_	
214-23	39960-39967	alcohol	_	
214-24	39968-39972	cues	_	
214-25	39972-39973	,	_	
214-26	39974-39984	increasing	_	
214-27	39985-39995	inhibitory	_	
214-28	39996-40003	control	_	
214-29	40004-40007	and	_	
214-30	40008-40015	emotion	_	
214-31	40016-40026	regulation	_	
214-32	40026-40027	,	_	
214-33	40028-40031	and	_	
214-34	40032-40040	reducing	_	
214-35	40041-40051	appetitive	_	
214-36	40052-40057	drive	_	
214-37	40057-40058	.	_	

#Text=Our EEG results seem to show more pronounced coherence differences between NSAC and LTAA in the left hemisphere.
215-1	40059-40062	Our	_	
215-2	40063-40066	EEG	_	
215-3	40067-40074	results	_	
215-4	40075-40079	seem	_	
215-5	40080-40082	to	_	
215-6	40083-40087	show	_	
215-7	40088-40092	more	_	
215-8	40093-40103	pronounced	_	
215-9	40104-40113	coherence	_	
215-10	40114-40125	differences	_	
215-11	40126-40133	between	_	
215-12	40134-40138	NSAC	_	
215-13	40139-40142	and	_	
215-14	40143-40147	LTAA	_	
215-15	40148-40150	in	_	
215-16	40151-40154	the	_	
215-17	40155-40159	left	_	
215-18	40160-40170	hemisphere	_	
215-19	40170-40171	.	_	

#Text=The vast majority of participants were right handed (18/21 NSAC, 18/20 LTAA), so the laterality of difference cannot be explained by handedness.
216-1	40172-40175	The	_	
216-2	40176-40180	vast	_	
216-3	40181-40189	majority	_	
216-4	40190-40192	of	_	
216-5	40193-40205	participants	_	
216-6	40206-40210	were	_	
216-7	40211-40216	right	_	
216-8	40217-40223	handed	_	
216-9	40224-40225	(	_	
216-10	40225-40227	18	_	
216-11	40227-40228	/	_	
216-12	40228-40230	21	_	
216-13	40231-40235	NSAC	_	
216-14	40235-40236	,	_	
216-15	40237-40239	18	_	
216-16	40239-40240	/	_	
216-17	40240-40242	20	_	
216-18	40243-40247	LTAA	_	
216-19	40247-40248	)	_	
216-20	40248-40249	,	_	
216-21	40250-40252	so	_	
216-22	40253-40256	the	_	
216-23	40257-40267	laterality	_	
216-24	40268-40270	of	_	
216-25	40271-40281	difference	_	
216-26	40282-40288	cannot	_	
216-27	40289-40291	be	_	
216-28	40292-40301	explained	_	
216-29	40302-40304	by	_	
216-30	40305-40315	handedness	_	
216-31	40315-40316	.	_	

#Text=However, our original voxel-wise analysis using the same rs-fMRI images and NAcc seed-correlation maps as used in this paper revealed significantly higher strength of RSS in LTAA vs.
217-1	40317-40324	However	_	
217-2	40324-40325	,	_	
217-3	40326-40329	our	_	
217-4	40330-40338	original	_	
217-5	40339-40349	voxel-wise	_	
217-6	40350-40358	analysis	_	
217-7	40359-40364	using	_	
217-8	40365-40368	the	_	
217-9	40369-40373	same	_	
217-10	40374-40381	rs-fMRI	_	
217-11	40382-40388	images	_	
217-12	40389-40392	and	_	
217-13	40393-40397	NAcc	_	
217-14	40398-40414	seed-correlation	_	
217-15	40415-40419	maps	_	
217-16	40420-40422	as	_	
217-17	40423-40427	used	_	
217-18	40428-40430	in	_	
217-19	40431-40435	this	_	
217-20	40436-40441	paper	_	
217-21	40442-40450	revealed	_	
217-22	40451-40464	significantly	_	
217-23	40465-40471	higher	_	
217-24	40472-40480	strength	_	
217-25	40481-40483	of	_	
217-26	40484-40487	RSS	_	
217-27	40488-40490	in	_	
217-28	40491-40495	LTAA	_	
217-29	40496-40498	vs	_	
217-30	40498-40499	.	_	

#Text=NSAC between the NAcc and the left DLPFC only, and other recent work in actively drinking individuals showed lower synchrony (and therefore less ability to inhibit their alcohol consumption) in AUD vs. controls for the left but not right executive control network.
218-1	40500-40504	NSAC	_	
218-2	40505-40512	between	_	
218-3	40513-40516	the	_	
218-4	40517-40521	NAcc	_	
218-5	40522-40525	and	_	
218-6	40526-40529	the	_	
218-7	40530-40534	left	_	
218-8	40535-40540	DLPFC	_	
218-9	40541-40545	only	_	
218-10	40545-40546	,	_	
218-11	40547-40550	and	_	
218-12	40551-40556	other	_	
218-13	40557-40563	recent	_	
218-14	40564-40568	work	_	
218-15	40569-40571	in	_	
218-16	40572-40580	actively	_	
218-17	40581-40589	drinking	_	
218-18	40590-40601	individuals	_	
218-19	40602-40608	showed	_	
218-20	40609-40614	lower	_	
218-21	40615-40624	synchrony	_	
218-22	40625-40626	(	_	
218-23	40626-40629	and	_	
218-24	40630-40639	therefore	_	
218-25	40640-40644	less	_	
218-26	40645-40652	ability	_	
218-27	40653-40655	to	_	
218-28	40656-40663	inhibit	_	
218-29	40664-40669	their	_	
218-30	40670-40677	alcohol	_	
218-31	40678-40689	consumption	_	
218-32	40689-40690	)	_	
218-33	40691-40693	in	_	
218-34	40694-40697	AUD	_	
218-35	40698-40700	vs	_	
218-36	40700-40701	.	_	
218-37	40702-40710	controls	_	
218-38	40711-40714	for	_	
218-39	40715-40718	the	_	
218-40	40719-40723	left	_	
218-41	40724-40727	but	_	
218-42	40728-40731	not	_	
218-43	40732-40737	right	_	
218-44	40738-40747	executive	_	
218-45	40748-40755	control	_	
218-46	40756-40763	network	_	
218-47	40763-40764	.	_	

#Text=Our EEG coherence results appear to reflect the laterality of resting-state fMRI differences between alcoholics and controls reported in the literature.
219-1	40765-40768	Our	_	
219-2	40769-40772	EEG	_	
219-3	40773-40782	coherence	_	
219-4	40783-40790	results	_	
219-5	40791-40797	appear	_	
219-6	40798-40800	to	_	
219-7	40801-40808	reflect	_	
219-8	40809-40812	the	_	
219-9	40813-40823	laterality	_	
219-10	40824-40826	of	_	
219-11	40827-40840	resting-state	_	
219-12	40841-40845	fMRI	_	
219-13	40846-40857	differences	_	
219-14	40858-40865	between	_	
219-15	40866-40876	alcoholics	_	
219-16	40877-40880	and	_	
219-17	40881-40889	controls	_	
219-18	40890-40898	reported	_	
219-19	40899-40901	in	_	
219-20	40902-40905	the	_	
219-21	40906-40916	literature	_	
219-22	40916-40917	.	_	

#Text=Our psychological measures support the interpretation that our EEG coherence and NAcc seed-correlation ICA components reflect enhanced top-down processing that support the maintenance of abstinence.
220-1	40918-40921	Our	_	
220-2	40922-40935	psychological	_	
220-3	40936-40944	measures	_	
220-4	40945-40952	support	_	
220-5	40953-40956	the	_	
220-6	40957-40971	interpretation	_	
220-7	40972-40976	that	_	
220-8	40977-40980	our	_	
220-9	40981-40984	EEG	_	
220-10	40985-40994	coherence	_	
220-11	40995-40998	and	_	
220-12	40999-41003	NAcc	_	
220-13	41004-41020	seed-correlation	_	
220-14	41021-41024	ICA	_	
220-15	41025-41035	components	_	
220-16	41036-41043	reflect	_	
220-17	41044-41052	enhanced	_	
220-18	41053-41061	top-down	_	
220-19	41062-41072	processing	_	
220-20	41073-41077	that	_	
220-21	41078-41085	support	_	
220-22	41086-41089	the	_	
220-23	41090-41101	maintenance	_	
220-24	41102-41104	of	_	
220-25	41105-41115	abstinence	_	
220-26	41115-41116	.	_	

#Text=However, there were no significant correlations between the loading parameters of the ICA components with any drinking measure or psychological measure.
221-1	41117-41124	However	_	
221-2	41124-41125	,	_	
221-3	41126-41131	there	_	
221-4	41132-41136	were	_	
221-5	41137-41139	no	_	
221-6	41140-41151	significant	_	
221-7	41152-41164	correlations	_	
221-8	41165-41172	between	_	
221-9	41173-41176	the	_	
221-10	41177-41184	loading	_	
221-11	41185-41195	parameters	_	
221-12	41196-41198	of	_	
221-13	41199-41202	the	_	
221-14	41203-41206	ICA	_	
221-15	41207-41217	components	_	
221-16	41218-41222	with	_	
221-17	41223-41226	any	_	
221-18	41227-41235	drinking	_	
221-19	41236-41243	measure	_	
221-20	41244-41246	or	_	
221-21	41247-41260	psychological	_	
221-22	41261-41268	measure	_	
221-23	41268-41269	.	_	

#Text=All our measurements were cross-sectional, and it is perhaps not surprising that synchrony within networks after a long period of abstinence is not correlated with lifetime measures of alcohol use or behavior.
222-1	41270-41273	All	_	
222-2	41274-41277	our	_	
222-3	41278-41290	measurements	_	
222-4	41291-41295	were	_	
222-5	41296-41311	cross-sectional	_	
222-6	41311-41312	,	_	
222-7	41313-41316	and	_	
222-8	41317-41319	it	_	
222-9	41320-41322	is	_	
222-10	41323-41330	perhaps	_	
222-11	41331-41334	not	_	
222-12	41335-41345	surprising	_	
222-13	41346-41350	that	_	
222-14	41351-41360	synchrony	_	
222-15	41361-41367	within	_	
222-16	41368-41376	networks	_	
222-17	41377-41382	after	_	
222-18	41383-41384	a	_	
222-19	41385-41389	long	_	
222-20	41390-41396	period	_	
222-21	41397-41399	of	_	
222-22	41400-41410	abstinence	_	
222-23	41411-41413	is	_	
222-24	41414-41417	not	_	
222-25	41418-41428	correlated	_	
222-26	41429-41433	with	_	
222-27	41434-41442	lifetime	_	
222-28	41443-41451	measures	_	
222-29	41452-41454	of	_	
222-30	41455-41462	alcohol	_	
222-31	41463-41466	use	_	
222-32	41467-41469	or	_	
222-33	41470-41478	behavior	_	
222-34	41478-41479	.	_	

#Text=A longitudinal study from very early abstinence through extended abstinence, where changes in network synchrony, psychological symptoms, and neuropsychological tests reflecting appetitive drive and executive function, might reveal a tighter connection between network synchrony and behavior.
223-1	41480-41481	A	_	
223-2	41482-41494	longitudinal	_	
223-3	41495-41500	study	_	
223-4	41501-41505	from	_	
223-5	41506-41510	very	_	
223-6	41511-41516	early	_	
223-7	41517-41527	abstinence	_	
223-8	41528-41535	through	_	
223-9	41536-41544	extended	_	
223-10	41545-41555	abstinence	_	
223-11	41555-41556	,	_	
223-12	41557-41562	where	_	
223-13	41563-41570	changes	_	
223-14	41571-41573	in	_	
223-15	41574-41581	network	_	
223-16	41582-41591	synchrony	_	
223-17	41591-41592	,	_	
223-18	41593-41606	psychological	_	
223-19	41607-41615	symptoms	_	
223-20	41615-41616	,	_	
223-21	41617-41620	and	_	
223-22	41621-41639	neuropsychological	_	
223-23	41640-41645	tests	_	
223-24	41646-41656	reflecting	_	
223-25	41657-41667	appetitive	_	
223-26	41668-41673	drive	_	
223-27	41674-41677	and	_	
223-28	41678-41687	executive	_	
223-29	41688-41696	function	_	
223-30	41696-41697	,	_	
223-31	41698-41703	might	_	
223-32	41704-41710	reveal	_	
223-33	41711-41712	a	_	
223-34	41713-41720	tighter	_	
223-35	41721-41731	connection	_	
223-36	41732-41739	between	_	
223-37	41740-41747	network	_	
223-38	41748-41757	synchrony	_	
223-39	41758-41761	and	_	
223-40	41762-41770	behavior	_	
223-41	41770-41771	.	_	

#Text=In this study, we used parallel ICA to complete a multivariate, multimodal analysis of rs-fMRI and EEG.
224-1	41772-41774	In	_	
224-2	41775-41779	this	_	
224-3	41780-41785	study	_	
224-4	41785-41786	,	_	
224-5	41787-41789	we	_	
224-6	41790-41794	used	_	
224-7	41795-41803	parallel	_	
224-8	41804-41807	ICA	_	
224-9	41808-41810	to	_	
224-10	41811-41819	complete	_	
224-11	41820-41821	a	_	
224-12	41822-41834	multivariate	_	
224-13	41834-41835	,	_	
224-14	41836-41846	multimodal	_	
224-15	41847-41855	analysis	_	
224-16	41856-41858	of	_	
224-17	41859-41866	rs-fMRI	_	
224-18	41867-41870	and	_	
224-19	41871-41874	EEG	_	
224-20	41874-41875	.	_	

#Text=Multimodal analysis of fMRI and EEG is an active area of research, with different approaches targeted toward the goals of each study.
225-1	41876-41886	Multimodal	_	
225-2	41887-41895	analysis	_	
225-3	41896-41898	of	_	
225-4	41899-41903	fMRI	_	
225-5	41904-41907	and	_	
225-6	41908-41911	EEG	_	
225-7	41912-41914	is	_	
225-8	41915-41917	an	_	
225-9	41918-41924	active	_	
225-10	41925-41929	area	_	
225-11	41930-41932	of	_	
225-12	41933-41941	research	_	
225-13	41941-41942	,	_	
225-14	41943-41947	with	_	
225-15	41948-41957	different	_	
225-16	41958-41968	approaches	_	
225-17	41969-41977	targeted	_	
225-18	41978-41984	toward	_	
225-19	41985-41988	the	_	
225-20	41989-41994	goals	_	
225-21	41995-41997	of	_	
225-22	41998-42002	each	_	
225-23	42003-42008	study	_	
225-24	42008-42009	.	_	

#Text=A recently published paper investigated frequency-specific ECoG (electrocorticography) correlates of resting state fMRI networks in epileptic patients, using a technique that mapped the fMRI signal onto the ECoG electrode locations, filtered the timeseries to compute band-limited power, computed correlations between all electrode pairs (separately for ECoG and mapped fMRI signals), then compared the resulting correlation maps between modalities.
226-1	42010-42011	A	_	
226-2	42012-42020	recently	_	
226-3	42021-42030	published	_	
226-4	42031-42036	paper	_	
226-5	42037-42049	investigated	_	
226-6	42050-42068	frequency-specific	_	
226-7	42069-42073	ECoG	_	
226-8	42074-42075	(	_	
226-9	42075-42095	electrocorticography	_	
226-10	42095-42096	)	_	
226-11	42097-42107	correlates	_	
226-12	42108-42110	of	_	
226-13	42111-42118	resting	_	
226-14	42119-42124	state	_	
226-15	42125-42129	fMRI	_	
226-16	42130-42138	networks	_	
226-17	42139-42141	in	_	
226-18	42142-42151	epileptic	_	
226-19	42152-42160	patients	_	
226-20	42160-42161	,	_	
226-21	42162-42167	using	_	
226-22	42168-42169	a	_	
226-23	42170-42179	technique	_	
226-24	42180-42184	that	_	
226-25	42185-42191	mapped	_	
226-26	42192-42195	the	_	
226-27	42196-42200	fMRI	_	
226-28	42201-42207	signal	_	
226-29	42208-42212	onto	_	
226-30	42213-42216	the	_	
226-31	42217-42221	ECoG	_	
226-32	42222-42231	electrode	_	
226-33	42232-42241	locations	_	
226-34	42241-42242	,	_	
226-35	42243-42251	filtered	_	
226-36	42252-42255	the	_	
226-37	42256-42266	timeseries	_	
226-38	42267-42269	to	_	
226-39	42270-42277	compute	_	
226-40	42278-42290	band-limited	_	
226-41	42291-42296	power	_	
226-42	42296-42297	,	_	
226-43	42298-42306	computed	_	
226-44	42307-42319	correlations	_	
226-45	42320-42327	between	_	
226-46	42328-42331	all	_	
226-47	42332-42341	electrode	_	
226-48	42342-42347	pairs	_	
226-49	42348-42349	(	_	
226-50	42349-42359	separately	_	
226-51	42360-42363	for	_	
226-52	42364-42368	ECoG	_	
226-53	42369-42372	and	_	
226-54	42373-42379	mapped	_	
226-55	42380-42384	fMRI	_	
226-56	42385-42392	signals	_	
226-57	42392-42393	)	_	
226-58	42393-42394	,	_	
226-59	42395-42399	then	_	
226-60	42400-42408	compared	_	
226-61	42409-42412	the	_	
226-62	42413-42422	resulting	_	
226-63	42423-42434	correlation	_	
226-64	42435-42439	maps	_	
226-65	42440-42447	between	_	
226-66	42448-42458	modalities	_	
226-67	42458-42459	.	_	

#Text=They found that theta band-limited power corresponded more strongly to fMRI in the default mode network and fronto-parietal control system, while alpha band-limited power corresponded more strongly to fMRI in the sensorimotor and dorsal attention network.
227-1	42460-42464	They	_	
227-2	42465-42470	found	_	
227-3	42471-42475	that	_	
227-4	42476-42481	theta	_	
227-5	42482-42494	band-limited	_	
227-6	42495-42500	power	_	
227-7	42501-42513	corresponded	_	
227-8	42514-42518	more	_	
227-9	42519-42527	strongly	_	
227-10	42528-42530	to	_	
227-11	42531-42535	fMRI	_	
227-12	42536-42538	in	_	
227-13	42539-42542	the	_	
227-14	42543-42550	default	_	
227-15	42551-42555	mode	_	
227-16	42556-42563	network	_	
227-17	42564-42567	and	_	
227-18	42568-42583	fronto-parietal	_	
227-19	42584-42591	control	_	
227-20	42592-42598	system	_	
227-21	42598-42599	,	_	
227-22	42600-42605	while	_	
227-23	42606-42611	alpha	_	
227-24	42612-42624	band-limited	_	
227-25	42625-42630	power	_	
227-26	42631-42643	corresponded	_	
227-27	42644-42648	more	_	
227-28	42649-42657	strongly	_	
227-29	42658-42660	to	_	
227-30	42661-42665	fMRI	_	
227-31	42666-42668	in	_	
227-32	42669-42672	the	_	
227-33	42673-42685	sensorimotor	_	
227-34	42686-42689	and	_	
227-35	42690-42696	dorsal	_	
227-36	42697-42706	attention	_	
227-37	42707-42714	network	_	
227-38	42714-42715	.	_	

#Text=Another recent paper examined simultaneously recorded EEG-fMRI and preprocessed EEG using either a microstate analysis or spontaneous power analysis to create normalized frequency-specific timecourses for convolution with the BOLD timeseries for use as regressors in a general linear model with fMRI data.
228-1	42716-42723	Another	_	
228-2	42724-42730	recent	_	
228-3	42731-42736	paper	_	
228-4	42737-42745	examined	_	
228-5	42746-42760	simultaneously	_	
228-6	42761-42769	recorded	_	
228-7	42770-42778	EEG-fMRI	_	
228-8	42779-42782	and	_	
228-9	42783-42795	preprocessed	_	
228-10	42796-42799	EEG	_	
228-11	42800-42805	using	_	
228-12	42806-42812	either	_	
228-13	42813-42814	a	_	
228-14	42815-42825	microstate	_	
228-15	42826-42834	analysis	_	
228-16	42835-42837	or	_	
228-17	42838-42849	spontaneous	_	
228-18	42850-42855	power	_	
228-19	42856-42864	analysis	_	
228-20	42865-42867	to	_	
228-21	42868-42874	create	_	
228-22	42875-42885	normalized	_	
228-23	42886-42904	frequency-specific	_	
228-24	42905-42916	timecourses	_	
228-25	42917-42920	for	_	
228-26	42921-42932	convolution	_	
228-27	42933-42937	with	_	
228-28	42938-42941	the	_	
228-29	42942-42946	BOLD	_	
228-30	42947-42957	timeseries	_	
228-31	42958-42961	for	_	
228-32	42962-42965	use	_	
228-33	42966-42968	as	_	
228-34	42969-42979	regressors	_	
228-35	42980-42982	in	_	
228-36	42983-42984	a	_	
228-37	42985-42992	general	_	
228-38	42993-42999	linear	_	
228-39	43000-43005	model	_	
228-40	43006-43010	with	_	
228-41	43011-43015	fMRI	_	
228-42	43016-43020	data	_	
228-43	43020-43021	.	_	

#Text=A third approach that was recently used utilizes a sliding window of simultaneous EEG-fMRI data to examine whether temporal variations in coupling are associated with the amplitude of alpha and theta oscillations.
229-1	43022-43023	A	_	
229-2	43024-43029	third	_	
229-3	43030-43038	approach	_	
229-4	43039-43043	that	_	
229-5	43044-43047	was	_	
229-6	43048-43056	recently	_	
229-7	43057-43061	used	_	
229-8	43062-43070	utilizes	_	
229-9	43071-43072	a	_	
229-10	43073-43080	sliding	_	
229-11	43081-43087	window	_	
229-12	43088-43090	of	_	
229-13	43091-43103	simultaneous	_	
229-14	43104-43112	EEG-fMRI	_	
229-15	43113-43117	data	_	
229-16	43118-43120	to	_	
229-17	43121-43128	examine	_	
229-18	43129-43136	whether	_	
229-19	43137-43145	temporal	_	
229-20	43146-43156	variations	_	
229-21	43157-43159	in	_	
229-22	43160-43168	coupling	_	
229-23	43169-43172	are	_	
229-24	43173-43183	associated	_	
229-25	43184-43188	with	_	
229-26	43189-43192	the	_	
229-27	43193-43202	amplitude	_	
229-28	43203-43205	of	_	
229-29	43206-43211	alpha	_	
229-30	43212-43215	and	_	
229-31	43216-43221	theta	_	
229-32	43222-43234	oscillations	_	
229-33	43234-43235	.	_	

#Text=These three approaches all directly compare the timeseries of EEG to fMRI and try to account for differing temporal and spatial resolutions of the two modalities.
230-1	43236-43241	These	_	
230-2	43242-43247	three	_	
230-3	43248-43258	approaches	_	
230-4	43259-43262	all	_	
230-5	43263-43271	directly	_	
230-6	43272-43279	compare	_	
230-7	43280-43283	the	_	
230-8	43284-43294	timeseries	_	
230-9	43295-43297	of	_	
230-10	43298-43301	EEG	_	
230-11	43302-43304	to	_	
230-12	43305-43309	fMRI	_	
230-13	43310-43313	and	_	
230-14	43314-43317	try	_	
230-15	43318-43320	to	_	
230-16	43321-43328	account	_	
230-17	43329-43332	for	_	
230-18	43333-43342	differing	_	
230-19	43343-43351	temporal	_	
230-20	43352-43355	and	_	
230-21	43356-43363	spatial	_	
230-22	43364-43375	resolutions	_	
230-23	43376-43378	of	_	
230-24	43379-43382	the	_	
230-25	43383-43386	two	_	
230-26	43387-43397	modalities	_	
230-27	43397-43398	.	_	

#Text=Since we did not record the EEG and fMRI simultaneously, we did not compare timeseries or adjust for different spatial resolutions in our analysis, but instead used parallel ICA to look for features in derived maps (either seed-correlation or coherence) that covaried across subjects.
231-1	43399-43404	Since	_	
231-2	43405-43407	we	_	
231-3	43408-43411	did	_	
231-4	43412-43415	not	_	
231-5	43416-43422	record	_	
231-6	43423-43426	the	_	
231-7	43427-43430	EEG	_	
231-8	43431-43434	and	_	
231-9	43435-43439	fMRI	_	
231-10	43440-43454	simultaneously	_	
231-11	43454-43455	,	_	
231-12	43456-43458	we	_	
231-13	43459-43462	did	_	
231-14	43463-43466	not	_	
231-15	43467-43474	compare	_	
231-16	43475-43485	timeseries	_	
231-17	43486-43488	or	_	
231-18	43489-43495	adjust	_	
231-19	43496-43499	for	_	
231-20	43500-43509	different	_	
231-21	43510-43517	spatial	_	
231-22	43518-43529	resolutions	_	
231-23	43530-43532	in	_	
231-24	43533-43536	our	_	
231-25	43537-43545	analysis	_	
231-26	43545-43546	,	_	
231-27	43547-43550	but	_	
231-28	43551-43558	instead	_	
231-29	43559-43563	used	_	
231-30	43564-43572	parallel	_	
231-31	43573-43576	ICA	_	
231-32	43577-43579	to	_	
231-33	43580-43584	look	_	
231-34	43585-43588	for	_	
231-35	43589-43597	features	_	
231-36	43598-43600	in	_	
231-37	43601-43608	derived	_	
231-38	43609-43613	maps	_	
231-39	43614-43615	(	_	
231-40	43615-43621	either	_	
231-41	43622-43638	seed-correlation	_	
231-42	43639-43641	or	_	
231-43	43642-43651	coherence	_	
231-44	43651-43652	)	_	
231-45	43653-43657	that	_	
231-46	43658-43666	covaried	_	
231-47	43667-43673	across	_	
231-48	43674-43682	subjects	_	
231-49	43682-43683	.	_	

#Text=Although our results are encouraging, our analysis is limited.
232-1	43684-43692	Although	_	
232-2	43693-43696	our	_	
232-3	43697-43704	results	_	
232-4	43705-43708	are	_	
232-5	43709-43720	encouraging	_	
232-6	43720-43721	,	_	
232-7	43722-43725	our	_	
232-8	43726-43734	analysis	_	
232-9	43735-43737	is	_	
232-10	43738-43745	limited	_	
232-11	43745-43746	.	_	

#Text=We only analyzed 20 LTAA and 21 NSAC, and our confidence would increase if our results were replicated in a larger sample or independent sample.
233-1	43747-43749	We	_	
233-2	43750-43754	only	_	
233-3	43755-43763	analyzed	_	
233-4	43764-43766	20	_	
233-5	43767-43771	LTAA	_	
233-6	43772-43775	and	_	
233-7	43776-43778	21	_	
233-8	43779-43783	NSAC	_	
233-9	43783-43784	,	_	
233-10	43785-43788	and	_	
233-11	43789-43792	our	_	
233-12	43793-43803	confidence	_	
233-13	43804-43809	would	_	
233-14	43810-43818	increase	_	
233-15	43819-43821	if	_	
233-16	43822-43825	our	_	
233-17	43826-43833	results	_	
233-18	43834-43838	were	_	
233-19	43839-43849	replicated	_	
233-20	43850-43852	in	_	
233-21	43853-43854	a	_	
233-22	43855-43861	larger	_	
233-23	43862-43868	sample	_	
233-24	43869-43871	or	_	
233-25	43872-43883	independent	_	
233-26	43884-43890	sample	_	
233-27	43890-43891	.	_	

#Text=Also, in this initial attempt to find EEG correlates of rs-fMRI networks, we only examined the magnitude-squared coherence.
234-1	43892-43896	Also	_	
234-2	43896-43897	,	_	
234-3	43898-43900	in	_	
234-4	43901-43905	this	_	
234-5	43906-43913	initial	_	
234-6	43914-43921	attempt	_	
234-7	43922-43924	to	_	
234-8	43925-43929	find	_	
234-9	43930-43933	EEG	_	
234-10	43934-43944	correlates	_	
234-11	43945-43947	of	_	
234-12	43948-43955	rs-fMRI	_	
234-13	43956-43964	networks	_	
234-14	43964-43965	,	_	
234-15	43966-43968	we	_	
234-16	43969-43973	only	_	
234-17	43974-43982	examined	_	
234-18	43983-43986	the	_	
234-19	43987-44004	magnitude-squared	_	
234-20	44005-44014	coherence	_	
234-21	44014-44015	.	_	

#Text=It is possible that the phase-angle component of coherence carries important information, and future work should consider both amplitude and phase.
235-1	44016-44018	It	_	
235-2	44019-44021	is	_	
235-3	44022-44030	possible	_	
235-4	44031-44035	that	_	
235-5	44036-44039	the	_	
235-6	44040-44051	phase-angle	_	
235-7	44052-44061	component	_	
235-8	44062-44064	of	_	
235-9	44065-44074	coherence	_	
235-10	44075-44082	carries	_	
235-11	44083-44092	important	_	
235-12	44093-44104	information	_	
235-13	44104-44105	,	_	
235-14	44106-44109	and	_	
235-15	44110-44116	future	_	
235-16	44117-44121	work	_	
235-17	44122-44128	should	_	
235-18	44129-44137	consider	_	
235-19	44138-44142	both	_	
235-20	44143-44152	amplitude	_	
235-21	44153-44156	and	_	
235-22	44157-44162	phase	_	
235-23	44162-44163	.	_	

#Text=It is worth pointing out that our resting EEG was acquired with eyes open, in order to minimize the influence of the alpha rhythm that dominates at parietal electrodes during the eyes closed condition, while the rs-fMRI was acquired with eyes closed.
236-1	44164-44166	It	_	
236-2	44167-44169	is	_	
236-3	44170-44175	worth	_	
236-4	44176-44184	pointing	_	
236-5	44185-44188	out	_	
236-6	44189-44193	that	_	
236-7	44194-44197	our	_	
236-8	44198-44205	resting	_	
236-9	44206-44209	EEG	_	
236-10	44210-44213	was	_	
236-11	44214-44222	acquired	_	
236-12	44223-44227	with	_	
236-13	44228-44232	eyes	_	
236-14	44233-44237	open	_	
236-15	44237-44238	,	_	
236-16	44239-44241	in	_	
236-17	44242-44247	order	_	
236-18	44248-44250	to	_	
236-19	44251-44259	minimize	_	
236-20	44260-44263	the	_	
236-21	44264-44273	influence	_	
236-22	44274-44276	of	_	
236-23	44277-44280	the	_	
236-24	44281-44286	alpha	_	
236-25	44287-44293	rhythm	_	
236-26	44294-44298	that	_	
236-27	44299-44308	dominates	_	
236-28	44309-44311	at	_	
236-29	44312-44320	parietal	_	
236-30	44321-44331	electrodes	_	
236-31	44332-44338	during	_	
236-32	44339-44342	the	_	
236-33	44343-44347	eyes	_	
236-34	44348-44354	closed	_	
236-35	44355-44364	condition	_	
236-36	44364-44365	,	_	
236-37	44366-44371	while	_	
236-38	44372-44375	the	_	
236-39	44376-44383	rs-fMRI	_	
236-40	44384-44387	was	_	
236-41	44388-44396	acquired	_	
236-42	44397-44401	with	_	
236-43	44402-44406	eyes	_	
236-44	44407-44413	closed	_	
236-45	44413-44414	.	_	

#Text=It is unclear whether this acquisition difference affected our results.
237-1	44415-44417	It	_	
237-2	44418-44420	is	_	
237-3	44421-44428	unclear	_	
237-4	44429-44436	whether	_	
237-5	44437-44441	this	_	
237-6	44442-44453	acquisition	_	
237-7	44454-44464	difference	_	
237-8	44465-44473	affected	_	
237-9	44474-44477	our	_	
237-10	44478-44485	results	_	
237-11	44485-44486	.	_	

#Text=Another limitation is that our rs-fMRI scans are only about 4 min long, while recent work suggests that much longer scans (on the order of 8–12 min) are required for stability and reproducibility of network measurements.
238-1	44487-44494	Another	_	
238-2	44495-44505	limitation	_	
238-3	44506-44508	is	_	
238-4	44509-44513	that	_	
238-5	44514-44517	our	_	
238-6	44518-44525	rs-fMRI	_	
238-7	44526-44531	scans	_	
238-8	44532-44535	are	_	
238-9	44536-44540	only	_	
238-10	44541-44546	about	_	
238-11	44547-44548	4	_	
238-12	44548-44549	 	_	
238-13	44549-44552	min	_	
238-14	44553-44557	long	_	
238-15	44557-44558	,	_	
238-16	44559-44564	while	_	
238-17	44565-44571	recent	_	
238-18	44572-44576	work	_	
238-19	44577-44585	suggests	_	
238-20	44586-44590	that	_	
238-21	44591-44595	much	_	
238-22	44596-44602	longer	_	
238-23	44603-44608	scans	_	
238-24	44609-44610	(	_	
238-25	44610-44612	on	_	
238-26	44613-44616	the	_	
238-27	44617-44622	order	_	
238-28	44623-44625	of	_	
238-29	44626-44627	8	_	
238-30	44627-44628	–	_	
238-31	44628-44630	12	_	
238-32	44630-44631	 	_	
238-33	44631-44634	min	_	
238-34	44634-44635	)	_	
238-35	44636-44639	are	_	
238-36	44640-44648	required	_	
238-37	44649-44652	for	_	
238-38	44653-44662	stability	_	
238-39	44663-44666	and	_	
238-40	44667-44682	reproducibility	_	
238-41	44683-44685	of	_	
238-42	44686-44693	network	_	
238-43	44694-44706	measurements	_	
238-44	44706-44707	.	_	

#Text=These two limitations (eyes closed vs. eyes open and length of EEG and fMRI acquisition) underscore that our major limitation is that the fMRI and EEG were not obtained simultaneously.
239-1	44708-44713	These	_	
239-2	44714-44717	two	_	
239-3	44718-44729	limitations	_	
239-4	44730-44731	(	_	
239-5	44731-44735	eyes	_	
239-6	44736-44742	closed	_	
239-7	44743-44745	vs	_	
239-8	44745-44746	.	_	
239-9	44747-44751	eyes	_	
239-10	44752-44756	open	_	
239-11	44757-44760	and	_	
239-12	44761-44767	length	_	
239-13	44768-44770	of	_	
239-14	44771-44774	EEG	_	
239-15	44775-44778	and	_	
239-16	44779-44783	fMRI	_	
239-17	44784-44795	acquisition	_	
239-18	44795-44796	)	_	
239-19	44797-44807	underscore	_	
239-20	44808-44812	that	_	
239-21	44813-44816	our	_	
239-22	44817-44822	major	_	
239-23	44823-44833	limitation	_	
239-24	44834-44836	is	_	
239-25	44837-44841	that	_	
239-26	44842-44845	the	_	
239-27	44846-44850	fMRI	_	
239-28	44851-44854	and	_	
239-29	44855-44858	EEG	_	
239-30	44859-44863	were	_	
239-31	44864-44867	not	_	
239-32	44868-44876	obtained	_	
239-33	44877-44891	simultaneously	_	
239-34	44891-44892	.	_	

#Text=Ideally, we would use simultaneous recording of EEG and rs-fMRI to identify EEG indices that vary on a moment-to-moment basis in conjunction with rs-fMRI.
240-1	44893-44900	Ideally	_	
240-2	44900-44901	,	_	
240-3	44902-44904	we	_	
240-4	44905-44910	would	_	
240-5	44911-44914	use	_	
240-6	44915-44927	simultaneous	_	
240-7	44928-44937	recording	_	
240-8	44938-44940	of	_	
240-9	44941-44944	EEG	_	
240-10	44945-44948	and	_	
240-11	44949-44956	rs-fMRI	_	
240-12	44957-44959	to	_	
240-13	44960-44968	identify	_	
240-14	44969-44972	EEG	_	
240-15	44973-44980	indices	_	
240-16	44981-44985	that	_	
240-17	44986-44990	vary	_	
240-18	44991-44993	on	_	
240-19	44994-44995	a	_	
240-20	44996-45012	moment-to-moment	_	
240-21	45013-45018	basis	_	
240-22	45019-45021	in	_	
240-23	45022-45033	conjunction	_	
240-24	45034-45038	with	_	
240-25	45039-45046	rs-fMRI	_	
240-26	45046-45047	.	_	

#Text=Despite these limitations, our results offer the hope that EEG analogues of rs-fMRI networks can be identified, and in the future may be used in a relatively low-cost neurofeedback approach for treatment of alcoholics.
241-1	45048-45055	Despite	_	
241-2	45056-45061	these	_	
241-3	45062-45073	limitations	_	
241-4	45073-45074	,	_	
241-5	45075-45078	our	_	
241-6	45079-45086	results	_	
241-7	45087-45092	offer	_	
241-8	45093-45096	the	_	
241-9	45097-45101	hope	_	
241-10	45102-45106	that	_	
241-11	45107-45110	EEG	_	
241-12	45111-45120	analogues	_	
241-13	45121-45123	of	_	
241-14	45124-45131	rs-fMRI	_	
241-15	45132-45140	networks	_	
241-16	45141-45144	can	_	
241-17	45145-45147	be	_	
241-18	45148-45158	identified	_	
241-19	45158-45159	,	_	
241-20	45160-45163	and	_	
241-21	45164-45166	in	_	
241-22	45167-45170	the	_	
241-23	45171-45177	future	_	
241-24	45178-45181	may	_	
241-25	45182-45184	be	_	
241-26	45185-45189	used	_	
241-27	45190-45192	in	_	
241-28	45193-45194	a	_	
241-29	45195-45205	relatively	_	
241-30	45206-45214	low-cost	_	
241-31	45215-45228	neurofeedback	_	
241-32	45229-45237	approach	_	
241-33	45238-45241	for	_	
241-34	45242-45251	treatment	_	
241-35	45252-45254	of	_	
241-36	45255-45265	alcoholics	_	
241-37	45265-45266	.	_	

#Text=References
#Text=
#Text=Dissociable brain signatures of choice conflict and immediate reward preferences in alcohol use disorders
#Text=Computerized administration of the Diagnostic Interview Schedule
#Text=Towards a unified understanding of event-related changes in the EEG: the firefly model of synchronization through cross-frequency phase modulation
#Text=A feature-based approach to combine functional MRI, structural MRI and EEG brain imaging data
#Text=
#Text=Resting-state synchrony in long-term abstinent alcoholics
#Text=Resting-state synchrony in short-term versus long-term abstinent alcoholics
#Text=High gamma power is phase-locked to theta oscillations in human neocortex
#Text=Characterization of functional brain activity and connectivity using EEG and fMRI in patients with sickle cell disease
#Text=EEG correlates of time-varying BOLD functional connectivity
#Text=Frequency of gamma oscillations routes flow of information in the hippocampus
#Text=Low-resolution electromagnetic tomography neurofeedback
#Text=Risky decision-making: an FMRI study of youth at high risk for alcoholism
#Text=Increased frontocerebellar activation in alcoholics during verbal working memory: an fMRI study
#Text=From local inhibition to long-range integration: a functional dissociation of alpha-band synchronization across cortical scales in visuospatial attention
#Text=Rhythms of consciousness: binocular rivalry reveals large-scale oscillatory network dynamics mediating visual perception
#Text=
#Text=Antisocial symptoms decrease to normal levels in long-term abstinence
#Text=Theory, development, and interpretation of the CPI socialization scale
#Text=Stimulus-specific neuronal oscillations in orientation columns of cat visual cortex
#Text=Frequency-specific electrophysiologic correlates of resting state fMRI networks
#Text=Self-control in decision-making involves modulation of the vmPFC valuation system
#Text=
#Text=Differentiating heavy from light drinkers by neural responses to visual alcohol cues and other motivational stimuli
#Text=Cross-frequency coupling between neuronal oscillations
#Text=Visual inspection of independent components: defining a procedure for artifact removal from fMRI data
#Text=Automated Talairach atlas labels for functional brain mapping
#Text=Altered impulse control in alcohol dependence: neural measures of stop signal performance
#Text=Storage of 7 +/− 2 short-term memories in oscillatory subcycles
#Text=Alcohol affects the brain's resting-state network in social drinkers
#Text=Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA
#Text=Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia
#Text=Synapses with inhibitory neurons differentiate anterior cingulate from dorsolateral prefrontal pathways associated with cognitive control
#Text=Differential brain activity in alcoholics and social drinkers to alcohol cues: relationship to craving
#Text=Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people
#Text=The insula and drug addiction: an interoceptive view of pleasure, urges, and decision-making
#Text=Genetic sources of subcomponents of event-related potential in the dimension of psychosis analyzed from the B-SNIP study
#Text=Neural activation during inhibition predicts initiation of substance use in adolescence
#Text=Standardized low resolution brain electromagnetic tomography (sLORETA): technical details
#Text=
#Text=The possible meaning of the upper and lower alpha frequency ranges for cognitive and creative tasks
#Text=Reorganization of frontal systems used by alcoholics for spatial working memory: an fMRI study
#Text=
#Text=
#Text=Synchronization between prefrontal and posterior association cortex during human working memory
#Text=Alcohol dependence syndrome: measurement and validation
#Text=Reliability of alcohol use indices.
242-1	45267-45277	References	_	
242-2	45279-45290	Dissociable	_	
242-3	45291-45296	brain	_	
242-4	45297-45307	signatures	_	
242-5	45308-45310	of	_	
242-6	45311-45317	choice	_	
242-7	45318-45326	conflict	_	
242-8	45327-45330	and	_	
242-9	45331-45340	immediate	_	
242-10	45341-45347	reward	_	
242-11	45348-45359	preferences	_	
242-12	45360-45362	in	_	
242-13	45363-45370	alcohol	_	
242-14	45371-45374	use	_	
242-15	45375-45384	disorders	_	
242-16	45385-45397	Computerized	_	
242-17	45398-45412	administration	_	
242-18	45413-45415	of	_	
242-19	45416-45419	the	_	
242-20	45420-45430	Diagnostic	_	
242-21	45431-45440	Interview	_	
242-22	45441-45449	Schedule	_	
242-23	45450-45457	Towards	_	
242-24	45458-45459	a	_	
242-25	45460-45467	unified	_	
242-26	45468-45481	understanding	_	
242-27	45482-45484	of	_	
242-28	45485-45498	event-related	_	
242-29	45499-45506	changes	_	
242-30	45507-45509	in	_	
242-31	45510-45513	the	_	
242-32	45514-45517	EEG	_	
242-33	45517-45518	:	_	
242-34	45519-45522	the	_	
242-35	45523-45530	firefly	_	
242-36	45531-45536	model	_	
242-37	45537-45539	of	_	
242-38	45540-45555	synchronization	_	
242-39	45556-45563	through	_	
242-40	45564-45579	cross-frequency	_	
242-41	45580-45585	phase	_	
242-42	45586-45596	modulation	_	
242-43	45597-45598	A	_	
242-44	45599-45612	feature-based	_	
242-45	45613-45621	approach	_	
242-46	45622-45624	to	_	
242-47	45625-45632	combine	_	
242-48	45633-45643	functional	_	
242-49	45644-45647	MRI	_	
242-50	45647-45648	,	_	
242-51	45649-45659	structural	_	
242-52	45660-45663	MRI	_	
242-53	45664-45667	and	_	
242-54	45668-45671	EEG	_	
242-55	45672-45677	brain	_	
242-56	45678-45685	imaging	_	
242-57	45686-45690	data	_	
242-58	45692-45705	Resting-state	_	
242-59	45706-45715	synchrony	_	
242-60	45716-45718	in	_	
242-61	45719-45728	long-term	_	
242-62	45729-45738	abstinent	_	
242-63	45739-45749	alcoholics	_	
242-64	45750-45763	Resting-state	_	
242-65	45764-45773	synchrony	_	
242-66	45774-45776	in	_	
242-67	45777-45787	short-term	_	
242-68	45788-45794	versus	_	
242-69	45795-45804	long-term	_	
242-70	45805-45814	abstinent	_	
242-71	45815-45825	alcoholics	_	
242-72	45826-45830	High	_	
242-73	45831-45836	gamma	_	
242-74	45837-45842	power	_	
242-75	45843-45845	is	_	
242-76	45846-45858	phase-locked	_	
242-77	45859-45861	to	_	
242-78	45862-45867	theta	_	
242-79	45868-45880	oscillations	_	
242-80	45881-45883	in	_	
242-81	45884-45889	human	_	
242-82	45890-45899	neocortex	_	
242-83	45900-45916	Characterization	_	
242-84	45917-45919	of	_	
242-85	45920-45930	functional	_	
242-86	45931-45936	brain	_	
242-87	45937-45945	activity	_	
242-88	45946-45949	and	_	
242-89	45950-45962	connectivity	_	
242-90	45963-45968	using	_	
242-91	45969-45972	EEG	_	
242-92	45973-45976	and	_	
242-93	45977-45981	fMRI	_	
242-94	45982-45984	in	_	
242-95	45985-45993	patients	_	
242-96	45994-45998	with	_	
242-97	45999-46005	sickle	_	
242-98	46006-46010	cell	_	
242-99	46011-46018	disease	_	
242-100	46019-46022	EEG	_	
242-101	46023-46033	correlates	_	
242-102	46034-46036	of	_	
242-103	46037-46049	time-varying	_	
242-104	46050-46054	BOLD	_	
242-105	46055-46065	functional	_	
242-106	46066-46078	connectivity	_	
242-107	46079-46088	Frequency	_	
242-108	46089-46091	of	_	
242-109	46092-46097	gamma	_	
242-110	46098-46110	oscillations	_	
242-111	46111-46117	routes	_	
242-112	46118-46122	flow	_	
242-113	46123-46125	of	_	
242-114	46126-46137	information	_	
242-115	46138-46140	in	_	
242-116	46141-46144	the	_	
242-117	46145-46156	hippocampus	_	
242-118	46157-46171	Low-resolution	_	
242-119	46172-46187	electromagnetic	_	
242-120	46188-46198	tomography	_	
242-121	46199-46212	neurofeedback	_	
242-122	46213-46218	Risky	_	
242-123	46219-46234	decision-making	_	
242-124	46234-46235	:	_	
242-125	46236-46238	an	_	
242-126	46239-46243	FMRI	_	
242-127	46244-46249	study	_	
242-128	46250-46252	of	_	
242-129	46253-46258	youth	_	
242-130	46259-46261	at	_	
242-131	46262-46266	high	_	
242-132	46267-46271	risk	_	
242-133	46272-46275	for	_	
242-134	46276-46286	alcoholism	_	
242-135	46287-46296	Increased	_	
242-136	46297-46313	frontocerebellar	_	
242-137	46314-46324	activation	_	
242-138	46325-46327	in	_	
242-139	46328-46338	alcoholics	_	
242-140	46339-46345	during	_	
242-141	46346-46352	verbal	_	
242-142	46353-46360	working	_	
242-143	46361-46367	memory	_	
242-144	46367-46368	:	_	
242-145	46369-46371	an	_	
242-146	46372-46376	fMRI	_	
242-147	46377-46382	study	_	
242-148	46383-46387	From	_	
242-149	46388-46393	local	_	
242-150	46394-46404	inhibition	_	
242-151	46405-46407	to	_	
242-152	46408-46418	long-range	_	
242-153	46419-46430	integration	_	
242-154	46430-46431	:	_	
242-155	46432-46433	a	_	
242-156	46434-46444	functional	_	
242-157	46445-46457	dissociation	_	
242-158	46458-46460	of	_	
242-159	46461-46471	alpha-band	_	
242-160	46472-46487	synchronization	_	
242-161	46488-46494	across	_	
242-162	46495-46503	cortical	_	
242-163	46504-46510	scales	_	
242-164	46511-46513	in	_	
242-165	46514-46526	visuospatial	_	
242-166	46527-46536	attention	_	
242-167	46537-46544	Rhythms	_	
242-168	46545-46547	of	_	
242-169	46548-46561	consciousness	_	
242-170	46561-46562	:	_	
242-171	46563-46572	binocular	_	
242-172	46573-46580	rivalry	_	
242-173	46581-46588	reveals	_	
242-174	46589-46600	large-scale	_	
242-175	46601-46612	oscillatory	_	
242-176	46613-46620	network	_	
242-177	46621-46629	dynamics	_	
242-178	46630-46639	mediating	_	
242-179	46640-46646	visual	_	
242-180	46647-46657	perception	_	
242-181	46659-46669	Antisocial	_	
242-182	46670-46678	symptoms	_	
242-183	46679-46687	decrease	_	
242-184	46688-46690	to	_	
242-185	46691-46697	normal	_	
242-186	46698-46704	levels	_	
242-187	46705-46707	in	_	
242-188	46708-46717	long-term	_	
242-189	46718-46728	abstinence	_	
242-190	46729-46735	Theory	_	
242-191	46735-46736	,	_	
242-192	46737-46748	development	_	
242-193	46748-46749	,	_	
242-194	46750-46753	and	_	
242-195	46754-46768	interpretation	_	
242-196	46769-46771	of	_	
242-197	46772-46775	the	_	
242-198	46776-46779	CPI	_	
242-199	46780-46793	socialization	_	
242-200	46794-46799	scale	_	
242-201	46800-46817	Stimulus-specific	_	
242-202	46818-46826	neuronal	_	
242-203	46827-46839	oscillations	_	
242-204	46840-46842	in	_	
242-205	46843-46854	orientation	_	
242-206	46855-46862	columns	_	
242-207	46863-46865	of	_	
242-208	46866-46869	cat	_	
242-209	46870-46876	visual	_	
242-210	46877-46883	cortex	_	
242-211	46884-46902	Frequency-specific	_	
242-212	46903-46921	electrophysiologic	_	
242-213	46922-46932	correlates	_	
242-214	46933-46935	of	_	
242-215	46936-46943	resting	_	
242-216	46944-46949	state	_	
242-217	46950-46954	fMRI	_	
242-218	46955-46963	networks	_	
242-219	46964-46976	Self-control	_	
242-220	46977-46979	in	_	
242-221	46980-46995	decision-making	_	
242-222	46996-47004	involves	_	
242-223	47005-47015	modulation	_	
242-224	47016-47018	of	_	
242-225	47019-47022	the	_	
242-226	47023-47028	vmPFC	_	
242-227	47029-47038	valuation	_	
242-228	47039-47045	system	_	
242-229	47047-47062	Differentiating	_	
242-230	47063-47068	heavy	_	
242-231	47069-47073	from	_	
242-232	47074-47079	light	_	
242-233	47080-47088	drinkers	_	
242-234	47089-47091	by	_	
242-235	47092-47098	neural	_	
242-236	47099-47108	responses	_	
242-237	47109-47111	to	_	
242-238	47112-47118	visual	_	
242-239	47119-47126	alcohol	_	
242-240	47127-47131	cues	_	
242-241	47132-47135	and	_	
242-242	47136-47141	other	_	
242-243	47142-47154	motivational	_	
242-244	47155-47162	stimuli	_	
242-245	47163-47178	Cross-frequency	_	
242-246	47179-47187	coupling	_	
242-247	47188-47195	between	_	
242-248	47196-47204	neuronal	_	
242-249	47205-47217	oscillations	_	
242-250	47218-47224	Visual	_	
242-251	47225-47235	inspection	_	
242-252	47236-47238	of	_	
242-253	47239-47250	independent	_	
242-254	47251-47261	components	_	
242-255	47261-47262	:	_	
242-256	47263-47271	defining	_	
242-257	47272-47273	a	_	
242-258	47274-47283	procedure	_	
242-259	47284-47287	for	_	
242-260	47288-47296	artifact	_	
242-261	47297-47304	removal	_	
242-262	47305-47309	from	_	
242-263	47310-47314	fMRI	_	
242-264	47315-47319	data	_	
242-265	47320-47329	Automated	_	
242-266	47330-47339	Talairach	_	
242-267	47340-47345	atlas	_	
242-268	47346-47352	labels	_	
242-269	47353-47356	for	_	
242-270	47357-47367	functional	_	
242-271	47368-47373	brain	_	
242-272	47374-47381	mapping	_	
242-273	47382-47389	Altered	_	
242-274	47390-47397	impulse	_	
242-275	47398-47405	control	_	
242-276	47406-47408	in	_	
242-277	47409-47416	alcohol	_	
242-278	47417-47427	dependence	_	
242-279	47427-47428	:	_	
242-280	47429-47435	neural	_	
242-281	47436-47444	measures	_	
242-282	47445-47447	of	_	
242-283	47448-47452	stop	_	
242-284	47453-47459	signal	_	
242-285	47460-47471	performance	_	
242-286	47472-47479	Storage	_	
242-287	47480-47482	of	_	
242-288	47483-47484	7	_	
242-289	47485-47486	+	_	
242-290	47486-47487	/	_	
242-291	47487-47488	−	_	
242-292	47488-47489	 	_	
242-293	47489-47490	2	_	
242-294	47491-47501	short-term	_	
242-295	47502-47510	memories	_	
242-296	47511-47513	in	_	
242-297	47514-47525	oscillatory	_	
242-298	47526-47535	subcycles	_	
242-299	47536-47543	Alcohol	_	
242-300	47544-47551	affects	_	
242-301	47552-47555	the	_	
242-302	47556-47563	brain's	_	
242-303	47564-47577	resting-state	_	
242-304	47578-47585	network	_	
242-305	47586-47588	in	_	
242-306	47589-47595	social	_	
242-307	47596-47604	drinkers	_	
242-308	47605-47614	Combining	_	
242-309	47615-47619	fMRI	_	
242-310	47620-47623	and	_	
242-311	47624-47627	SNP	_	
242-312	47628-47632	data	_	
242-313	47633-47635	to	_	
242-314	47636-47647	investigate	_	
242-315	47648-47659	connections	_	
242-316	47660-47667	between	_	
242-317	47668-47673	brain	_	
242-318	47674-47682	function	_	
242-319	47683-47686	and	_	
242-320	47687-47695	genetics	_	
242-321	47696-47701	using	_	
242-322	47702-47710	parallel	_	
242-323	47711-47714	ICA	_	
242-324	47715-47727	Multivariate	_	
242-325	47728-47736	analysis	_	
242-326	47737-47744	reveals	_	
242-327	47745-47752	genetic	_	
242-328	47753-47765	associations	_	
242-329	47766-47768	of	_	
242-330	47769-47772	the	_	
242-331	47773-47780	resting	_	
242-332	47781-47788	default	_	
242-333	47789-47793	mode	_	
242-334	47794-47801	network	_	
242-335	47802-47804	in	_	
242-336	47805-47814	psychotic	_	
242-337	47815-47822	bipolar	_	
242-338	47823-47831	disorder	_	
242-339	47832-47835	and	_	
242-340	47836-47849	schizophrenia	_	
242-341	47850-47858	Synapses	_	
242-342	47859-47863	with	_	
242-343	47864-47874	inhibitory	_	
242-344	47875-47882	neurons	_	
242-345	47883-47896	differentiate	_	
242-346	47897-47905	anterior	_	
242-347	47906-47915	cingulate	_	
242-348	47916-47920	from	_	
242-349	47921-47933	dorsolateral	_	
242-350	47934-47944	prefrontal	_	
242-351	47945-47953	pathways	_	
242-352	47954-47964	associated	_	
242-353	47965-47969	with	_	
242-354	47970-47979	cognitive	_	
242-355	47980-47987	control	_	
242-356	47988-48000	Differential	_	
242-357	48001-48006	brain	_	
242-358	48007-48015	activity	_	
242-359	48016-48018	in	_	
242-360	48019-48029	alcoholics	_	
242-361	48030-48033	and	_	
242-362	48034-48040	social	_	
242-363	48041-48049	drinkers	_	
242-364	48050-48052	to	_	
242-365	48053-48060	alcohol	_	
242-366	48061-48065	cues	_	
242-367	48065-48066	:	_	
242-368	48067-48079	relationship	_	
242-369	48080-48082	to	_	
242-370	48083-48090	craving	_	
242-371	48091-48097	Effect	_	
242-372	48098-48100	of	_	
242-373	48101-48111	naltrexone	_	
242-374	48112-48115	and	_	
242-375	48116-48127	ondansetron	_	
242-376	48128-48130	on	_	
242-377	48131-48138	alcohol	_	
242-378	48139-48150	cue-induced	_	
242-379	48151-48161	activation	_	
242-380	48162-48164	of	_	
242-381	48165-48168	the	_	
242-382	48169-48176	ventral	_	
242-383	48177-48185	striatum	_	
242-384	48186-48188	in	_	
242-385	48189-48206	alcohol-dependent	_	
242-386	48207-48213	people	_	
242-387	48214-48217	The	_	
242-388	48218-48224	insula	_	
242-389	48225-48228	and	_	
242-390	48229-48233	drug	_	
242-391	48234-48243	addiction	_	
242-392	48243-48244	:	_	
242-393	48245-48247	an	_	
242-394	48248-48261	interoceptive	_	
242-395	48262-48266	view	_	
242-396	48267-48269	of	_	
242-397	48270-48278	pleasure	_	
242-398	48278-48279	,	_	
242-399	48280-48285	urges	_	
242-400	48285-48286	,	_	
242-401	48287-48290	and	_	
242-402	48291-48306	decision-making	_	
242-403	48307-48314	Genetic	_	
242-404	48315-48322	sources	_	
242-405	48323-48325	of	_	
242-406	48326-48339	subcomponents	_	
242-407	48340-48342	of	_	
242-408	48343-48356	event-related	_	
242-409	48357-48366	potential	_	
242-410	48367-48369	in	_	
242-411	48370-48373	the	_	
242-412	48374-48383	dimension	_	
242-413	48384-48386	of	_	
242-414	48387-48396	psychosis	_	
242-415	48397-48405	analyzed	_	
242-416	48406-48410	from	_	
242-417	48411-48414	the	_	
242-418	48415-48421	B-SNIP	_	
242-419	48422-48427	study	_	
242-420	48428-48434	Neural	_	
242-421	48435-48445	activation	_	
242-422	48446-48452	during	_	
242-423	48453-48463	inhibition	_	
242-424	48464-48472	predicts	_	
242-425	48473-48483	initiation	_	
242-426	48484-48486	of	_	
242-427	48487-48496	substance	_	
242-428	48497-48500	use	_	
242-429	48501-48503	in	_	
242-430	48504-48515	adolescence	_	
242-431	48516-48528	Standardized	_	
242-432	48529-48532	low	_	
242-433	48533-48543	resolution	_	
242-434	48544-48549	brain	_	
242-435	48550-48565	electromagnetic	_	
242-436	48566-48576	tomography	_	
242-437	48577-48578	(	_	
242-438	48578-48585	sLORETA	_	
242-439	48585-48586	)	_	
242-440	48586-48587	:	_	
242-441	48588-48597	technical	_	
242-442	48598-48605	details	_	
242-443	48607-48610	The	_	
242-444	48611-48619	possible	_	
242-445	48620-48627	meaning	_	
242-446	48628-48630	of	_	
242-447	48631-48634	the	_	
242-448	48635-48640	upper	_	
242-449	48641-48644	and	_	
242-450	48645-48650	lower	_	
242-451	48651-48656	alpha	_	
242-452	48657-48666	frequency	_	
242-453	48667-48673	ranges	_	
242-454	48674-48677	for	_	
242-455	48678-48687	cognitive	_	
242-456	48688-48691	and	_	
242-457	48692-48700	creative	_	
242-458	48701-48706	tasks	_	
242-459	48707-48721	Reorganization	_	
242-460	48722-48724	of	_	
242-461	48725-48732	frontal	_	
242-462	48733-48740	systems	_	
242-463	48741-48745	used	_	
242-464	48746-48748	by	_	
242-465	48749-48759	alcoholics	_	
242-466	48760-48763	for	_	
242-467	48764-48771	spatial	_	
242-468	48772-48779	working	_	
242-469	48780-48786	memory	_	
242-470	48786-48787	:	_	
242-471	48788-48790	an	_	
242-472	48791-48795	fMRI	_	
242-473	48796-48801	study	_	
242-474	48804-48819	Synchronization	_	
242-475	48820-48827	between	_	
242-476	48828-48838	prefrontal	_	
242-477	48839-48842	and	_	
242-478	48843-48852	posterior	_	
242-479	48853-48864	association	_	
242-480	48865-48871	cortex	_	
242-481	48872-48878	during	_	
242-482	48879-48884	human	_	
242-483	48885-48892	working	_	
242-484	48893-48899	memory	_	
242-485	48900-48907	Alcohol	_	
242-486	48908-48918	dependence	_	
242-487	48919-48927	syndrome	_	
242-488	48927-48928	:	_	
242-489	48929-48940	measurement	_	
242-490	48941-48944	and	_	
242-491	48945-48955	validation	_	
242-492	48956-48967	Reliability	_	
242-493	48968-48970	of	_	
242-494	48971-48978	alcohol	_	
242-495	48979-48982	use	_	
242-496	48983-48990	indices	_	
242-497	48990-48991	.	_	

#Text=The lifetime drinking history and the MAST
#Text=Advances in functional and structural MR image analysis and implementation as FSL
#Text=
#Text=The reliability of alcohol abusers' self-reports of drinking and life events that occurred in the distant past.
243-1	48992-48995	The	_	
243-2	48996-49004	lifetime	_	
243-3	49005-49013	drinking	_	
243-4	49014-49021	history	_	
243-5	49022-49025	and	_	
243-6	49026-49029	the	_	
243-7	49030-49034	MAST	_	
243-8	49035-49043	Advances	_	
243-9	49044-49046	in	_	
243-10	49047-49057	functional	_	
243-11	49058-49061	and	_	
243-12	49062-49072	structural	_	
243-13	49073-49075	MR	_	
243-14	49076-49081	image	_	
243-15	49082-49090	analysis	_	
243-16	49091-49094	and	_	
243-17	49095-49109	implementation	_	
243-18	49110-49112	as	_	
243-19	49113-49116	FSL	_	
243-20	49118-49121	The	_	
243-21	49122-49133	reliability	_	
243-22	49134-49136	of	_	
243-23	49137-49144	alcohol	_	
243-24	49145-49152	abusers	_	
243-25	49152-49153	'	_	
243-26	49154-49166	self-reports	_	
243-27	49167-49169	of	_	
243-28	49170-49178	drinking	_	
243-29	49179-49182	and	_	
243-30	49183-49187	life	_	
243-31	49188-49194	events	_	
243-32	49195-49199	that	_	
243-33	49200-49208	occurred	_	
243-34	49209-49211	in	_	
243-35	49212-49215	the	_	
243-36	49216-49223	distant	_	
243-37	49224-49228	past	_	
243-38	49228-49229	.	_	

#Text=Studies of
#Text=EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research
#Text=Different frequencies for different scales of cortical integration: from local gamma to long range alpha/theta synchronization
#Text=
#Text=Synchronous neural oscillations and cognitive processes
#Text=Reduced left executive control network functional connectivity is associated with alcohol use disorders
#Text=Patterns of cortical oscillations organize neural activity into whole-brain functional networks evident in the fMRI BOLD signal
#Text=Abnormal affective decision making revealed in adolescent binge drinkers using functional magnetic imaging study
#Text=Supplementary data
#Text=Supplementary data to this article can be found online at https://doi.org/10.1016/j.nicl.2017.11.008.
244-1	49230-49237	Studies	_	
244-2	49238-49240	of	_	
244-3	49241-49244	EEG	_	
244-4	49245-49256	biofeedback	_	
244-5	49257-49259	as	_	
244-6	49260-49261	a	_	
244-7	49262-49271	treatment	_	
244-8	49272-49275	for	_	
244-9	49276-49285	substance	_	
244-10	49286-49289	use	_	
244-11	49290-49299	disorders	_	
244-12	49299-49300	:	_	
244-13	49301-49307	review	_	
244-14	49307-49308	,	_	
244-15	49309-49315	rating	_	
244-16	49316-49318	of	_	
244-17	49319-49327	efficacy	_	
244-18	49327-49328	,	_	
244-19	49329-49332	and	_	
244-20	49333-49348	recommendations	_	
244-21	49349-49352	for	_	
244-22	49353-49360	further	_	
244-23	49361-49369	research	_	
244-24	49370-49379	Different	_	
244-25	49380-49391	frequencies	_	
244-26	49392-49395	for	_	
244-27	49396-49405	different	_	
244-28	49406-49412	scales	_	
244-29	49413-49415	of	_	
244-30	49416-49424	cortical	_	
244-31	49425-49436	integration	_	
244-32	49436-49437	:	_	
244-33	49438-49442	from	_	
244-34	49443-49448	local	_	
244-35	49449-49454	gamma	_	
244-36	49455-49457	to	_	
244-37	49458-49462	long	_	
244-38	49463-49468	range	_	
244-39	49469-49474	alpha	_	
244-40	49474-49475	/	_	
244-41	49475-49480	theta	_	
244-42	49481-49496	synchronization	_	
244-43	49498-49509	Synchronous	_	
244-44	49510-49516	neural	_	
244-45	49517-49529	oscillations	_	
244-46	49530-49533	and	_	
244-47	49534-49543	cognitive	_	
244-48	49544-49553	processes	_	
244-49	49554-49561	Reduced	_	
244-50	49562-49566	left	_	
244-51	49567-49576	executive	_	
244-52	49577-49584	control	_	
244-53	49585-49592	network	_	
244-54	49593-49603	functional	_	
244-55	49604-49616	connectivity	_	
244-56	49617-49619	is	_	
244-57	49620-49630	associated	_	
244-58	49631-49635	with	_	
244-59	49636-49643	alcohol	_	
244-60	49644-49647	use	_	
244-61	49648-49657	disorders	_	
244-62	49658-49666	Patterns	_	
244-63	49667-49669	of	_	
244-64	49670-49678	cortical	_	
244-65	49679-49691	oscillations	_	
244-66	49692-49700	organize	_	
244-67	49701-49707	neural	_	
244-68	49708-49716	activity	_	
244-69	49717-49721	into	_	
244-70	49722-49733	whole-brain	_	
244-71	49734-49744	functional	_	
244-72	49745-49753	networks	_	
244-73	49754-49761	evident	_	
244-74	49762-49764	in	_	
244-75	49765-49768	the	_	
244-76	49769-49773	fMRI	_	
244-77	49774-49778	BOLD	_	
244-78	49779-49785	signal	_	
244-79	49786-49794	Abnormal	_	
244-80	49795-49804	affective	_	
244-81	49805-49813	decision	_	
244-82	49814-49820	making	_	
244-83	49821-49829	revealed	_	
244-84	49830-49832	in	_	
244-85	49833-49843	adolescent	_	
244-86	49844-49849	binge	_	
244-87	49850-49858	drinkers	_	
244-88	49859-49864	using	_	
244-89	49865-49875	functional	_	
244-90	49876-49884	magnetic	_	
244-91	49885-49892	imaging	_	
244-92	49893-49898	study	_	
244-93	49899-49912	Supplementary	_	
244-94	49913-49917	data	_	
244-95	49918-49931	Supplementary	_	
244-96	49932-49936	data	_	
244-97	49937-49939	to	_	
244-98	49940-49944	this	_	
244-99	49945-49952	article	_	
244-100	49953-49956	can	_	
244-101	49957-49959	be	_	
244-102	49960-49965	found	_	
244-103	49966-49972	online	_	
244-104	49973-49975	at	_	
244-105	49976-49981	https	_	
244-106	49981-49982	:	_	
244-107	49982-49983	/	_	
244-108	49983-49984	/	_	
244-109	49984-49991	doi.org	_	
244-110	49991-49992	/	_	
244-111	49992-49999	10.1016	_	
244-112	49999-50000	/	_	
244-113	50000-50006	j.nicl	_	
244-114	50006-50018	.2017.11.008	_	
244-115	50018-50019	.	_	
